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Nitrate, (NOR3RP-P) is an oxidized form of nitrogen and it is an integral part of the 
nitrogen cycle in the natural environment. Nitrates are extensively used in agricultural 
practices as fertilizers, applied as either animal manures or derived slurries or as chemical 
fertilizers in the form of ammonium nitrate. Most of the toxicologically relevant nitrate 
enters the human body through consumption of vegetables, fruits, processed food 
products, and drinking water. In the ground water system, nitrates are a problematic and 
widespread contaminant, especially in agricultural areas such as the Midwest, South, and 
Northeastern U.S. Low-levels of nitrate exposure in drinking water below the EPA level 
of 10 ppm are not currently considered acutely lethal to humans, but long-term exposure 
has been increasingly called into question due to concerns about some forms of cancer 
risk. Nitrate itself is relatively non-toxic, but it transforms to different metabolites once it 
enters the human body such as nitrite, nitric oxide (NO), and nitrosamine. These 
metabolites are more harmful to human health than nitrate and cause various kinds of 
acute human illness such as acute methemoglobinemia (in infants), low blood pressure, 
increased heart rate, headache, abdominal cramps, vomiting, and, possible chronic 
disease concerns such as cancer of the digestive tract, thyroid, and ovary.  
Another chronic disease concern that may be impacted by nitrite/nitrate exposure 
is Osteoarthritis (OA). OA, the subject of this study, is the most common type of arthritis 
that wears down the articular cartilage between bones and thus weakens the whole joint. 
NO production is considered as a mediator for proinflammatory cytokine production that 
elevates that pain among OA patients. Nitrate and nitrite are responsible for the 
 
 
production of NO endogenously. Therefore, this study is important to explore various 
concentrations of nitrite exposure and its impact on people having OA and lymphocyte 
response, stress, and DNA damage.  
This in-vitro case control study explores whether different levels of nitrite 
exposure in human mononuclear cells (lymphocytes) has an impact on their proliferation, 
NO stress activity, and DNA damage. This will increase understanding of the impacts of 
nitrite/nitrate exposure on human lymphocytes and clarify innate, immunotoxicological 
impacts at various low doses of nitrite concentration. A total of 32 participants took part 
in the study, 16 were cases and 16 were controls. Cases were chosen on the criteria of a 
medically diagnosed OA in any joint, and the controls were participants without OA. 
Standard cell culture techniques were used to gather lymphocytes from whole blood, 
culture and expose those lymphocytes to increasing concentrations of sodium nitrite (0, 1, 
5, 10, 15 ppm) and challenge the exposed cells (via mitogen) to monitor lymphocyte 
proliferation, NO activity, and DNA damage via immunoassay and flow cytometry. 
Additionally, a brief questionnaire about demographics, health history, smoking status, 
and herbs/supplement, medications was completed by each participant to explore any 
relationships between the self-report factors and lymphocyte proliferation, NO activity 
and DNA damage at various nitrite concentrations. 
 Findings indicated that increasing nitrite concentrations suppressed lymphocyte 
proliferation among all participants (p<0.05). Among case and control participants, the 
study found increased lymphocyte proliferation, following mitogen stimulation, among 
the participants not having OA compared to having OA at the exposure levels of 5 ppm. 
 
 
Overall there was no increased NO stress activity observed among the cells challenged 
with various nitrite concentrations. The DNA damage test showed some interesting 
results indicating light DNA damage occurred when exposed to 5ppm or more nitrite 
concentration (p<0.05) for pooled cases and controls. Additionally, questionnaire data 
indicated some associations between lymphocyte proliferation, NO activity, and DNA 
Damage under the circumstances stressful life events, multiple prescription drugs, recent 
immunization and a diagnosis of fibromyalgia. 
Keywords: Nitrate, Nitrite, Nitric oxide, Lymphocyte Proliferation, NO activity, DNA 
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Nitrate is a natural form of nitrogen and it is an integral part of the nitrogen cycle 
in natural environments (Santamaria, 2006). Nitrates are generally considered as water 
pollutants which occurs due to its extensive use in agricultural practices taking such 
forms as fertilizers and manures from animals (Lundberg, Weitzberg & Benjamin, 
2004). The proportion of nitrogen load in the environment, from various sources such as 
fertilizers, manure, atmospheric deposition, sewage, and industrial sources varies 
depending on locality. For example, the fertilizer sources of nitrogen are proportionally 
greater in agricultural areas namely the west and the Midwest than other parts of the 
nation. Similarly, animal manure contributes mainly in the South and part of the 
Northeast as a major source of nitrogen deposition (Puckett, 1994). Nevertheless, 
throughout the U.S. nitrates in groundwater are a problematic and widespread 
contaminant (Canter, 1997) that occurs due to natural and anthropogenic sources.  About 
90% of the rural population in the United States uses ground water drawn from private 
wells, which are not regulated by the Environmental Protection Agency (EPA) under the 
Safe Drinking Water Act (Ward, 2008). Increased nitrate concentrations in the ground 
water of Iowa are mainly due to various agricultural practices such as nitrogen fertilizers 
and intensive animal farming (Weyer et al., 2001).   
Additionally, nitrates are used in various commercial applications such as in the 




considered acutely lethal to humans but long-term exposure to nitrate could cause gastric 
cancer (Lundberg et al., 2004; WHO, 2011). Research indicates that there is a close 
relationship between increasing nitrate concentration in drinking water and colon cancer 
(Chui, Tsai, Wu & Tang, 2010; McElory et al., 2008). The research also found that 
people drinking water below 10 ppm had osteoarthritis complaints, poorer health, lower 
recreational activity, muscle, and nerve pain (Zeman et al., 2011) but, further research is 
needed before causality can be confirmed beyond reasonable doubt.  
Osteoarthritis (OA) is the most common type of arthritis, or inflammatory joint 
disease that wears down the articulating cartilage between bones, weakening the whole 
joint. According to CDC, 52.5 million adults have arthritis and about 294,000 U.S. kids 
under age 18 have arthritis or other rheumatic conditions (American Public Health 
Association, 2016). Osteoarthritis is not generally considered as a systemic 
inflammatory disease, but associated with mild to moderate localized inflammatory 
changes in OA synovium (membranes associated with articulating joints). Nitric Oxide 
(NO) production may influence OA through both cartilage and bone metabolism (Lane 
et al., 2003). The pro-inflammatory cytokines such as IL-1, TNF and several other 
cytokines including IL-6, IL-15, IL-17, IL-18, IL-21, and IL-8 have also been detected 
in OA synovial fluid and shown in OA implication (Grabowski et al., 1997; Kapoor, 
Pelletier, Lajeunesse, Pelletier & Fahmi, 2011). The study also finds overproduction of 
pro-inflammatory mediators such as NO, IL-1, (TNF)-α and prostaglandins on 
chondrocytes (a unique cell type found in cartilage connective tissues that is essential for 




(Abramson, 2008; Lin, Willers, Xu & Zheng, 2006; Pelletier, Pelletier & Abramson, 
2001).  A study done by 31TErsoy et al.31T (2002) found that serum nitrate and nitrite levels 
were high in patients with OA as compared to the control group. In addition, older 
women using nitrates as medications (for angina) were found to have increased risk of 
developing new radiographic findings in hip of OA indicating that nitrates increased NO 
production in the articular cartilage, potentially leading to greater catabolism of the 




Nitrate itself is relatively non-toxic but transforms to different metabolites 
(nitrite, NO, nitrosamine) after ingestion that, depending on concentration, age, and 
genetics, can be harmful to human health. About 80% of nitrate in the human body 
enters through consuming vegetables, fruits, and processed food products (Hord, Tang & 
Bryan, 2009). Once ingested, nitrate circulates in plasma and distributes to the tissues. It 
has a half-life of approximately five hours (Lundberg, Larsen & Weitzberg, 2011). 
Dietary nitrate and nitrite are useful for cardiovascular health via several mechanisms 
following reduction to nitric oxide such as vascular relaxation, inhibition of platelet 
aggregation and improvement of endothelial functions (Machha & Schechter, 2001). 
The World Health Organization, WHO suggests that the No Observed Adverse Effect 
Level (NOEL) of nitrate ion for humans is 370 mg per kg of body weight. In addition, 




body weight (Joint FAO/WHO Expert Committee on Food Additives, 2002). Therefore 
there is reason for concern about nitrate content in the daily human diet, especially 
vegetables and excess nitrates/nitrites in drinking water (Shao-ting, Tong-Song & Xian-
Yong, 2007). 
Dietary nitrate metabolizes into nitrite through a symbiotic process by nitrate 
reducing bacteria in the human gut which then increases serum levels of nitrite and, 
ultimately, salivary nitrite concentration on the posterior surface of the tongue. The 
converted nitrite in the gastrointestinal tract, under acidic conditions, forms nitrous acid 
which is a potent nitrating/nitrosating agent (Santamaria, 2006; Hord et al., 2009). Since 
mammals lack specific nitrate reductase enzymes, the commensal bacteria in the 
gastrointestinal tract initially reduce nitrates to nitrites. Formed nitrites, through various 
biochemical pathways further reduce into nitric oxide (NO) through biochemical 
interactions with hemoglobin, myoglobin, ascorbate, and associated protons. The NO 
and NO-modified proteins formed from nitrite reduction, contribute to hypoxic signaling 
and create cellular responses to this ischemic stress. In excess this is problematic; on the 
other hand, it has been found that NO formed from nitrites in saliva is important for 
defending against pathogens that enter via the oral route (Lundberg, Weizberg, & 
Gladwin, 2008).  
There are two main health issues associated with nitrates; acute 
methemoglobinemia also called blue baby syndrome and cancers of the digestive tract 
due to chronic nitrosamine exposure (Powlson et al., 2007).  High-level nitrite 




blood has decreased ability to carry oxygen to tissues causing low blood pressure, 
increased heart rate, headaches, abdominal cramps, and vomiting (Gehle, 2013).  
As mentioned earlier, nitrate (NO3-) individually has remarkably low toxicity, 
but its conversion to nitrite (NO2-) and then to N-nitrosamines creates the carcinogenic 
effect. The carcinogenic properties of N-nitroso compounds such as nitrosamines and 
nitrosamides are well established in cell culture and animal experiments but the 
association of nitrate and its by-products is not as strongly associated epidemiologically 
to human gastric cancers and there are vocal advocates on both side of the issue 
(Lundberg et al., 2004). 
There have been exposure assessments completed on nitrate sources in the 
environment and the consequent exposure level in humans, particularly in regard to 
calculations of acceptable daily intake (ADI) and reference dose (RfD). Various acute 
and chronic health impacts of excess nitrate for human health are explored, but limited 
work is done on the immunotoxicological impacts of nitrate exposure to the first-line 
immunity (lymphocytes). There has been limited information on lymphocyte 
proliferation, DNA damage, and immune response. Thus, this study will help further 
knowledge of any effects of nitrate/nitrite on human immunity. 
 
USignificance of the Study 
This study will find the impact of nitrite exposure on lymphocyte proliferation in 
human blood and immunological response using the following nitrite concentrations (0, 




immune system, and have several forms including T-cells, B-cells and Natural Killer 
Cells (NK cells). B cells are produced in the bone marrow, whereas precursors of T cell 
are also produced in bone marrow but they leave the bone marrow and mature in the 
thymus. Lymphocytes aid the body in preventing diseases and infections (Berke & 
Clark, 2007).  
The main purpose of the study is to find whether different nitrite concentrations 
impact lymphocyte counts and find if there are viable cells after 96 hours of exposure. 
Additionally, nitric oxide activity and genetic damage will be assayed. This study is 
important because it helps understand possible harmful impacts of nitrite exposure in 
human lymphocytes at varying doses of nitrite, further clarifying the 
immunotoxicological impacts of varying doses of nitrite exposure. The study is an in-
vitro design, meaning blood samples are used with cells pulled from those samples being 
maintained in RPMI culture medium, no direct human exposure will occur. The nitric 
oxide stress and genetic assay work will aid in evaluation of any dose associated 
relationships in regard to intracellular nitric oxide activity levels, cellular membrane 
permeability, cell death, and the DNA damage response through the ATM dependent 
signaling pathway. Overall then, this study will provide information on how different 
nitrite exposures impact important aspects of the immune system.  










Environmentally and geochemically, nitrogen circulates through the nitrogen 
cycle, and it is an essential component for the growth of green plants and all life (found 
as a key component in the DNA, RNA, and proteins) on earth (Weitzberg, Hazel & 
Lundberg, 2010; Weitzberg & Lundberg, 2013). Global nitrogen fixation contributes 
413 Tg of reactive nitrogen in terrestrial and marine ecosystem per year of which 210 Tg 
is made from anthropogenic activities (Fowler at al., 2013). Nitrogen in its gaseous 
form, atmospheric nitrogen, are transformed or “fixed” by combining with oxygen in 
order to become water soluble and thus absorbable by plants and animals (Weitzberg & 
Lundberg, 2013; Puckett, 1994). In the twenty-first century, the Haber-Bosch chemical 
process, an artificial nitrogen fixation process used in industries for the production of 
ammonia,  was used to fix or convert, gaseous nitrogen in the atmosphere to solid, 
absorbable agricultural nitrogen to increase the yield of crops and provide sufficient 
food sources for increasing populations (Fowler et al., 2013). 
The Clean Water Act, implemented in 1972, is essential for controlling water 
pollution from point sources such as sewage discharge but there is a lack of control from 
non-point sources such as fertilizer and animal manure that triggers nitrogen in 
watersheds (Puckett, 1994). The Safe Drinking Water Act (SDWA) enacted in 1974 
determines the allowable nitrate level in publicly distributed water sources. Nitrate 
(NOR3RP-P) which is the environmentally stable form of nitrogen, undergoes chemical 




agricultural land (Ward, 2008).  In soil, fertilizers and animal waste containing inorganic 
and organic nitrogen are first decomposed to give ammonia and then oxidized to nitrite 
and nitrate. These nitrates are then taken up by plants during their growth (WHO, 2011). 
Nitrate is a common chemical compound found in nature especially in soil, water, and 
food (Shao-ting et al., 2007). Nitrate in the human diet is mainly found in vegetables 
such as beetroot, carrot, cabbage, potato, lettuce, and so on (Santamaria, 2006). The 
dietary source of nitrate mainly includes vegetables and animal-based food products 
containing nitrate and nitrite for preservatives to enhance taste and appearance with 
water adding additional nitrate to the diet depending on its level (Hord et al., 2009; 
Skibsted, 2011; WHO, 2011). In 2000, Americans consumed 20 percent more fruit and 
vegetables than did their counterparts in 1970s. Per capita consumption of grain 
products such as flour and cereal was 200 pounds (45 percent higher) annually in 2000, 
which also increased compared to annual average consumption of 138 pounds in 1970s 
(USDA, 2003).  Additionally, the increased use of synthetic nitrogen fertilizers and 
livestock manure in intensive agriculture may be contributing to higher nitrate 
concentration in vegetables and drinking water compared to past years (Santamaria, 
2006). In the United States, most surface and ground waters have nitrate levels below 
4mg/l, with levels exceeding 20mg/l in about six percent of ground water (WHO, 2011).  
However, in certain rural areas both surface and groundwater can have seasonally high 
spikes in excess of 50 ppm, necessitating removal or tertiary treatment of the water for 
publicly distributed systems which is quite costly (Zeman, personal communication, 




USources of Nitrate and Nitrite 
Nitrogen (N) in the form of Nitrogen gas (N2) is the most abundant element in 
the atmosphere, making up approximately 78% of the atmosphere, and the largest 
“store” or “sink” of nitrogen on Earth. Atmospheric nitrogen is fixed chemically in the 
ecosystem through various genera of bacteria that form symbiotic relationships with the 
root structures of legumes where it is then converted to ammonia, nitrite, and nitrate in 
the soil. The inert atmospheric nitrogen is fixed to make it biologically available or 
absorbable to all livable organisms in the form of nitrate, nitrite, and nitric oxide 
(Gilchrist & Benjamin, 2011). Plants uptake nitrate as their major nutrient and, along 
with phosphorus and potassium, are often limiting factors in plant growth (Fowler et al., 
2013, Gilchrist & Benjamin, 2011; Erisman et al., 2013). There has been demand for 
more food which is increasing fertilizer use and expanded acres of land (most more 
erosion prone) under production, leading to enhanced losses of reactive nitrogen (Nr) 
creating various negative effects such as nitrous oxide emission, eutrophication and 
fresh water pollution, biodiversity loss and so on (Erisman et al., 2013).   
 
UNatural Sources 
Natural sources of nitrogen input in the ecosystem involve non-anthropogenic 
activities such as atmosphere, lightning, terrestrial and marine ecosystem functions 
(Fowler et al., 2013). Two natural processes convert inert nitrogen gas to reactive 
nitrogen; lightning and biological nitrogen fixation (BNF) by symbiotic bacteria in the 




1995). The terrestrial and marine ecosystems account for the highest reactive nitrogen 
species production from Biological Nitrogen Fixation (BNF) processes in the 
preindustrial world (Gruber & Galloway, 2008; Galloway et al., 1995; Fowler et al., 
2013). Table 1 shows that lightning is relatively unimportant as a means of fixing 
nitrogen to its’ reactive nitrogen and bioavailable form, comprising only 2.4 percent of 
annual, fixed global nitrogen budget; whereas, the marine ecosystem accounts for the 
highest percentage, comprising two-thirds of the total budget (Fowler et al., 2013).   
 
 
Table 1: Global Nitrogen Fixation Prior To Human Influence on Agricultural Biological 
Nitrogen (Source: Fowler et al., 2013) 
 
Pre-industrial terrestrial biological nitrogen 
fixation 
58 Tg Nyr P-1 
Marine biological nitrogen fixation 140Tg Nyr P-1 
Lightning fixation of nitrogen 5Tg Nyr P-1 




There are three main drivers of increased nitrogen production from 
anthropogenic sources; land-use change, fossil-fuel burning, and industrial nitrogen 
fixation (Gruber & Galloway, 2008). After WWII man-made nitrogen fertilizers became 
widely popular in U.S. Agriculture, providing an inexpensive way of applying the 
nutrient to plants and meeting increased demand in agriculture productivity (Ward, 




host of nitrogen cycle disruptions by pulling non-reactive nitrogen from the gas phase 
into bioavailable/reactive and water-soluble forms, leading to environmental problems 
such as eutrophication of terrestrial and aquatic systems, global acidification, 
atmospheric deposition of airborne soluble nitrates, ground water pollution and human 
health problems (Gruber & Galloway, 2008; Puckett, 1994). For example, the ecological 
effect of too much soluble nitrogen in the aquatic environment causes algal blooms 
resulting in “dead zone” areas in fresh water and coastal areas such as the massive 
hypoxic zone in the Gulf of Mexico at the terminus of the Mississippi river (Ward, 
2008).  
When ground water pollution with nitrate is the issue of concern, nitrate isotopic 
signatures are used as a tool to understand the source of nitrate contamination, especially 
from agriculture. Animal manure, sewage from septic tanks, orchards, vegetables, and 
agriculture were the main cause of groundwater nitrate pollution (Pastén-Zapata, 
Ledesma-Ruiz, Harter, Ramírez & Mahlknecht, 2014). In addition to agriculture 
sources, nitrate can enter ground water systems from non-agricultural sources. The 
difference between rural and urban nitrate concentration is often small because there are 
significant sources of nitrogen that are concentrated in cities such as use of lawn 
fertilizers, waste water disposal and solid waste disposal (Wakida & Lerner, 2005).  
Since the 1970s, the atmospheric deposition of anthropogenic nitrate increased, 
reflecting the human impact on the global nitrogen cycle from the burning of fossil fuels 
and the increasing reliance on catalytic converters which burn more fully gasoline but 




isotope ratio in Greenland and North American remote lake sediments snow decreased 
gradually showing increased atmospheric nitrogen deposition (Geng et al., 2014). Again, 
this underscores that humanity has become one of the main drivers of a reoriented, 
global nitrogen cycle. 
URoute of Exposure 
The primary route of human exposure is through ingestion of nitrate-
contaminated water and vegetable consumption in the diet (Ward, 2008). The nitrate 
ingestion through the water is an additional exposure that can push the individual 
towards excess nitrate consumption. Populations living in agricultural areas typically 
have high exposure to nitrate especially through private wells (Puckett, 1994; 
Santamaria, 2006; Ward, 2008). Nitrates are also found in food such as in vegetables, 
meat products, cheese and cheese products, fish products, and liqueurs (Santamaria, 
2006; Shao-ting et al., 2007). The amount of nitrate ingestion by humans mainly 
depends on the type of food consumed, for example, conventionally grown spinach has 
nitrate levels exceeding the maximum level specified by European Commission 
Regulation which is more than organic spinach (Muramoto, 1999).  The US 
Environmental Protection Agency (USEPA) has set Reference Dose (RfD) for nitrate as 
1.6 mg nitrate-nitrogen/kg body weight per day which is equivalent to about 7.0 mg 
nitrate/kg body weight per day. With the support from a human volunteer study EPA has 
set an RfD of 0.1mg nitrite nitrogen / kg of body weight per day which is equivalent to 





UThe Nitrate-Nitrite-Nitric Oxide Pathway 
All living systems need nitrogen to produce complex organic molecules, such as 
proteins, nucleic acids, vitamins, hormones and enzymes (Mensinga et al., 2003). Nitrate 
levels in human blood and tissues originate mainly from two sources: oxidation of 
endogenously produced NO through the L-arginine-NO synthase pathway and 
exogenous sources such as our diet (Weitzberg & Lundberg, 2013).  
 
UExogenous Sources of Nitrate 
 Consumption of vegetables and drinking water are the major sources of dietary 
nitrate exposure in the human body. A single dose of leafy vegetables such as spinach or 
lettuce has more nitrate content than what is formed endogenously through NO synthase 
pathways (Lundberg et al., 2008; Lundberg et al., 2004). After ingesting food and water 
containing nitrate, it is mostly concentrated in saliva where nitrate is rapidly converted 
to nitrite by facultative anaerobic bacteria (Santamaria, 2006; Benjamin et al., 1994). 
Conversion of nitrate to nitrite in saliva is mainly due to the symbiotic relationship 
involving nitrate reducing bacteria on the tongue surface. Nitrite formed in this process 
is then converted to nitric oxides in the stomach under acidic conditions and aid in the 








UEndogenous Sources of Nitrate 
Nitrates are also formed endogenously through the L-arginine- NO pathway. L-
arginine is a proteinogenic amino acid found naturally in dietary proteins and involved 
in various metabolic pathways including nitric oxide synthase (Böger, 2007). The L-
arginine- NO pathway is constitutively active in numerous cell types throughout the 
body where NO is produced from amino acid L-arginine and molecular oxygen by an 
enzyme called NO synthase (Moncada et al., 1991; Lundberg et al., 2004). The L-
arginine-NOS pathway is oxygen dependent and there is no sufficient formation of NO 
when oxygen supply is less (Lundberg et al., 2008). NO is produced by different cells 
such as vascular endothelial cells, platelets, macrophages, neutrophils, and other cells. In 
these tissues, L-arginine acts as a transduction mechanism that releases NO. The 
released NO acts as a part of host defense mechanisms, cytotoxic to tumor cells, and 
mediates other aspects of the immunological response caused my invasive organisms 
(Moncada et al., 1991).  
Figure 1 shows nitrate-nitrite-nitric oxide pathways where ingested inorganic 
nitrate metabolizes to nitric oxide and other bioactive nitrogen oxides. The figure also 
illustrates both endogenous and exogenous sources of nitrate in the human body. Nitrate 
generates mainly through diet and nitric oxide through nitric oxide synthase.  Nitric 
oxide converts to nitrate in two different ways; first is rapid oxidation to nitrite and then 
to nitrate and second is through oxyhemoglobin. On the other hand, dietary nitrate 
converts to nitric oxide through bacterial nitrate reductase under acidic conditions 






















Figure 1: Schematic Presentation of a Mammalian Nitrogen Cycle 
(Source: Weitzberg et al., 2010) 
 
UNitrate-Nitrite-Nitric Oxide and Human Health 
Nitrogen is essential to all living organisms to produce complex organic 
molecules such as proteins, nucleic acid, vitamins, hormones, and enzymes (Mensinga et 
al., 2003). In the human body, only 5-10% of ingested nitrate is converted to more toxic 
nitrite by salivary or gastrointestinal reduction. However, people should avoid high 
nitrate intake for a prolonged period (Boink & Speijers, 2001). Presence of nitrates in 
vegetables, drinking water, and other foods, in excessive amounts, is a serious threat to 
human health (Santamaria, 2006). Two major toxicological concerns are related with 
nitrite. First, nitrite induces methemoglobinemia resulting in tissue hypoxia and possibly 
death, particularly in children less than one year of age. Second is the formation of N-




The study by Weyer et al. (2001) showed the relation between drinking water nitrate 
level and cancer risk in older women in Iowa. The study showed a positive association 
for bladder and ovarian cancer and an inverse association observed for uterine and rectal 
cancer among women drinking water from public sources. In addition, there was no 
association between drinking water and non-Hodgkin lymphoma, leukemia, melanoma, 
and cancers of the rectum, pancreas, kidney, and lung. Nitrate in drinking water is also 
associated with a risk of thyroid cancer and thyroid disease among populations 
consuming water containing more than 5 ppm nitrate for more than five years. It appears 
that nitrate entering the human body may compete with an uptake of iodide by the 
thyroid (Ward et al., 2010). Dietary nitrate and nitrite from processed meats are also 
associated with increased risk of breast cancer among postmenopausal women (Choi, 
Sinha, Gierach & Ward, 2015). 
Long-term nitrate therapy in the form of various prescription medications shows 
possible genotoxic activity in the form of cytotoxicity and cell cycle delay. In vitro 
treatment of peripheral lymphocytes showed dose-dependent increases in the frequency 
of micro-nucleated lymphocytes with increasing sodium nitroprusside concentrations 
indicating signs of genotoxicity (Andreassi et al., 2001).  
A retrospective cohort study done in Iowa on private well users also indicated a 
positive association between higher nitrate exposure and health problems such as high 
body mass index, low recreational activity, poorer health, and susceptibility to illness. In 
addition, nitrate exposure positively correlated with methemoglobin level, high tumor 




complaint of osteoarthritis, and production of various cytokines associated with bone 
and joint disorders such as TNF-β and the Th2/Treg cytokine, IL-10 (Zeman et al., 
2011).   
UOsteoarthritis 
OA is the most prevalent arthritic disease and affects 10 to 15 percent of world’s 
population. The frequency of this disease increases with aging and the incidence is 
higher than 60 percent among the population over 65 years of age. Since OA is closely 
associated with the aging process, there is also a growing public health cost worldwide 
(Pelletier & Pelletier, 2007).  In the United States, 23 percent of all adults have arthritis 
and it is estimated that by 2040, 26 percent of all adults will have arthritis. Among the 
people having arthritis, 60 percent are of working age, (18-64 years) creating a public 
health problem that translates into a workforce productivity issue. OA is the most 
common form of arthritis affecting 30 million adults in the United States and was the 
second most expensive health condition treated at US hospitals in 2013 (CDC, 2016).  In 
the athlete or young individual, injury, occupational activities, and obesity are the main 
factors contributing to the development of OA. Among the athlete, diagnosis of OA is 
often delayed and difficult because of their high tolerance to pain and preference for an 
expedited return to play (Amoako & Pujalte, 2014).  
OA is a degenerative joint disease that causes abnormal remodeling of the joint 
and articular tissues. Inflammatory mediators present elevate pain within affected joints. 
The pathologic changes seen in OA are degeneration of articular cartilage, thickening of 




Goldring, 2012). The articular cartilage has a limited repair capacity and therefore it is 
difficult to heal the damaged cartilage resulting, in loss of cartilage and ultimately loss 
of joint function (Kraan, 2012).  
URisk Factors for Osteoarthritis 
Age is one of the strongest risk factors for the onset of OA in all joints. It is a 
chronic disease which is associated with cumulative exposure to various joint damage 
risk factors and biological changes. With increasing OA incidence, there is greater 
mobility restriction and increasing financial burden among older people. The conditions 
creates greater chronic disease care cost while decreasing opportunities for mobility 
related social events and activities. The joints are less able to cope with adversity effects 
experienced with aging such as cartilage thinning, weak muscle strength, and oxidative 
damage (CDC, 2016; Zhang & Jordan, 2010).  Aging causes articular cartilage 
degeneration that includes fibrillation of the articular surface, aggregation of 
proteoglycan aggrecans, loss of tensile strength, and stiffness (Martin & Buckwalter, 
2001).  
Gender is another important factor for the prevalence of OA. A Korean study 
completed with the elderly population indicated that knee OA is highly prevalent among 
the elderly population and elderly women are at high risk of requiring total knee 
arthroplasty (Cho et al., 2011). The risk of OA increases among postmenopausal women 
due to lack of estrogen. There is increasing evidence that estrogen plays a protective role 
in maintaining the homeostasis of articular tissues and hence protects the joint. Estrogen 




and functional changes in articular cartilage begin at early menopause and persist post 
menopause. This lack of estrogen leads to increased prevalence of OA especially in 
older women, creating a big impact on health costs among these populations (Roman-
Blas, Castañeda, Largo & Herrero-Beaumont, 2009). 
Obesity is another factor associated with the incidence and progression of OA. 
About 2 in 3 Americans may develop symptomatic knee OA by the age of 85 years 
among the obese population. It has a significant impact on the musculoskeletal system 
including both degenerative and inflammatory conditions. Obesity leads to increased 
loading on the weight-bearing joints leading to knee adduction and impacting the 
articular cartilage (Garfinkel, Dilisio, & Agrawal, 2017; King, March, & 
Anandacoomarasamy, 2013). Coggon et al. (2001) found that the risk of knee OA 
increases by 13.6 times for people having a body mass index of 36 kg/mP2P or higher. 
They also suggested that if all overweight and obese people reduced their weight by 5kg 
or within the recommended level, then 24 percent of surgical interventions for OA of the 
knee could be avoided (Coggon, Reading, Croft, McLaren, Barrett, & Cooper, 2001).  
Other risk factors associated with OA include diet and physical activity. People 
with poor nutrition and lack of physical activity have a greater risk of gaining weight 
and have a higher chance for accelerated joint damage. Messier and colleagues did an 
intervention study to find the effects of diet and exercise for weight loss in overweight 
and obese adults with knee OA. Participants who followed the diet and exercise 
programs had less inflammation, less pain, better function, faster-walking speed, and 




reduction of inflammation and influences T and B lymphocytes, macrophages, and 
dendritic cells. Vitamin D sufficient patients have a lower risk of developing OA and 
decreased articular cartilage degeneration radiographically. Therefore, Vitamin D 
supplementation may be a safe method to treat and prevent OA (Garfinkel et al., 2017). 
Occupational physical activity is also related to the onset of knee OA. This 
disease is common among the populations who have performed heavy physical work 
particularly jobs involving knee bending, kneeling, or squatting. Prolonged knee 
bending in addition to occupational lifting lead to a higher risk of knee OA. Repetitive 
joint injury and high impact exercise are also related to the radiographic progression of 
knee OA. Individuals having normal joints and with low-impact exercise did not have 
increased risk of developing knee OA, but former elite athletes who performed high-
impact activities involving joints that had accommodated serious stress and load had 
increased risk of OA (Hunter, March, & Sambrook, 2002). 
UEffects of Environmental Contaminants on Osteoarthritis 
Environmental contaminants such as synthetic perfluorooctanoate (PFOA) and 
perfluorooctane sulfonate (PFOS) used in the nonstick and stain-resistant coating of 
cookware, furniture, food container, and carpets affect metabolic regulation, 
inflammation, and implicate the pathogenesis of OA. People with highest quartile serum 
PFOA levels were approximately 40% more likely to report a diagnosis of OA, and 
people with highest quartile serum PFOS levels were approximately 25% more likely to 




association with PFOA and PFOS serum levels indicating important public health 
implications (Innes, Ducatman, Luster, & Shankar, 2011).  
Persistent organic pollutants (POPs) are organic chemical compounds that are 
highly toxic, persist in the environment, and bioaccumulate in liver and fatty tissue such 
as skin and endocrine system. POPs are stored in adipose tissue. According to Kim et al. 
(2011), total POP burden was 2 to 3 times higher in obese than in lean individuals. 
Metabolic factors related to obesity such as secretion of leptin (hormone produced by 
adipose tissue) have been linked with the onset of OA. Exposure to some kinds of POPs 
such as dioxins and poly chlorinated biphenyls (PCB) was positively associated with 
arthritis in women. POPs are also endocrine disruptors  which are thought to contribute 
to the development of obesity and also influence the immune system, possibly 
increasing the risk of rheumatoid arthritis (RA) (Lee, Stefffes, & Jacobs, 2007; 
Newbold, 2010).   
Nitrate is an environmental contaminant present in food, drinking water, and 
medications. In an adult’s diet, the largest portion of the nitrite exposure comes from 
vegetable consumption. In addition to that, consuming water (depending on water’s 
nitrate level) increases individual exposure to this contaminant above dietary intakes. 
According to Zeman et al. (2011) people consuming an increased level of nitrate in 
drinking water complained of pain in their bone, muscle, and nerve (F=6.05, p=0.015). 
In addition, those people also complained about stomach and intestinal problems 




elderly white women who took nitrate medication for chest pain had twice the chance of 
having osteoarthritis of hip when compared to controls not taking nitrate medications.  
UNitrate and Its Metabolite’s Effects on Osteoarthritis 
   Osteoarthritis (OA) predominantly affects the diarthrodial joints causing 
articular cartilage destruction. There is also evidence that inflammatory mediators such 
as proinflammatory cytokines, NO, prostaglandins, and leukotriene are involved in OA 
pathophysiology (Pelletier & Pelletier, 2007). NO involvement in arthritis was first 
demonstrated when elevated levels of nitrite, which is the stable end product of NO 
metabolism, was found in serum and synovial fluid samples of rheumatoid and 
osteoarthritis patients (Jang & Murrell, 1998). NO compound supplemental therapy 
enhances local NO production and has an estrogen-like beneficial effect in bone, but 
without estrogenic adverse effects, and can be an attractive alternative to estrogen 
therapy for osteoporosis (Wimalawansa, 2010).   
NO is a proinflammatory factor associated with OA, but evidence suggests that 
NO and its redox derivatives may also play protective roles in the joint. But an excess 
local production of NO aggravates bone destruction in inflammatory arthropathies 
(Abramson, 2008; Wimalawansa, 2010).  In addition, excess formation of NO results in 
the development of osteoarthritis and triggers chondrocyte apoptosis (death of cells 
found in healthy cartilage) and matrix destruction (enhancing cartilage destruction). In 
osteoarthritis cartilage, 18-21% of chondrocytes showed apoptotic features as opposed 
to only 2-5% observed in normal cartilage. The deleterious role of NO can be observed 




oxide synthase (iNOS) in various cell cultures such as biopsy specimens, cartilage 
explants, and cytokine stimulated cells (Feelisch, 2008; Heraud, Heraud & Harmand, 
2000; Mackenzie, Rutherford & Mac Donald, 2008). Figure 2 shows various 
heterogeneous processes that promote cartilage injury and nitric oxide redox stress, 
mainly from iNOS as one of the factors causing osteoarthritis cartilage calcification. 
 
Figure 2: Disease Associated With Promotion of OA and Matrix Calcification 
(Source: Terkeltaub, 2007) 
 
UEffects of Nitrate/Nitrite/Nitric Oxide in Cells 
As discussed earlier, nitrate is mainly ingested from diets such as by consuming 
vegetables and drinking nitrate-contaminated water. Sodium nitrite salt has an anti-
oxidant property used as flavoring, coloring, and preservative agent to cure meat like 
ham, bacon, and hot dogs. It also helps block the growth of botulism causing bacteria 
and prevent spoilage of meat (Abuharfeil, Jaran, Shabsough & Darmani, 2001; Archer, 




A study on the effects of sodium nitrite on red blood cells (RBC) showed 
hyperpolarization of the erythrocyte membrane and increases in membrane rigidity due 
to RBC oxidation. In addition, exposure to sodium nitrite changed intracellular 
methemoglobin (metHg) and reduced glutathione (GSH) levels in the RBC (Zavodnik et 
al., 1999). An in-vitro study on the effect of sodium nitrite (NaNO2) on human 
erythrocytes also showed a dose dependent decrease of glutathione, total sulfhydryl, and 
amino groups. In addition, sodium nitrite was also associated with induction of oxidative 
stress resulting in an imbalance between free radicals and detoxification by the body 
(Ansari, Ali, & Mahmood, 2015).  
Oxatriazole derivatives GEA 3162 and GEA 3175, which is a pharmaceutical 
drug containing NO, also showed effects on NK cell proliferation. This drug inhibited 
mononuclear cell proliferation in a dose-dependent manner (Kosonen, Kankaanranta, 
Vuorinen & Moilanen, 1997).    
 
UNitrite and Lymphocyte Proliferation 
 Lymphocytes such as T cells, B cells, and NK cells are “white blood cells” that 
are essential for the immunological functioning of the human body (Yaqoob & Calder, 
1998). T cells or T lymphocytes are the part of the immune system that protects the body 
from infection and may help fight cancer. B cells are also one of the white blood cells 
that make antibodies. Natural killer cells produce enzymes that can kill tumor cell or 
cells infected with a virus. Lower lymphocyte production also called lymphopenia is a 




Decreased lymphocytes raise the risk of infection (Brass, Mckay, & Scott, 2014). 
Lymphopenia is also associated with the onset of infectious diseases such as HIV, 
rubella, tuberculosis etc. and occurs in a wide variety of conditions such as Hodgkin 
lymphoma, anemia, autoimmune disease, and blood cancer.  
Lymphocytosis, on the other hand, is associated with an increased number of 
peripheral blood lymphocytes (>4500/µl in individuals older than 12 years of age and 
>8000/ µl in individuals younger than 12 years of age). Lymphocytosis is commonly 
related to viral infection and is a temporary situation. But in some cases, it can be more 
serious such as blood cancer or chronic infection/inflammation (Naeim, Rao, Song, & 
Grody, 2013).  
Nitric oxide is a free radical that is formed through the reduction of nitrate and 
nitrite in a human body. In high concentrations nitric oxide is known to suppress T cell 
proliferation (Sato et al., 2007). Sodium nitrite, mainly used as a food preservative, is of 
environmental health concern because of its inhibitory effects on natural killer (NK) 
cells. NK cells are important in the immune system because they defend the body 
against pathogens and tumor cells by modulating both innate and adaptive immune 
response. Inhibition of the NK cells contributes to tumor promotion in vivo. Exposure to 
several concentrations of sodium nitrite (0, 0.1, 0.2, 0.4, and 0.8 mg/ml) showed 
significant inhibition (25.3-66.6%) of NK cell activity. In addition, sodium nitrite also 
inhibited the proliferation activity of NK cells in a dose-dependent fashion (Abuharfeil, 




The study by Ustyugova, Zeman, Dhanwada and Beltz (2002) indicated that 
nitrite decreased lymphocyte proliferation. With regard to lymphocyte cytokine 
expression, the study found that in one-third to two-thirds of subjects tested, both 
sodium nitrate and nitrite decreased the production of T-helper 1 cytokines such as IL-2, 
INF-γ, and TNF-β.  
UNitrite and Nitric Oxide Activity 
Inorganic nitrate ingested through food, water, and medications is converted to 
nitrite by facultative bacteria found in the dorsal surface of the tongue and in some areas 
of the gut in children less than one year of age. The saliva concentrated with nitrite 
arrives in the stomach where it is converted into NO which provides a strong 
antibacterial effect (Lundberg et al., 2008). Dietary supplementation, in the form of 
beetroot juice, increases plasma nitrite concentration, thereby producing NO. In 
addition, dietary nitrate and nitrite also serve as a source to produce nitrogen metabolites 
such as RNS (Bailey et al., 2009; Hord, 2011). NO is a marker of inflammation in the 
body. 
Chronic inflammation is one of the risk factors for human cancer at various sites, 
for example, Helicobacter pylori (H. pylori) is associated with chronic gastritis  a risk 
factor for gastric cancer, inflammatory bowel disease (ulcerative colitis and Crohn’s 
disease) a risk for colorectal cancer, and viral hepatitis leading to cirrhosis for liver 
cancer. Inflammation of many of the tissues is associated with upregulation of NO for a 
prolonged period. Accumulating NO-derived reactive nitrogen species (RNS) have a 




DNA and tissue damage by increasing mutation rate, genome instability, and cell 
apoptosis. Concurrent generations of NO and superoxide can induce single-strand 
breakage under a variety of conditions (Sawa & Ohshima, 2006).    
UNitrite and DNA Damage 
 DNA damage, in particular, DNA double-strand break causes damage to DNA 
bases and causes lesions that can block progression and replication in chromosomes. It is 
the most deleterious type of damage, if not properly repaired. It can also be caused by 
environmental exposure such as irradiation, various genotoxic chemical agents, or 
ultraviolet light (UV) (Negritto, 2010). Ataxia telangiectasia- mutated (ATM), encodes a 
protein, pATM which acts as a checkpoint that senses DNA damage and in particular 
DNA double-strand break (Paules et al., 2001).  
 Another maker of DNA double-strand break is phosphorylation of histone H2AX 
variant (pH2AX). It is the most sensitive marker that can be used to examine DNA 
damage. The pH2AX is typically deactivated at the completion of proper DNA repair. 
Additionally, activation of the ATM through phosphorylation of one of the variants of 
histone H2AX is an early marker of a cell’s response to DNA damage (mainly formation 
of DNA double-strand break). The modification of ATM and H2AX are involved in 
DNA repair and in activating checkpoints that halt the progression of damage (Zhao et 
al., 2017).  







RESEARCH HYPOTHESIS, QUESTIONS, OBJECTIVES, AND LIMITATIONS 
 
UNull Hypothesis 
H01: There is no statistical difference in lymphocyte proliferation between different 
nitrite concentrations.  
H02: There is no statistical difference in lymphocyte proliferation between case 
(osteoarthritis) and controls (no osteoarthritis). 
H03: There is no statistical difference in NO activity at different nitrite concentrations.  
H04: There is no statistical difference in NO activity between case (osteoarthritis) and 
controls (no osteoarthritis). 
H05: There is no statistical difference in DNA damage at different nitrite concentrations. 
H06: There is no statistical difference in DNA damage between case (osteoarthritis) and 
controls (no osteoarthritis). 
 
UAlternate Hypothesis 
Ha1: There is a statistical difference in lymphocyte proliferation between different nitrite 
concentrations.  
H a2: There is a statistical difference in lymphocyte proliferation between case 
(osteoarthritis) and controls (no osteoarthritis). 





Ha4: There is a statistical difference in nitric oxide activity between case (osteoarthritis) 
and controls (no osteoarthritis). 
Ha5: There is a statistical difference in DNA damage at different nitrite concentrations. 
Ha6: There is a statistical difference in DNA damage between case (osteoarthritis) and 
controls (no osteoarthritis). 
 
UResearch Questions 
1. Are there differences in lymphocyte proliferation among different nitrite 
concentrations? 
2. How do lymphocytes from individuals with and without osteoarthritis respond to 
various nitrite concentrations? 
3. Are signs of NO activity evident with the nitric oxide activity test? And, if so, 
does it exhibit a dose response relation? 
4. How do NO activity test from individuals with and without osteoarthritis respond 
to various nitrite concentrations? 
5. Are signs of DNA damage evident with the DNA damage test? And, if so, does it 
exhibit a dose response relation? 
6. How do DNA damage test from individuals with and without osteoarthritis 






● To find whether elevated nitrite concentrations have impact on overall 
lymphocyte proliferation, nitric oxide activity, and DNA Damage. 
● To find whether elevated nitrite concentrations have impact on lymphocytes 
proliferation between case and controls. 
● To find whether elevated nitrite concentration has an impact on nitric oxide 
activity between cases and controls. 
● To find whether elevated nitrite concentrations have impact on DNA Damage 
between cases and controls. 
 
ULimitations 
• The study had only 32 participants, 16 with osteoarthritis and 16 without 
osteoarthritis. The sample size was relatively small.  
• The participants self-reported health, medication, and herbs/supplement 
information which might impact the experimental outcomes. 













This in-vitro case-control study examined the impact of different low dose nitrite 
concentrations (0, 1, 5, 10, and 15 ppm exposure scenarios) on the human mononuclear 
cell (lymphocyte proliferation and viability), cellular nitric oxide activity, and DNA 
damage. This study focused on participants with osteoarthritis (case) and without 
osteoarthritis (control) with ages ranging from 40 to 65, inclusive. This method also 
included the addition of phytohaemagglutinin (PHA), a mitogen that triggers 
lymphocyte mitosis, to the human mononuclear cells to determine the difference in cell 
counts between the stimulated and non-stimulated cells for both cases and controls under 
the five exposure scenarios.  
UStudy Design 
The study is an in-vitro experiment that incorporated the Ficoll-Hypaque density 
gradient centrifugation method to process participants’ blood and extract mononuclear 
cells. Peripheral blood mononuclear cells (PBMCs) consist of mostly lymphocytes and 
monocytes that are used for various experiments including issues with human 
immunology and production of cytokines (Panda & Ravindran, 2013). After extracting 
the mononuclear cells, a Millipore, Muse (S.N. 7200121194) flow cytometer was used 
to perform cell counts and viability, DNA damage, and nitric oxide activity tests on 





Following initial cell counts and viability analysis (Muse), cell concentrations were 
determined and adjusted to 4x10P6Pcells/ml with plating of cells to micro-cell-well plates, 
these mononuclear cells were then experimentally dosed with different nitrite 
concentrations such as 0, 1, 5, 10, and 15 ppm wherein the cells in 0 ppm mean un-
dosed and the cells in 1, 5, 10, and 15 ppm indicated dosed. In stimulated wells, PHA 
was added to trigger lymphocyte mitosis. These cells were then incubated at 35PoPC with 
5% COR2R. After 48 hours of incubation, the nitric oxide stress and DNA damage tests 
were completed using the MUSE Unit Flow Cytometer. The functional principle of each 
test relies on flow cytometry detection of key immune assay linked molecules indicative 
of the outcome under study. The main objective of the nitric oxide activity test was to 
detect changes in cellular nitric oxide activity level. Similarly, DNA damage analysis 
tests are designed to detect ATM and H2A.X signaling pathways (indicative of DNA 
damage through decoupling of phosphorylation pathways and/or DNA strand breaks). 
After 96 hours of incubation, the total number of viable cells was counted through the 






















Figure 3: Flowchart of Research Design 
Analysis & Report 
Eliminate 
from the study 
NO activity: After 48 
hours of incubation, this 
test was conducted to 
find cellular NO activity 
DNA Damage: After 48 
hours of incubation, this 
test was conducted to 
detect activation of 
signaling pathways 
Counts & Viability: After 
96 hours of incubation, 
this test was conducted to 
count viability cells at 
different nitrite 
concentrations 








Selection of Participants 






Scheduled a blood draw appointment with the target 
population at the Student Health Clinic at University 
of Northern Iowa and Questionnaire Survey 
Sample Collection and Processing: 
• 15-20 ml of blood collected from each 
participant 
• The blood sample was processed on the 
same day to extract mononuclear cells 
Eliminate 
from the study 
Sample Collection and Processing: 
• The extracted mononuclear cells was 
exposed to different nitrite 
concentrations (0, 1, 5, 10, 15 ppm) 
• The samples were incubated at 35oC at 




UInstitutional Review Board (IRB) Approval 
The study design followed the Institutional Review Board (IRB) Approval in 
order to maintain confidentiality of the participants and adhere to strict rule of protecting 
human subjects from unpredicted consequences due to intervention such as answering 
the questionnaire and giving a blood sample. The IRB approval assures the participants 
that the research they are involved in meets the required standards and will protect the 
identity of the participants. This study was approved by the IRB board at the University 
of Northern Iowa and is valid until the completion of the project. All participants gave 
full, informed consent to participate (Appendix B) 
 
UStudy Participants 
The population chosen for this in-vitro case-control study was 40 to 65 years old, 
both with and without OA. Each participant filled out a consent form along with a brief 
questionnaire survey about their health and medications (Appendix C). The participation 
was voluntary, and there was only slight physical risk (blood draw) and no emotional 
stress to the participants. The study involved 32 participants; 16 with osteoarthritis (case 
group) and 16 without osteoarthritis (control group). The study excluded participants if 
they reported any prior autoimmune disease such as rheumatoid arthritis, Grave’s 
disease, etc. or if they were outside the chosen age group. 






 URecruiting Participants 
The research adopted various strategies to recruit participants. First, the flyer 
(See Appendix A) about the study was distributed across the University area including 
departments and the community for their voluntary participation. Second, a brief 
presentation about the research was given in faculty meetings and classes to recruit 
potential participants. Third, a community outreach approach was done to recruit 
additional participants from places such as the YMCA, Cedar Valley Medical Specialist 
at the University of Northern Iowa, and Churches. The research provided a $10 Kwik 
Star gas card as a gratitude for participation. 
 
UBlood Draw Appointment 
Once the individual made contact with the researcher, expressing his/her interest 
in participating, a blood draw appointment with the Student Health Center (SHC) at 
University of Northern Iowa was scheduled. Participants donated 15-20 mL of blood (2-
5 teaspoons which falls within Red Cross Guidelines), which was drawn by a trained 
phlebotomist, at the SHC.  
 
UQuestionnaire Survey 
At the time of the blood draw appointment, participants filled out a short 
questionnaire survey that included demographic, health, and medication information. 
The study assumed that the information provided by each participant is correct and not 




if current health and medication status in addition to the experimental exposures would 
impact the mononuclear cell counts. Also, demographic information determines the 
social and demographic status of the participants (See Appendix C).      
 
ULaboratory Procedures and Preparing Chemicals  
The following general summary outlines the basic procedures of cell culture. 
1. Make RPMI* mixture (See Appendix D1) 
2. Make RPMI+ mixture (See Appendix D2) 
3. Reconstitute PHA (See Appendix D3) 
4. Make sodium nitrite solution (See Appendix D4) 
 
UPreparation of Peripheral Blood Mononuclear Cells (PBMC) 
The laboratory procedure for preparing mononuclear cells followed a standard 
protocol provided by Kanof, Smith, and Zola (1996) section 1 unit 7.1 entitled “Isolation 
of whole mononuclear cells from peripheral blood and cord blood.” For detailed 
information, please see Appendix E 
After isolating mononuclear cells from whole blood, depending on the viable cell 
counts, the cells were diluted to get experimental cell concentrations of 4*10P6P cells/ml. 
Finally, the cells were cultured in experimental sterile microcell well culture plates with 
different nitrite concentrations (0, 1,5,10, and 15 ppm) followed by adding PHA to the 




there were three different tests (counts and viability, DNA damage, and nitric oxide 
stress). 
The prepared culture plates of each test were incubated at 35P0PC at 5% CO2 level. 
After 48 and 96 hours of incubation respectively, the MUSE flow cytometer provided 
DNA damage and nitric oxide activity results, and a count and viability of the cells (see 
Appendix F and G).    
UQuality Control and Assurance 
The laboratory procedures followed all aseptic techniques to minimize 
contamination from external sources (see Appendix H). All pipettes were calibrated each 
month to ensure accuracy of the equipment. The system check procedure of the 
Millipore, MUSE Unit Flow cytometer was performed before each experiment to control 
for error in the final data. In addition, 10% Penicillin Streptomycin was added in RPMI 
medium to protect from bacterial and fungal growth in the media.     
 
UMUSE Unit Flow Cytometer System Check 
A system check procedure is important for quality control of the Muse Unit. 
Before running any tests, a system check procedure was run to check the accuracy and 
reliability of the instrument. The system check kit included a bead reagent tube and a 
small bottle of diluent. For the system check procedure, 20µl of bead reagent was added 
to 380 µl of system check diluent in a clean micro-centrifuge tube and mixed thoroughly 
on a vortex machine. The system check was run on the Muse instrument. After running 




result. If the system check was ran properly, then the result showed a “PASS” and after 
that the samples were run through the instrument to find lymphocytes proliferation, 
nitric oxide activity, and DNA damage among the cultured cells.      
 
UDisinfection and Cleaning Equipment and Apparatus 
The laboratory followed strict aseptic technique to minimize any external 
contamination during extracting mononuclear cells and then analyzing the lymphocytes 
on Muse Unit. Once in a month, the COR2R incubator was cleaned thoroughly with high 
heat disinfection technique to ensure that there was no biological contamination inside 
the incubation. In this technique, a program was set to increase the internal temperature 
of the incubator to 120°C for 4 hours, and then programmed to cool the temperature to 
37°C. In addition, the incubator was sterilized with 99.8% isopropanol to remove any 
contamination before incubating the cultured plates.  
 
UCalibrating Pipettes 
 This laboratory method used pipettes of different volume to meet the need of an 
experiment. The manufacture or the company calibrated the pipettes used in this 
experiment which was valid for one year. In addition, the pipettes were cross checked 
each month by following standard calibration technique to ensure accuracy and 










The data collected from the questionnaire survey, counts and viability, DNA 
damage, and nitric oxide activity was entered into an MS Excel program and then 
imported to JMP 13 software for statistical analysis. Data were analyzed by a standard 
statistical procedure that includes univariate, bivariate, and multivariate analysis as 
appropriate. Univariate analysis includes descriptive statistics such as age, gender, 
location, health status and habits. Bivariate analysis includes one way ANOVA, t-test, 
and correlational analysis. Multivariate analysis includes Whole Model Test. The 








 This chapter presents the analysis of all data collected from questionnaire survey 
and laboratory experiment that included cultured cells from case and control groups. 
Results from the MUSE Unit (flow cytometry) include data on counts and viability of 
lymphocytes proliferation, nitric oxide stress, and DNA damage. All experimental data 
were recorded in MS Excel along with the questionnaire responses and then transferred 
to JMP 13 for statistical analysis. Following are the findings from the study.  
UDemographic Information 
UAge 
The total number of participants in this study was 32, among which 16 
participants had osteoarthritis and 16 did not have osteoarthritis. The participants’ ages 
ranged from 41 (minimum) to 65 (maximum). The mean age of case and control groups 
was 54.13 and 52.56 (Table 2) respectively. 
 
Table 2: Age Distribution among Case and Control Groups 
 N Minimum Maximum Mean Std. Deviation 
Case (With OA) 16 44.00 65.00 54.3125 5.59427 
Control (Without OA) 16 41.00 65.00 52.5625 8.39816 






 Bivariate fit tests were conducted between three laboratory experiments on 
mononuclear cells (lymphocyte proliferation, NO activity, and DNA damage) with 
various nitrite exposures. Since participants ranged in age (see above) age was examined 
as a possible confounder or effect modifier of lymphocyte proliferation. Overall, the age 
of the participants did not impact the lymphocyte proliferation, however, there was a 
decreasing trend of proliferation observed at 10 ppm nitrite concentration with 
increasing age but was not statistically significant (p>0.05) (Table 3 and Appendix I1).  
In the case of NO activity, a slightly decreasing trend of NO activity by total 
cells was observed at 0 ppm nitrite concentration with increasing age but the result was 
not statistically significant. However, increasing trend of NO activity by total cells was 
observed at 5 ppm nitrite concentration with increasing age and this relationship was 
statistically significant (F=6.92, p=0.0144). Therefore, the result indicated that the NO 
activity increased by 6.92 times at 5 ppm nitrite concentration among the participant 
with increasing age (Table 3 and Appendix I1).       
Similarly, for DNA stress, a strong decreasing trend of pH2A.X (histone protein 
damage) activated cells was observed at 5ppm nitrite exposure with increasing age. The 
result was statistically significant (F=5.01, p=0.034) which indicated that pH2A.X 
activated cells declined at 5 ppm nitrite concentration among the participants with 





Table 3: Lymphocyte Proliferation, NO Activity, and DNA Damage at Various Nitrite 




0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte Proliferation 0.7881 0.5261 0.1348 0.1047 0.6076 
NO activity with Live Cells 0.2522 0.7315 0.0825 0.4475 0.5421 
NO activity with Dead Cells 0.1239 0.9031 0.1564 0.4944 0.2489 
NO activity Total Cells 0.0613 0.7481 0.0144*(I) 0.5508 0.4647 
pATM Activated Cells 0.8971 0.7552 0.486 0.8444 0.2123 
PH2A.X Activated Cells 0.9892 0.2348 0.034*(D) 0.9203 0.4266 
DNA Double-strand Break 0.665 0.3084 0.693 0.7075 0.5492 
Total DNA Damage 0.665 0.3084 0.693 0.7075 0.5492 
X-Axis: Age (41-65)  
Y-Axis: Lymphocyte Proliferation, NO Activity, DNA Damage at various Nitrite 
concentrations 
I: Increasing Trend; D: Decreasing Trend 




The study included more female participants than male, accounting for more than 
75% of total participants. The total number of female participants was 25 whereas the 





Figure 4: Gender Distribution of Study Participants 
 
The t-Test was conducted between the three laboratory experiments on 
mononuclear cells (lymphocyte proliferation, NO activity, and DNA damage) with 
various nitrite exposures and gender. The result did not show any significant difference 
between lymphocyte proliferation at various nitrite exposure and gender. In the case of 
the NO activity and DNA stress test, male participants showed a high response to 5 ppm 
nitrite concentration. Results indicated that the mononuclear cells of male participants 
produced high NO activity at 5 ppm nitrite concentration. Similarly, in regard to the 
DNA stress test, the total DNA damage was high among male participants at 5 ppm 
nitrite concentration. Both of the results were statistically significant, F= 6.10 and 
p=0.025, NO activity among dead cells and, F= 5.47 and p=0.26, in Total DNA damage 









Table 4: Lymphocyte Proliferation, NO Activity, and DNA Damage at Various Nitrite 




0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte Proliferation 0.3143 0.3636 0.2556 0.4079 0.3921 
NO activity with Live Cells 0.7679 0.1149 0.5933 0.5026 0.9769 
NO activity with Dead Cells 0.5054 0.6935 0.025*(M) 0.3258 0.8166 
NO activity Total Cells 0.582 0.1139 0.4055 0.7235 0.1135 
pATM Activated Cells 0.9058 0.593 0.3937 0.1073 0.2267 
PH2A.X Activated Cells 0.4751 0.3068 0.7509 0.2899 0.8799 
DNA Double-strand Break 0.8796 0.9324 0.3367 0.4789 0.808 
Total DNA Damage 0.8185 0.6711 0.026*(M) 0.5364 0.6377 
X-Axis: Gender (Male or Female) 
Y-Axis: Lymphocyte Proliferation, NO Activity, and DNA Damage at various 
Nitrite concentrations 
M: Male; F: Female 




UCity of Residence 
 
 Of the 32 participants, 13 were from Cedar Falls and 19 were from other cities 
such as Waterloo, Reinbeck, Fayette, Shell Rock, Eldora, Hudson, and New Hartford. 
The t-Test was conducted between the city of residence (Cedar Falls and Others) and the 
three laboratory experiments on mononuclear cells (Lymphocyte Proliferation, NO 
Activity, and DNA Stress at various Nitrite concentrations). The participants from Cedar 
Falls showed low lymphocyte proliferation at 5 ppm nitrite concentration compared to 
participants living in other cities. The result was statistically significant (F=4.72, 




decrease at the 5 ppm sodium nitrite concentration when the mononuclear cells of the 
participant residing in Cedar Falls were exposed in-vitro. However, there was no 
association found between NO activity at various nitrite concentration and city of 
residence. In case of DNA stress, the percentage of pH2A.X activated cells increased 
among the participants living in Cedar Falls area at 5 ppm nitrite concentration. This 
association was statistically significant (F=18.93, p=0.0002), indicating that the Cedar 
Falls participants were 18.93 times more likely to show this form of DNA damage 
(histone protein damage). Additionally, DNA double-strand breaks were prominently 
observed at 0ppm (control) nitrite concentration among the participants residing in 
“other” cities. The result was statistically significant (F=5.24, p=0.0303) (Table 5, 
Appendix I3). 
 
Table 5: Lymphocyte Proliferation, NO Activity, and DNA Damage at Various Nitrite 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte Proliferation 0.7388 0.078 0.0378*(CF) 0.0994 0.2279 
NO activity with Live Cells 0.1876 0.5864 0.621 0.0551 0.2294 
NO activity with Dead Cells 0.4481 0.2448 0.4724 0.3927 0.3591 
NO activity Total Cells 0.6748 0.6892 0.276 0.101 0.34 
pATM Activated Cells 0.3981 0.8424 0.6866 0.159 0.6855 
PH2A.X Activated Cells 0.928 0.2334 0.0002*(CF) 0.5956 0.388 
DNA Double-strand Break 0.0303*(O) 0.9294 0.5109 0.8953 0.238 
Total DNA Damage 0.1452 0.8575 0.0947 0.2231 0.2961 
X-Axis: City of Residence (Cedar Falls, Others)  
Y-Axis: Lymphocyte Proliferation, NO activity, and DNA damage at various Nitrite 
concentrations 
CF: Cedar Falls; O: Others 




 UDrinking Water Sources 
Most of the participants in this study used city water as their major drinking 
water source. Of the 32 participants, 19 participants used water from a public/city 
supply, 10 participants used water from a private water source, 1 used bottled water, and 
2 used city water with reverse osmosis filtration for drinking purpose (Figure 5). A one-
way ANOVA analysis was conducted between lymphocyte proliferation, NO activity, 
DNA stress at various nitrite concentrations and drinking water source. The analysis did 
not yield any significant association between these variables indicating that drinking 
water source did not affect lymphocyte proliferation, NO activity, and DNA stress at 



















Medications, Herbs, and Supplement Information 
 
Participants were asked about their prescribed medication, herb, and supplement 
intake information. Of the 32 participants in this study, 17 took some form of herb or 
supplement, 7 did not answer the question, and 8 did not take any herb or supplement. In 
total, the participants used 28 different types of herbs and supplements. Most of the 
participants used various forms of vitamins such as Vitamin D (7 participants), 
Multivitamin (5 participants), Vitamin B12 (2 participants), and Vitamin C (1 
participant). Apart from vitamins, the participants used other supplements such as 
Melatonin (2 participants), Fish Oil (2 participants), Lysine (2 participants), Biotin (2 










To examine the relationship between the total number of supplements taken and 
the experimental outcomes using bivariate analysis, the number of herbs and 
supplements were totaled for each participant (Table 6 and Appendix I6). The total 
number of herbs and supplements were correlated with lymphocyte proliferation, NO 
activity, and DNA damage at various nitrite concentrations. Findings indicated no 
significant relationship between lymphocyte proliferation at various nitrite 
concentrations and the total number of supplements taken by each participant. Regarding 
the NO activity test, the participants taking more supplements had decreased NO activity 
for live cells at 10ppm nitrite concentration (F=5.53, p=0.02). Additionally, increasing 
numbers of herbs and supplements taken significantly decreased NO activity by total 
cells (live and dead) at 0 ppm (control) nitrite concentration (F=4.31, p=0.049).  For the 
DNA stress test, the pATM (dephosphorylation) activated cells significantly decreased 
with increasing number of herbs and supplements at 10 ppm nitrite concentration 
(F=9.011, p=0.008). Therefore, the result suggested that taking herbs and supplement 
did not impact the lymphocyte proliferation and decreased NO activity and pATM 





Table 6: Lymphocyte Proliferation, NO Activity, and DNA Damage at Various Nitrite 




0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte Proliferation 0.4088 0.4286 0.2747 0.9371 0.7411 
NO activity with Live Cells 0.1996 0.4774 0.922 0.02*(D) 0.073 
NO activity with Dead Cells 0.9985 0.8634 0.0951 0.4992 0.9585 
NO activity Total Cells 0.049*(D) 0.5728 0.5049 0.057 0.3533 
pATM Activated Cells 0.5261 0.2876 0.9414 0.008*(D) 0.4782 
PH2A.X Activated Cells 0.4812 0.4892 0.6794 0.3432 0.9527 
DNA Double-strand Break 0.4622 0.1189 0.7016 0.8288 0.2984 
Total DNA Damage 0.7714 0.1407 0.846 0.8849 0.4823 
X-Axis: No. of Supplements; No Answer, 0 to 7  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage 
 at various Nitrite concentrations) 
I: Increasing Trend; D: Decreasing Trend 
*: statistically significant (p<0.05) 
 
 
Prescription medication use was also surveyed, 18 participants took prescribed 
medications, 5 did not answer the question, and 9 did not take any prescribed 
medications. The participants used 45 different brand names of prescribed medications. 
The most common brand names were Baby aspirin (3 participants), Omeprazole (3 
participants), Crestor (2 participants), Fluoxetine (2 participants), and Atorvastatin (2 
participants) (Figure 7). Furthermore, all brand name medications were categorized 
according to their overall purpose (Figure 8). Most of the people taking prescribed 




medications (8 participants), NSAIDs, hormone supplements, and histamine blockers (3 
participants each). 
 






Figure 8: Prescribed Medications Categories 
To look for confounding or effect modification relationships between 
medications taken and experimental outcomes, bivariate analysis tests were ran on the 
total number of medications taken by each participant and each of the experimental 
outcomes by exposure category (Table 7 and Appendix I7)).  Results indicated that with 
increasing numbers of medications consumed there was a significantly decreased 
lymphocyte proliferation at 15 ppm nitrite concentration (F=5.57, p=0.026). There was 
no statistically significant relationship observed between the number of medications and 
NO activity at various nitrite concentrations. Further, in the case of DNA stress, a 
significant relationship was observed between increasing numbers of prescription 
medications taken and increased DNA double-strand breaks at 15 ppm nitrite 
concentration (F=5.79, p=0.025). Finally, a significant decrease in Total DNA damage 
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Table 7: Lymphocyte Proliferation, NO Activity, and DNA Damage at Various Nitrite 




0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte Proliferation 0.5294 0.3636 0.0804 0.5371 0.026*(D) 
NO activity with Live Cells 0.6089 0.3738 0.592 0.5658 0.7308 
NO activity with Dead Cells 0.7172 0.3676 0.6053 0.337 0.2716 
NO activity Total Cells 0.9537 0.394 0.475 0.5447 0.2671 
pATM Activated Cells 0.2168 0.5812 0.8731 0.212 0.8334 
PH2A.X Activated Cells 0.898 0.2675 0.2173 0.3494 0.7733 
DNA Double-strand Break 0.0991 0.2456 0.0812 0.4567 0.025*(I) 
Total DNA Damage 0.3348 0.013*(D) 0.9008 0.5779 0.4146 
X-Axis: No. of Medications; No Answer, 0 to 6  
Y-Axis: Lymphocyte Proliferation, NO Activity, and DNA Damage at various Nitrite 
concentrations 
I: Increasing Trend; D: Decreasing Trend 




The participants were asked about their pain related to osteoarthritis. Of the 16 
participants having osteoarthritis, 11 reported pain in their body. Among the 11 
participants who reported pain their body, five had pain in their hip, three had pain in 
their knee. Additionally, pain in the back, neck, ankles, joints, and hands was reported 





Figure 9: Pain Related to Osteoarthritis 
 
Participants completing the questionnaire were asked the following general 
health related questions: if they had experienced a cold/flu in the past two weeks, had 
any diagnosed immunological disease, had any major life changes/losses in the past six 
months, had any immunization history in the past two weeks, had any allergies, if they 
would describe themselves as having a “sweet-tooth” tendency, their smoking habits, 
and total hours spent outside per day. 
Of the 32 participants in this study, 31 had not had a cold/flu in the past two 
weeks prior to survey and one did not answer the question (Table 8). In the question on 
major life changes/loss, 29 had not had any major life changes in the past six months 
prior to survey, while three experienced a major life change/loss (Table 8). Participants 
were also asked about their immunological disease history other than osteoarthritis and 
29 participants did not report any immunological disease whereas two had fibromyalgia 
(chronic disease) and one had psoriasis (immunological disease) (Table 8). Regarding 















the participant’s immunization history, 30 participants had not had an immunization in 
the past two weeks at time of blood draw, whereas; two participants had received flu 
shots within two weeks of the blood draw (Table 8).  
Participants were also asked if they suffered from any form of allergies. Of the 
32 participants, 16 suffered with some form of allergies and 16 did not have any type of 
allergies (Table 8). Of the 16 participants who suffered from allergies, they reported that 
they were related to environmental, pollens, medication, and seasonal (Figure 10). 
Regarding the question of whether or not the participant viewed themselves as having a 
“sweet-tooth,” (predilection toward sweet foods and candies), 21 reported they did not 
have sugar cravings while 11 reported they did (Table 8). Participant were also surveyed 
about their smoking habits, and among the 32 participants, two had smoking habits 
whereas 30 did not have smoking habits (Table 8). Lastly, the participants were asked 
about time spent outside on a good day. The answer ranged from zero hours to seven 
hours per day.   
 














Yes 0 3 3 2 16 21 2 
No 31 29 29 30 16 11 30 
No 
Answer 
1 0 0 0 0 0 0 
















Figure 10: Type of Allergies Reported by the Participants 
  
Bivariate statistical analysis was conducted on each health-related questionnaire 
item previously described with the three laboratory experiments (lymphocyte 
proliferation, NO activity, and DNA Stress) test at various nitrite exposure 
concentrations.  
 
Major Life Changing Events  
The t-Test was used to examine the difference between major life-changing 
events with lymphocyte proliferation, NO activity, and DNA Stress at various nitrite 
concentrations. In the case of lymphocyte proliferation, there was no indication of 
increase or decrease of lymphocytes with any major life-changing events. However, a 
significant difference was observed among the participants responding yes to having 











experienced major life changing events and NO activity by live cells at 0 ppm (F=11.08, 
p=0.0029) and 15 ppm (F=4.60, p=0.041) nitrite concentration. Similarly, a significant 
difference was observed on NO activity by dead cells at 0 ppm (F=4.84, p=0.0449) and 
10 ppm (F=16.32, p=0.0009) nitrite concentration among the participants responding yes 
to having experienced life-changing events. The NO activity by total cells also showed a 
significant difference at 0 ppm (F=25.06, p<.0001), and 10 ppm (F=1.86, p=0.035) 
nitrite concentration among participants indicating yes to the question. The DNA stress 
test also showed some significant difference. The pATM activated cells were higher at 0 
ppm (F=4.36, p=0.0498) nitrite concentration and DNA double-strand break was 
prominent at 1 ppm (F=6.42, p=0.018) nitrite concentration among the participants who 
responded yes to having experienced life-changing events (Table 9). 
 
Table 9: Lymphocyte Proliferation, NO Activity, and DNA Damage at Various 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte Proliferation 0.7188 0.6031 0.8043 0.067 0.9896 
NO activity with Live Cells 0.0029*(Y) 0.586 0.424 0.129 0.041*(Y) 
NO activity with Dead Cells 0.0449*(Y) 0.9792 0.1602 0.0009*(Y) 0.8381 
NO activity Total Cells <.0001*(Y) 0.4969 0.2731 0.035*(Y) 0.8442 
pATM Activated Cells 0.0498*(Y) 0.9225 0.4442 0.9977 0.3024 
PH2A.X Activated Cells 0.825 0.0796 0.3593 0.3887 0.424 
DNA Double-strand Break 0.825 0.018*(Y) 0.533 0.4528 0.9392 
Total DNA Damage 0.9771 0.2083 0.8223 0.0574 0.6716 
X-Axis: Major Life Changing Events; Yes or No  
Y-Axis: Lymphocyte Proliferation, NO Activity, DNA Damage at various Nitrite 
concentrations 
Y: Yes; N: No 





The t-Test was used to examine the difference between reported allergy response 
and lymphocyte proliferation, NO activity, and DNA stress at various nitrite 
concentrations. There were no statistically significant findings between lymphocyte 
proliferation, DNA stress and report of allergies at any of the exposure levels.  However, 
a statistically significant difference was observed between NO activity by dead cells at 5 
ppm exposure (F=7.70, p=0.0135) among the participants responding “no” to the allergy 
question (Appendix I8).  
Sweet-Tooth 
The t-Test was used to explore the difference between self-reported “sweet-
tooth,” lymphocyte proliferation and NO activity at various nitrite concentrations but did 
not show any significant difference. However, a positive association with DNA stress 
was found in that pATM activated cells increased at 10 ppm (F=4.9, p=0.038) nitrite 
concentration among the participants responding yes to the sweet-tooth question 
(Appendix I9).  
Immunological Disease and Chronic Disease 
 The one-way ANOVA was used to examine the relationship between 
immunological disease and chronic disease with lymphocyte proliferation, NO activity, 
and DNA stress at various nitrite concentrations with some positive associations found. 
There were no significant difference between lymphocyte proliferation and 
immunological disease. However, NO activity by live cells, indicated a positive 




concentration among the participants having fibromyalgia. A similar trend was observed 
on NO activity by dead cells (F=14.03, p=0.0016) and NO activity by total cells 
(F=4.69, p=0.0174) at 10 ppm nitrite concentration with the two participants reporting 
fibromyalgia diagnosis. DNA stress, pATM activated cells and DNA double-strand 
breaks increased among fibromyalgia participants. The pATM activated cells at 1 ppm 
nitrite concentration was (F=3.59, p=0.047) and DNA double-strand break at 10 ppm 
nitrite concentration was (F=4.80, p=0.017) (Table 10, Appendix I11).     
 
Table 10: Lymphocyte Proliferation, NO Activity, and DNA Damage at Various Nitrite 




0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte Proliferation 0.3491 0.5456 0.8161 0.8592 0.7597 
NO activity with Live Cells 0.9194 0.8947 0.3571 0.0482*(F) 0.0046*(F) 
NO activity with Dead Cells 0.8666 0.7417 0.8306 0.0016*(F) 0.7061 
NO activity Total Cells 0.7256 0.8597 0.6393 0.0174*(F) 0.4907 
pATM Activated Cells 0.047*(F) 0.508 0.0689 0.529 0.3307 
PH2A.X Activated Cells 0.9204 0.7082 0.3615 0.6954 0.6502 
DNA Double-strand Break 0.6338 0.5746 0.5351 0.0884 0.017*(F) 
Total DNA Damage 0.8516 0.4306 0.5386 0.7835 0.9073 
X-Axis: Immunological Disease and Chronic Disease; No, Fibromyalgia, Psoriasis 
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
N: No; F: Fibromyalgia, P: Psoriasis 




The t-Test was used to examine the difference between immunization response 




The analysis did not yield any significant difference between immunization and 
lymphocyte proliferation and NO activity. In the case of DNA stress, the pH2A.X 
activated cells were significantly higher among the participants having been recently 
immunized at the experimental levels of 1 ppm (F=19.58, p=0.0002) and 10ppm 
(F=5.83, p=0.0245) nitrite concentration (Appendix I12).  
Smoking Habit 
The t-Test was used to examine the difference between smoking habits and 
lymphocyte proliferation, NO activity, and DNA stress at various nitrite exposures but 
did not yield any significant difference, indicating that smoking habits did not contribute 
to any mononuclear damage at various nitrite concentrations (Appendix I13). 
Hours Spent Outside in a Good Day 
 The bivariate fit test was used to examine the relationship between hours spent 
outside and lymphocyte proliferation, NO activity, and DNA stress at various nitrite 
exposures. There was no significant relationship between hours spent outside and 
lymphocyte proliferation or NO activity at various nitrite concentrations. However, in 
the case of DNA stress, an increasing trend as observed between greater time spent 









Lymphocyte Proliferation of all Participants 
 
Lymphocyte Proliferation in Non-Stimulated and Stimulated Condition  
The Millipore MUSE flow cytometry unit was used to examine several 
parameters of lymphocyte proliferation and vigor. Analyses included: viable cell 
concentration, viability percentage, total cells, and events acquired. Among these results, 
viable cell concentration data indicative of lymphocyte proliferation response was used 
for further analysis. In the non-stimulated (not mitogen treated) condition, the mean 
viable cell concentration at 0 ppm nitrite exposure was 3.96E+05 cells/mL whereas, at 
15 ppm nitrite exposure, the mean viable cells decreased to 1.95E+05 cells/mL. In the 
stimulated condition, the mean viable cell concentration at 0 ppm nitrite exposure was 
4.17E+05 cells/mL whereas, at 15 ppm nitrite exposure, the mean viable cells decreased 
to 2.78E+05 cells/mL. Therefore, lymphocyte proliferation decreased with increasing 
dose of nitrite concentration under both non-stimulated and stimulated conditions (Table 
11) showing a dose-response relationship.  
 
Table 11: Lymphocyte Proliferation in both Non-Stimulated and Stimulated Conditions 
at Various Nitrite Concentrations 
 
Nitrite Concentrations  Non-Stimulated Stimulated 
0 ppm 3.96E+05 4.17E+05 
1 ppm 3.41E+05 3.79E+05 
5 ppm 3.09E+05 3.34E+05 
10 ppm 2.47E+05 2.82E+05 





Figure 11: Comparing Lymphocyte Proliferation between Non-stimulated and 
Stimulated Conditions 
 
One-way ANOVA analysis indicated that there was a statistically significant 
(F=7.28, p<.0001*) difference between mean lymphocyte proliferation among various 
nitrite concentrations (0, 1, 5, 10, and 15 ppm) in non-stimulated conditions (Table 12 
and Figure 12). The F-ratio indicated that the proliferation decreased 7.28 times with 
increased nitrite concentration. Similarly, the one-way ANOVA between lymphocyte 
proliferation and various nitrite concentrations in stimulated conditions showed some 
mean difference where increasing nitrite concentration decreased the lymphocyte 














0PPM 1PPM 5PPM 10PPM 15PPM
Comparing Mean Viability Cell Concentration in Non-
























0 1 5 10 15
Concentration
Analysis of Variance 
Level Mean Lower 95% Upper 95% R square F Ratio P Value 
0 ppm  395663 338135 453190 0.158283 7.2868 <.0001* 
1 ppm  341394 283866 398922 
5 ppm  309425 251897 366953 
10 ppm 246659 189132 304187 








Figure 13: Lymphocyte Proliferation in Stimulated Condition 
 
Degree of Change (Quotient) between Non-Stimulated and Stimulated Condition 
The magnitude of response (a quotient, r= st/ns, st=stimulated; ns=non-
stimulated) was calculated for lymphocyte proliferation under each of the experimental 
exposure conditions. A higher quotient value indicated a greater lymphocyte 






0 1 5 10 15
Concentration
Analysis of Variance 
Level Mean Lower 95% Upper 95% R square F Ratio P Value 
0 ppm  417069 313358 520779 0.033182 1.3299 0.2613 
1 ppm  378516 274805 482226 
5  ppm  334153 230443 437863 
10  ppm 282369 178658 386079 




used to compare mean lymphocyte proliferation quotients across the various nitrite 
exposures. There was a statistically significant difference (F=2.47, p=0.0463) between 
the magnitude of changes in lymphocyte proliferation at various nitrite concentrations 
(0, 1, 5, 10, and 15 ppm), (Table 14 and Figure 14). The F ratio indicated that an 
increase in nitrite concentration yielded a higher lymphocyte proliferation by 2.47 times.  
Table 14: Mean Degree of Change (Quotient) at Various Nitrite Concentrations 
 
 
Figure 14: Mean Lymphocyte Proliferation Quotient at Various Nitrite 
Concentrations 
 
Analysis of Variance 
Level Mean Lower 95% Upper 95% R square F Ratio P Value 
0 ppm  1.05090 0.8168 1.2850 0.060137 2.4794 0.0463* 
1 ppm  1.10541 0.8714 1.3395 
5 ppm  1.08449 0.8504 1.3186 
10 ppm 1.11889 0.8848 1.3530 




Lymphocyte Proliferation Quotient in Pooled Nitrite Concentration 
To explore breakpoints in the dose response relationships the nitrite 
concentrations were pooled into three different categories: 
1. Nitrite Concentration Less than 5 ppm to Equal or more than 5 ppm 
2. Nitrite Concentration Less than 10 ppm to equal or more than 10 ppm 
3. Nitrite Concentration Less than 15 ppm to Equal to 15 ppm 
A t-Test was conducted to detect any difference between mean lymphocyte 
proliferation quotients above/below pooled nitrite concentration exposures. Proliferation 
was impacted when cells were exposed to equal or more than 10ppm nitrite 
concentration and this was statistically significant (F= 4.4841, p=0.0358). Furthermore, 
the impact increased when the cells were exposed to even higher nitrite concentrations 
of 15 ppm (F= 9.9066, p=0.0020) (Table 15 and Figure 15, Table 16 and Figure 16).    
 
Table 15: Mean Lymphocyte Proliferation Quotient in Pooled Nitrite Concentration 
(Less Than 10 ppm to Equal or More Than 10 ppm) 
 






























Figure 15: Lymphocyte Proliferation Quotient in Pooled Nitrite Concentration (Less 




Table 16: Mean Lymphocyte Proliferation Quotient in Pooled Nitrite Concentration 
(Less Than 15 ppm to Equal to 15 ppm) 
 














DF F Ratio P Value 
Less than 
15 ppm 
1.503 0.982 1.197 -3.14747 -2.62887 0.059 1 9.9066 0.0020* 
Equal to 
15 ppm 







Figure 16: Lymphocyte Proliferation Quotient in Pooled Nitrite Concentration Less 
Than 15 ppm to Equal to 15 ppm) 
 
 
Lymphocytes Proliferation Quotient among Case (Osteoarthritis) and Control (Non-
Osteoarthritis) 
 The participants were categorized into two groups; Case group (participants 
having osteoarthritis) and Control group (participants without osteoarthritis). The case or 
control status (independent variable) was then compared to the various lymphocyte 
experimental conditions (dependent variables). The difference in mean lymphocyte 
proliferation in each nitrite exposure test was calculated using the t-test. The mean 
lymphocyte proliferation quotient (r=st/ns) varied between the case and the control 
group at 5 ppm (F= 4.28, p=0.0388) nitrite concentration and was found to be 




 Participants no having osteoarthritis had a high lymphocyte proliferation 
quotient compared to the case group and the result was statistically significant (F=4.67, 
p=0.0388). Therefore, the t-test indicated that the lymphocyte proliferation among 
control group was 4.28 times vigorous than the case groups (Table 17, Figure 17, and 
Appendix I20).   
 
 
Table 17: Mean Lymphocytes Proliferation Quotient between Case and Controls at 5 
ppm Nitrite Concentration 
 

















No 1.33 0.85 1.80 -2.16131 -2.16131 0.13473 1 4.2885 0.0388* 




















Nitric Oxide Activity Quotient of All Participants 
Using immunoassay tagging and the Millipore MUSE flow cytometer two 
important cell health parameters involving NO where analyzed at each of the exposure 
levels, first change in intracellular nitric oxide activity levels and second, cell death with 
and without NO expression. The test resulted in five distinct measures: 
1. No Nitric Oxide Activity 
2. Live Cells with Nitric Oxide Activity 
3. Dead Cells with Nitric Oxide Activity 
4. Dead Cells with no Nitric Oxide Activity 
5. Total cells with Nitric Oxide Activity  
In the statistical analysis tests, Live Cells with Nitric Oxide Activity, Dead Cells with 
Nitric Oxide Activity, and Total Cells (Live + Dead) were used.  These measures are 
thought to capture the possible range of responses the lymphocytes would express 
following increasing mitotic and exposure level stresses. 
Nitric Oxide Activity by Live Cells Quotient at Various Nitrite Concentrations 
 The one-way ANOVA analysis was conducted to find if there was any difference 
between mean live cells with nitric oxide activity at various nitrite concentration (0, 1, 5, 
10, and 15 ppm).  There was no statistically significant association between nitric oxide 
activity by live cells at various nitrite concentrations found (F=1.18, p=0.3186) (Table 




Table 18: Nitric Oxide Activity by Live cells Quotient at Various Nitrite Concentrations 
Nitric oxide live cells 










0 ppm 1.17780  -0.358 2.7140 0.0347 4 1.1892 0.3186 
1 ppm 2.68429 1.233 4.1358 
5 ppm 0.50808  -1.028 2.0442 
10 ppm 1.15733  -0.245 2.5596 
15 ppm 1.74821 0.322 3.1745 
 
 
 Nitric Oxide Activity by Dead Cells Quotient at Various Nitrite Concentrations 
The one-way ANOVA analysis was conducted to find if there was any difference 
between mean nitric oxide activity by dead cells at various nitrite concentrations (0, 1, 5, 
10, and 15 ppm).  The result indicated at there was no association between nitric oxide 
activity by dead cells at various nitrite concentrations and the difference was not 
statistically significant (F=0.494, p=0.7397) (Table 19). 
 
Table 19: Nitric Oxide Activity by Dead cells Quotient at Various Nitrite 
Concentrations 
 
Nitric oxide dead cells 










0 ppm 1.45669 0.0168 2.8965 0.0235 4 0.494 0.7397 
1 ppm 1.70100 0.2611 3.1409 
5 ppm 0.69439  -0.6631 2.0519 
10 ppm 0.95526  -0.3660 2.2766 




Nitric Oxide Activity by Total Cells Quotient (Live + Dead) at Various Nitrite 
Concentrations 
A one-way ANOVA was used to explore the difference between mean nitric 
oxide activity by total cells, both live and dead, at various nitrite concentrations (0, 1, 5, 
10, and 15 ppm).  There was no association between total nitric oxide activity by total 
cells at various nitrite concentrations (F=1.270, p=0.285) (Table 20). 
   
Table 20: Nitric Oxide Activity by Total Cells Quotient (Live + Dead) at Various Nitrite 
Concentrations 
Total Nitric oxide activity 










0 ppm 1.3189 0.5527 2.0851 0.03365 4 1.270 0.285 
1 ppm 1.9932 0.2716 3.7148 
5 ppm 0.5812 0.3743 0.7882 
10 ppm 1.1032 0.7495 1.4568 
15 ppm 1.3556 0.9360 1.7753 
 
 
Nitric Oxide Activity Quotient in Pooled Nitrite Concentrations 
A t-test was used to explore the difference between mean nitric oxide activity by 
live, dead, and total cells at various break points for pooled nitrite concentration 
categories (less than 5 ppm to equal or more than 5 ppm, less than 10 ppm to equal or 
more than 10 ppm, and less than 15 ppm to equal to 15 ppm). The results did not 




Table 21: Nitric Oxide Activity by Live Cells at Various Pooled Nitrite Concentrations 
Nitrite  
concentrations 















 (<5 ppm to >5 ppm) 
1 0.010 -1.18112 -0.96625 1.395 0.2396 
Concentration Pooled 
 (<10 ppm to >10 ppm) 
1 5.1e-5 -0.08331 -0.0928 0.006 0.9337 
Concentration Pooled 
(<15 ppm to =15 ppm) 
1 0.0012 -0.41691 -0.57949 0.173 0.6774 
 
Table 22: Nitric Oxide Activity by Dead Cells at Various Pooled Nitrite Concentrations 
Nitrite  
concentrations 















 (<5 ppm to >5 ppm) 
1 0.0052 -0.67041 -0.63508 0.449 0.5044 
Concentration Pooled 
 (<10 ppm to >10 ppm) 
1 0.0003 0.180707 0.176231 0.032 0.8570 
Concentration Pooled 
(<15 ppm to =15 ppm) 
1 0.0082 -0.84105 -0.59881 0.707 0.4027 
 



















 (<5 ppm to >5 ppm) 
1 0.0158 -1.54935 -1.32404 2.400 0.1234 
Concentration Pooled 
 (<10 ppm to >10 ppm) 
1 0.0004 -0.24748 -0.28538 0.061 0.8049 
Concentration Pooled 
(<15 ppm to =15 ppm) 




Nitric Oxide Activity Quotient among Case (Osteoarthritis) and Control (Non-
Osteoarthritis) 
The difference in mean nitric oxide activity between case and control was 
calculated using the t-test. The independent variable was osteoarthritis (Yes/No) and the 
dependent variable was nitric oxide activity level. In all of the NO expression measures 
considered (nitric oxide activity by live cells, nitric oxide activity by dead cells, and 
nitric oxide activity by total cells), there was no association with osteoarthritis case 
status (Table 24, Appendix I33).  
 
Table 24: Nitric Oxide Activity Quotient among Case and Control 
 NO Activity Parameters 
Nitrite Concentrations 
0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
NO activity with Live Cells 0.2429 0.4075 0.4815 0.1795 0.5362 
NO activity with Dead Cells 0.4588 0.2179 0.7559 0.5845 0.2319 
NO activity Total Cells 0.3104 0.4699 0.5696 0.3037 0.6897 
X-Axis: Osteoarthritis (Yes or No) 






DNA Damage Quotient of All Participants 
 
Using immunoassay tags and the Millipore MUSE flow cytometer, lymphocyte 
expression of DNA damage ranging from mild dephosphorylation to histone damage 
and double strand breaks was explored in relationship to the various nitrite exposure 
levels. The test protocol measured the following parameters: 
1. Percentage of negative cells (no DNA Damage) 
2. Percentage of ATM activated cells (dephosphorylation) 
3. Percentage of H2A.X activated cells (histone protein damage) 
4. Percentage of DNA double-strand break (dual activation of both ATM and 
H2A.X) 
5. Percentage of Total DNA Damage 
Using bivariate fit the percentage of ATM activated cells, the percentage of 
H2A.X activated cells, the percentage of DNA double-strand break (dual activation of 
both ATM and H2A.X), and percentage of total DNA damage was examined at each of 
the exposure levels of sodium nitrite.    
pATM Activated Cell Quotient at Various Nitrite Concentrations 
An ANOVA test was used to explore the difference between mean percentages 
of pATM activated cells at various nitrite concentrations. The pATM activated cells 
were recorded as a quotient of stimulated to the non-stimulate state. The activation of 




there was some trend of pATM activation with increased nitrite concentration (Table 25) 
but the result was not statistically significant (F=1.83, p=0.1281).  
 
Table 25: pATM Activated Cells at Various Nitrite Concentrations 
pATM activated cells 










0 ppm 0.50341 0.0576 0.9492 0.07252 4 1.837 0.1281 
1 ppm 0.43894 -0.0539 0.9318 
5 ppm 1.03872 0.5459 1.5316 
10 ppm 1.01609 0.5703 1.4619 


















pH2A.X Activated Cell Quotient at Various Nitrite Concentrations  
The activation of pH2AX precedes more severe damage to DNA and indicates 
potential double-strand breaks as it is a marker for disrupted histone protein. ANOVA 
analysis was used to explore the mean trend of pH2AX activated cells at various nitrite 
concentrations. The mean pH2AX activated cells were highest (Mean=1.46) at 15 ppm 
compared to at 0 ppm (Mean=1.29) nitrite concentration but the result was not 
statistically significant (F=1.12, p=0.3474) indicating that there was no statistically 
significant difference between mean pH2AX activation at various nitrite concentrations 
(Table 26 and Figure 19). 
 
Table 26: pH2AX Activated Cells at Various Nitrite Concentrations 
pH2AX  activated cells 










0 ppm 1.29073 0.71834 1.8631 0.037396 4 1.126 0.3474 
1 ppm 0.92967 0.38165 1.4777 
5 ppm 1.00242 0.47591 1.5289 
10 ppm 0.73725 0.18923 1.2853 






Figure 19: pH2AX Activated Cells at Various Nitrite Concentrations 
 
DNA Double-Strand Break Quotient at Various Nitrite Concentrations 
Activation of both ATM and H2A.X cells triggers DNA double-strand break 
which might lead to cell death if not repaired. ANOVA analysis was used to explore the 
difference between DNA double-strand break at various nitrite concentrations. Increased 
nitrite exposure was not positively, statistically associated with double-strand break (F= 
1.34, p>0.05). However, there was a trend in the data in that the double-strand break was 
higher as the nitrite exposure level increased to 10 ppm (Mean= 1.64) but the break 















Table 27: DNA Double-Strand Break at Various Nitrite Concentrations 
DNA double-strand break 










0 ppm 1.09593 0.6017 1.5901 0.039747 4 1.3453 0.2567 
1 ppm 1.16038 0.6475 1.6732 
5 ppm 1.21512 0.7023 1.7280 
10 ppm 1.64107 1.1469 2.1353 


















Total DNA Damage Quotient at Various Nitrite Concentrations 
ANOVA analysis was used to examine the difference between increased nitrite 
concentration and total DNA damage. Total DNA damage increased as cells were 
exposed to greater than 10ppm (Mean=1.73 for 10ppm and Mean=1.56 for 15ppm) as 
compared to control (Mean=1.24 for 0ppm). Even though there was some trend seen 
between nitrite exposure and total DNA damage, the result (Table 28, Figure 21) was 
not statistically significant (F=0.76, p=0.5527). 
 
Table 28: DNA Double-Strand Break at Various Nitrite Concentrations 
Total DNA damage 










0 ppm 1.24830 0.5135 1.9831 0.020406 4 0.7603 0.5527 
1 ppm 0.97857 0.2438 1.7133 
5 ppm 1.08683 0.3521 1.8216 
10 ppm 1.73725 1.0258 2.4487 







Figure 21: Total DNA Damage at Various Nitrite Concentrations 
 
pATM Activated Cells by 5 ppm Nitrite Concentration 
The study used five different level of nitrite concentration exposure (0, 1, 5, 10, 
and 15 ppm. For statistical analysis, the exposures were pooled together if find if there 
was any impact in DNA thorough pATM activated cells. The pooled nitrite 
concentration category (less than 5 ppm to equal or more than 5 ppm) was used for the 
analysis. The t-test was conducted to find if there was any difference in mean pATM 
activated cells in above two pooled categories. The result indicated positive difference 
indicating that the percentage of pATM activated cells was high when exposed to nitrite 
concentration of 5ppm or more (Figure 22). The t-test showed the statistically significant 
result (F=7.44, p=0.0076) indicating that cells exposed to higher nitrite concentration 















Figure 22: pATM Activation at 5 ppm Nitrite Concentrations 
 
  




























pH2AX Activated Cells by 5 ppm Nitrite Concentrations 
 In similar fashion, based on observed trends, the pooled nitrite concentration 
grouping (less than 5 ppm to equal or more than 5 ppm) was used to explore differences 
between the means of pH2AX (histone damage) activated cells above and below the 
break-point. The t-test was used; however, in this case there was no statistically 
significant difference (Table 30), (F=0.0131, p=0.9092).   
Table 30: pH2AX Activation at 5 ppm Nitrite Concentrations 
 
 
DNA Double-Strand Break at 5 ppm Nitrite Concentrations 
The t-test was used to explore the difference between the percentage of DNA 
double-strand break at less than 5 ppm and equal or more than 5 ppm sodium nitrite 
exposure. There was no statistically significant difference between mean pooled nitrite 
concentration and double-strand break above and below the 5 ppm exposure level (Table 
31; F= 0.21, p=0.64).  
  






























Table 31: DNA Double-Strand Break at 5 ppm Nitrite Concentrations 
 
Total DNA Damage at 5 ppm Nitrite Concentrations 
The t-test was used to explore the difference between total DNA damage at less 
than 5ppm and greater than 5 ppm.  There was a trend as mean total damage observed at 
less than 5 ppm was 1.11 and increased to 1.46 when cells were exposed to more than 
5ppm of nitrite (Table 32). Even though a trend was observed, the difference was not 
statistically significant (F= 1.10, p=0.2944).  
  

































Table 32: Total DNA Damage at 5 ppm Nitrite Concentrations 
 
 
DNA Damage Quotient among Case (Osteoarthritis) and Controls (Non-Osteoarthritis) 
The t-test was used to explore the difference between osteoarthritis cases and 
controls and DNA damage in the form of pATM activated cells, pH2AX activated cells, 
DNA double-strand break, and total DNA damage. All of the predictors of DNA damage 
showed no relationship to osteoarthritis. The analysis showed that there was no 
significant difference between pATM activated cells, double-strand break ,pH2AX 
activated cells , total DNA damage, and osteoarthritis (Yes/No) (Table 33, Appendix 
I42). 
  

































Table 33: DNA Damage Quotient among Case and Controls 
DNA Damage Parameters 
Nitrite Concentrations 
0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
pATM 0.7987 0.5433 0.7802 0.2676 0.7525 
PH2A.X Activated Cells 0.6141 0.4113 0.1809 0.7912 0.1587 
DNA Double-strand Break 0.9132 0.0595 0.1752 0.8126 0.1368 
Total DNA Damage 0.1457 0.2541 0.5199 0.7063 0.2356 
X-Axis: Osteoarthritis (Yes or No) 




A multivariate analysis was performed to explore to what degree significant 
findings between experimental measures and significant findings in demographic, 
medications, and health status variables were related or interacted and to what degree, if 
any, specific variables impacted lymphocyte survival and vigor the most. Variables used 
for the whole model log fit test were questions on age, gender, city of residence, 
drinking water source, life changing events in past six months, immunizations within 
last two weeks prior to the survey, allergies, smoking habits, immunological disease and 
chronic disease, osteoarthritis, sweet-tooth, hours spent outside per day, number of 
supplements, and number of medications by the exposure levels. The significant finding 
in the whole model test is shown in Table 34. The result showed that age impacted the 
double-strand break in increasing trend (F=12.320, p=0.039). The lymphocyte 
proliferation was significantly impacted at 5 ppm nitrite concentration among 




pATM activated cells was significantly high (ChiSq=4.778267, p= 0.028) among the 
participants drinking city water or public water. In the case of immunization in the past 
two weeks, participants with no immunization had significantly higher double-strand 
break at 1 ppm nitrite concentration (ChiSq=4.057145, p=0.043) and percentage of 
pH2AX activated cells at 1 ppm nitrite concentration (ChiSq=4.214185, p=0.040).  
Participants in control group i.e without osteoarthritis showed significant impact 
in lymphocyte proliferation at 5 ppm nitrite concentration (ChiSq=4.311354, p= 0.037). 
In addition, control group also showed significantly higher percentage of pH2AX 
activated cells at 0 ppm nitrite concentration (ChiSq=4.620307, p=0.031) and Total 
DNA damage at 0 ppm nitrite concentration (ChiSq=4.862667, p=0.027). Lastly, there 
was significantly decrease in lymphocyte proliferation at 15 ppm nitrite concentration 
(F=5.570, p= 0.026) among the participants taking higher number of medications 





Table 34: Whole Model Test of Demographic, Health, and Medication Survey with 












Age Not Significant Not 
Significant 
DSB 5 ppm 

















 p= 0.02882*) (CW) 
Immunization 
 
Not Significant Not 
Significant 
DSB 1 ppm  
(ChiSq=4.057145, p=0.04398*) 
(N) 






Quotient 5 ppm 
(ChiSq=4.311354, 





pH2AX 0 ppm  
(ChiSq=4.620307, p=0.0316*) 
(N) 
Total DNA Damage  






Quotient at 15 ppm 





X axis: Experiments (Lymphocyte Proliferation, NO Activity, and DNA Damage) 
Y axis: Demographic, Health, and Medications Survey 
DSB: Double-Strand Break 
I: Increasing Trend, D: Decreasing Trend, CF: Cedar Falls, CW: City Water, N:No 






DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS 
Discussion 
Findings from the questionnaire survey and laboratory analysis of the 32 subjects 
(16 Cases and 16 Controls) participating in this study are herein elaborated upon. As 
certain demographic characteristics were found to be statistically, significantly related to 
experimental outcomes these are discussed from the perspective of expected and 
unpredicted outcomes, the previous literature, and biological plausibility. These are 
discussed in light of the experimental exposures to low-level nitrite levels (0, 1, 5, 10, 
and 15 ppm) and response of the mononuclear cells. Demographic and health 
information is first addressed followed by a discussion of lymphocyte proliferation, 
nitric oxide activation, and DNA damage. 
Demographic Information 
In this study participants ranged in age from 40 to 65 years, consisting of both 
cases and controls. This age range corresponds to individuals most likely to have 
arthritis in the general population. The Centers for Disease Control, CDC indicates that 
34.6% of osteoarthritis patients were between the ages of 45 and 64 years and the risk of 
developing osteoarthritis increases with age (Barbour et al., 2013). Therefore, we invited 
participants from this age group.  
There were 25 female participants and 7 male participants. According to CDC, 




(CDC, 2016). The prevalence of osteoarthritis dramatically increases in women after 
menopause. Osteoarthritis and osteoporosis affects more than 60% of post-menopausal 
women in the United States (Avci & Bachmann, 2011). Estrogen is a hormone that has a 
protective role in the maintenance of joint homeostasis (Millán & Castañeda, 2013). In 
menopausal women, the estrogen level is lower than normal which accelerates the 
articular inflammation leading to osteoarthritis (Roman-Blas, Castañeda, Largo, & 
Herrero-Beaumont, 2009). This, is a likely reason for   getting more female participants 
as compared to male participants.   
Another demographic examined was the city of residence. An annual water 
quality report for public information purposes is required under the Safe Drinking Water 
Act, SDWA. Reports from Cedar Falls Utilities indicated that nitrate concentration in 
public drinking water was 9.8 ppm and 8.8 ppm in 2015 and 2016 respectively (CFU, 
2016 & CFU, 2017). Place of residence was added as a variable in this study to 
determine if any difference in mean lymphocyte proliferation, NO activity, and DNA 
damage could be detected between participants residing in Cedar Falls and other cities. 
The t-Test was used to explore differences in mean lymphocyte proliferation, NO 
activity, and DNA stress at various nitrite concentrations based on residence with an 
understanding that one local residence namely, Cedar Falls reflected a more highly 
exposed group. Results indicated city of residence was associated with an impact on 
lymphocyte proliferation and DNA damage at 5 ppm nitrite exposure and the result was 
statistically significant. This is interesting in light of the consistently high exposures 




Medication, Herbs, and Supplements 
Among the 16 participants who had osteoarthritis, nine took some form of 
vitamin as their supplement. Vitamin D is an essential supplement, especially for people 
suffering from osteoarthritis because it promotes the absorption of calcium and 
phosphorus that helps to build bone. Research done by Garfinkel et al. (2017) indicated 
that vitamin D deficiency poses a risk for osteoarthritis by decreasing cartilage 
thickness. Similarly, Vitamin B12 helps the body to produce healthy red blood cells and 
helps lower the production of homocysteine (high levels in the blood have been linked to 
weak bones and heart disease). Therefore, supplements such as Vitamin B12 decrease 
the level of homocysteine which is considered to weaken the bones and cartilage 
between the bones (Avci & Bachmann, 2011; McLean et al., 2004). A bivariate fit 
analysis indicated protective trend relative to NO activity by live cells (F=5.53, p=0.02 
at 10 ppm nitrite concentration), NO activity by total cells (F=4.311, p=0.049 at no 
nitrite exposure), and pATM activity (F= 9.01, p=0.008 at 10 ppm nitrite concentration) 
with an increasing number of herbs and supplements taken, indicating protective effect. 
Among the 32 participants, 18 were taking prescribed medications. There were 8 
participants taking antidepressants and blood pressure/ heart-related medications 
respectively. Nine out of 16 participants having OA were taking prescribed medications. 
Five were taking antidepressants and NSAIDs medications. Since OA is associated with 
chronic pain and long-term inflammatory processes this is also correlated with 
associated with depression (Jesus, Jesus, & Agius, 2016).  Therefore, it is not surprising 




medication. The most common brand names reported were duloxetine, fluoxetine, and 
Cymbalta, and there brands are commonly reported as prescribed in the literature (Jesus 
et al., 2016; Sullivan, Bentley, Fan, & Gardner, 2009). NSAIDs are another common 
prescription medication among the participants with osteoarthritis in this study. There 
were 10 osteoarthritis patients taking prescribed medications and among them three 
were taking NSAIDs. Since these medications are commonly used to relieve 
inflammation and pain, it is a common medication among the osteoarthritis patients 
(Milder, Williams, Ritchie, Lipworth, & Day, 2011). Interestingly, however, bivariate fit 
analysis indicated a decrease in lymphocyte vigor (F=5.57, p=0.026 at 15 ppm nitrite 
concentration) and response and an increase in double-strand break (F=5.79, p=0.025 at 
15 ppm nitrite concentration) and total DNA damage (F=7.05, p=0.013 at 1 ppm nitrite 
concentration) with an increased number of medications taken. Antidepressant 
medication is associated with decreased lymphocyte cells such as CD3 and CD4 T-
lymphocytes, and Natural Killer cells because it alters T-cell cytokine production mainly 
reducing proinflammatory cytokines production (Ravindran, Griffiths, Merali, & 
Anisman, 1995; Diamond, Kelly, & Connor, 2006).   
Health Information 
Among the various health-related questions, three of them showed a strong 
difference with lymphocyte proliferation, NO activity, and DNA stress. Those questions 
were; major life-changing events, immunological and chronic disease, and immunization 
history. Participants experiencing stressful life events showed a significant increase in 




live cells at 15 ppm nitrite concentration; F=4.84, p=0.0449 by dead cells at no nitrite 
exposure; F=16.32, p=0.0099 by dead cells at 10 ppm nitrite concentration; F=25.06, 
p<0.0001 by total cells at no nitrite exposure; F=4.86, p=0.035 by total cells at 10 ppm 
nitrite concentration) and DNA stress (F=4.36, p=0.049 for pATM activated cells at no 
nitrite exposure; F=6.42, p= 0.018 for double-strand break at 1 ppm nitrite 
concentration). Several studies indicated that stress contributes to DNA methylation 
which thereby modifies the function of the gene and affects the gene expression leading 
to epigenetic modification (Blaze & Roth, 2015; Klengel, Pape, Binder, & Mehta, 2014; 
Unternaehrer et al., 2012).  In the case of immunological and chronic disease, 
participants having fibromyalgia showed significant response regarding NO activity 
(F=3.4004, p=0.0482 by live cells at 10 ppm nitrite concentration; F=6.67, p=0.0046 by 
live cells at 15 ppm nitrite concentration; F=14.03, p=0.0016 by dead cells at 10 ppm 
nitrite concentration; F=4.69, p=0.0174 by total cells at 10 ppm nitrite concentration) 
and DNA damage (F=3.59, p=0.047 for pATM activated cells at no nitrite exposure; 
F=3.21, p=0.0689 for pATM activated cells at 5 ppm nitrite concentration). The reactive 
oxygen intermediates in autoimmune disease are responsible for genomic DNA damage. 
Studies found that a pro-mutagenic DNA lesion, 8-Oxo-7-hydrodeoxyguanosine (8-
oxodG) was significantly high among people having autoimmune disease (Bashir, 
Harris, Denman, Blake & Winyard, 1993; Ogawa et al., 2013). In addition, participants 
having had a flu shot within two weeks showed significant impact on DNA damage 
(F=19.58, p=0.0002 for pH2AX at 1 ppm nitrite concentration; F=5.83, p=0.0245 for 




develop in the body which provide protection against infection with the viruses that are 
in the vaccine (WHO, 2017). In elderly population mainly aged over 65 years, the 
influenza vaccination significantly lowered the lymphocytes counts at four weeks than at 
the baseline (Cummins, Wilson, Foulger, Dawson & Hogarth, 1998). Lymphocytes use 
reactive oxygen species (ROS) for carrying out their normal functions but excess 
amount of ROS lead to cell damage. ROS is also responsible for the activation of ATM 
cells which is also indicates DNA damage (Ash, 2010; Gautam et al., 2010). 
Lymphocyte Proliferation  
  ANOVA analysis was conducted on lymphocyte proliferation at various nitrite 
concentrations (0, 1, 5, 10, and 15ppm) to explore the difference between mean 
lymphocyte proliferation and nitrite concentration. Lymphocyte proliferation in each 
non-stimulated and stimulated exposure scenario was analyzed separately under the 
various nitrite exposure scenarios to explore dose-response relationships. In the non-
stimulated condition, the lymphocyte proliferation significantly decreased with higher 
exposure to nitrite concentration. Therefore, the study rejected the null hypothesis which 
signifies that there is a statistical difference in lymphocyte proliferation between 
different nitrite concentrations (F=7.28, p<0.0001). The mean lymphocyte count at no 
nitrite exposure (0 ppm) was 395663, which were reduced following various nitrite 
concentrations (1 ppm= 341394, 13.71% decrease; 5 ppm= 309425, 21.8% decrease; 10 
ppm= 246659, 37.66% decrease; 15 ppm=195369, 50.63% decrease). Similarly, in the 
stimulated condition, lymphocyte proliferation decreased with higher exposure to nitrite 




decrease) but the result was not statistically significant (F=1.32, p=0.2613). In a 
stimulated condition, the study had accepted the null hypothesis indicating that there is 
no statistical difference in lymphocyte proliferation between different nitrite 
concentrations. 
A quotient of stimulated to non-stimulated cells was generated to characterize 
the mitotic vigor of the samples following mitogen stimulation.  This quotient was then 
analyzed using one-way ANOVA which indicated that the proliferation vigor was highly 
impacted by increasing nitrite concentration. The dose-response relationship was 
observed where lymphocyte response significantly decreased with increasing nitrite 
(F=2.47, p=0.0463) exposure. Therefore, the null hypothesis was rejected as there was a 
statistically significant difference between proliferation response and exposure level.  
A study by Ustyugova et al. (2002) exposed human mononuclear cells to sodium 
nitrite and sodium nitrate salt, examining lymphocyte proliferation. The study found that 
nitrate had no effect on lymphocyte proliferation, but nitrite decreased proliferation. In 
addition, it decreased the production of T helper cell 1 (Th1) cytokines, which provides 
resistance to a variety of infectious diseases. Another study by Goedert et al. (1982) 
found that homosexual men who regularly used butyl nitrite had low counts of T 
lymphocytes and suggested that the nitrites may be immunosuppressive. The study used 
multiple nitrite concentrations finding nitrite significantly decreased lymphocyte 
proliferation at 10ppm (p<0.05) and that a trend was exhibited even at 1ppm although at 
other doses the suppression was not found to be statistically significant. Therefore, the 




it was not statistically significant. However, this should be considered due to the small 
sample size. 
In the real world, people are not exposed to only one source of nitrite exposure, 
but in fact, there are multiple sources of exposure such as drinking water (15-20%), 
vegetables (60-80%), cured meat products (0.3 to 2.6 mg/day of nitrite), as well as some 
medication (Weitzberg & Lundberg, 2013; WHO, 2011). Since low lymphocyte 
proliferation was observed with increasing exposure to nitrite, it is obvious that 
continuous exposure to nitrite from non-food sources at higher levels through drinking 
water (5-10 ppm nitrite, or 50-100 ppm nitrate) at concentrations not previously seen as 
harmful, could be impacting human health or worsening chronic inflammatory 
conditions.  
 In case of lymphocyte proliferation comparison between cases and controls, the 
study found that participants with osteoarthritis had decreased lymphocyte proliferation 
and mitogenic response as compared to participants without osteoarthritis. Although it 
has long been considered a “wear and tear” disease, recent studies found that 
osteoarthritis is a much more complex disease with inflammatory mediators released by 
cartilage, bone, and synovium (Berenbaum, 2013; Sokolove & Lepus, 2013). Leheita, 
Abed, Younes, and Mahmoud (2005) conducted a comparative study of T cell 
production among two group of patients, first were osteoarthritis knee patients and 
second were rheumatoid arthritis patients. The study revealed that there was no 
statistical difference between lymphocyte subsets of both groups indicating a similar 




the lymphocytes in osteoarthritis participants were already stressed due to inflammation. 
Addition of more stressor in the form of nitrite reduced the number of viable cells which 
decreased lymphocyte proliferation in osteoarthritis participants compared to non-
osteoarthritis participants.  
 In this study, the lymphocyte proliferation of participants with osteoarthritis was 
significantly lower when compared to participants without osteoarthritis. Therefore, the 
null hypothesis was rejected, signifying that there was a statistically significant 
difference between mean lymphocyte proliferation and case and control status.  
Nitric Oxide Activity 
Nitrite is recycled in blood and tissue to form nitric oxide (NO) and other 
bioactive nitrogen oxides (Lundberg et al., 2008).  It was hypothesized that there was a 
possibility of increased NO stress in the lymphocytes with increased nitrite 
concentration. NO is associated with increased production of proinflammatory cytokines 
that contribute to inflammation and apoptosis and are involved in the pathogenesis of 
inflammatory disorders of the joints, guts, and lungs (Abramson, 2008; Sharma, Al-
Omran, & Parvathy, 2007).  
In the case of nitric oxide activity, this study accepted the null hypothesis 
indicating that there was no statistically significant difference between nitric oxide 
activity in all lymphocyte states (live cells, dead cells, and total cells) and various nitrite 
concentrations as well as among the cases and controls. It is interesting to note, 




proinflammatory cytokines such as interleukin-1 and tumor necrosis factor- alfa which is 
present at the site of joint damage and responsible for destruction of cartilage which is 
part of the pathogenesis of osteoarthritis (Abramson, 2008; Kapoor et al., 2011; 
Vuolteenaho, Moulanen, Knowles, & Moilanen, 2007).  This study indicates that NO 
present around the lymphocytes is not increasing their production or release. 
DNA Stress 
Double-stranded DNA breaks must be preceded by the activation of ATM 
(Ataxia-telangiectasia mutated kinase). Once activated, ATM triggers other downstream 
factors such as phosphorylation of histone variant, H2A.X. The presence of ATM and 
Histone H2A.X indicates the level of DNA damage present within the cell. Therefore, 
understanding of DNA damage is an important area of human health research when 
attempting to understand the possible biomolecular impacts of toxicants and toxins 
(Millipore Sigma, 2013). This study used the Millipore Muse Multi-Color DNA damage 
Kit to detect the activation of ATM and H2A.X using flow cytometry. The activation of 
ATM indicates light DNA damage. As the percentage of ATM activated cells increase, 
the likelihood of DNA damage increases by disrupting the histone protein, which then 
results in activation of H2A.X cells. The activation of H2A.X cells indicates major DNA 
damage. The combination of ATM and H2A.X activated cells result in DNA double-
strand damage.  
This study found that light DNA damage (percentage of ATM activated cells) 
was increased with increased nitrite concentrations especially when cells were exposed 




hypothesis predicting no difference between DNA stress and lymphocyte DNA damage. 
Nitrite is converted to nitric oxide endogenously in the human body. The study by 
Cherng et al. (2008) indicated that exposure to sodium nitroprusside (SNP) increased 
cellular NO level which induced DNA fragmentation and cell apoptosis. The study 
indicated that administration of 1 mMol SNP significantly increased DNA fragmentation 
by 80% and increased apoptotic cells by 78%.  This study further supports those 
findings.  
Differences between osteoarthritis cases and controls, where not detected 
regarding signs of DNA damage such as pATM activated cells, pH2A.X, DNA double-
strand break, and total DNA damage. Therefore, the study accepted the null hypothesis 
indicating that there would be no statistically significant difference between cases and 
controls regarding DNA damage.  The increasing DNA damage seen in lymphocytes 






Conclusions and Recommendations 
Nitrite and nitrate occurs naturally in the environment and the body. It is of use 
in certain concentrations for vital bodily and environmental functions. However, levels 
of nitrate (nitrite is quickly oxidized in the ambient environment to nitrate) in the 
ambient environment near most human habitations and sources of drinking water has 
been steadily increasing since the late 1940s, early 1950s (Spiro & Stigliani, 2002). As 
levels in surface, ground and potable water have been steadily increasing, it is 
considered a water pollutant and agent of eutrophication. This is occurring because of 
extensive use of agricultural fertilizers and manures from animals. In groundwater, the 
presence of nitrate is problematic and widespread, especially in agricultural areas. Under 
Safe Drinking Water Act (SDWA), the EPA has regulated the maximum contaminant 
level (MCL) of nitrate at 10 ppm nitrate as nitrogen and nitrite at 1 ppm water from 
water treatment facilities. In humans, microorganisms convert 20% of total nitrate intake 
into nitrite on the tongue. For normal adults about 5-7% of ingested nitrate can be 
detected a salivary nitrite (EFSA, 2008).  
However, the population in the United States with private drinking water sources 
are consuming water without any regulatory or testing requirements as the SDWA does 
not apply to private wells. Nitrates are also commonly found in vegetables such as 
spinach, beets, lettuce, and other leafy vegetables. These nitrates in food and water are 
converted to nitrite (more toxic form) by microorganisms in saliva and the gut. Nitrite 
formed in this process is converted to nitric oxide in the stomach under acidic 




humans (Cherng et al., 2008). The excess nitric oxide results in a proinflammatory 
process which triggers chondrocytes apoptosis leading to pain related to osteoarthritis 
(Abramson, 2008) Although osteoarthritis is not considered a general inflammatory 
disease wherein the body’s immune system broadly attacks joints and other organs, 
synovial joint damage and wear and tear leads to local inflammation and the production 
of nitric oxide. Since previous studies had illustrated an in-vivo relationship between 
higher levels of nitrate in drinking water and complaints of bone and joint problems, 
particularly osteoarthritis, this study was done to determine if cases of osteoarthritis had 
a differing lymphocyte response to increasing nitrite exposures (Zeman et al., 2011).  
The results of this study illustrate that increasing nitrite exposure has some level 
of impact on human mononuclear cells and that there are differences in how the 
lymphocytes of arthritis cases versus controls respond to those exposures. Five different 
concentrations ranging from 0 ppm (no exposure, control) to 15 ppm (high exposure) 
nitrite were used. Lymphocyte proliferation decreased when the nitrite exposure 
concentration was increased to 1 ppm and then followed by 5, 10, and 15 ppm. 
However, the significant decrease in proliferation was observed at 10 ppm nitrite 
exposure (p<0.05). Even though the study included only 32 participants, a significant 
impact on proliferation was observed with increasing nitrite concentration. Similarly, for 
cases and controls, the result found that proliferation decreased among osteoarthritis 
participants.  
Further, while nitric oxide stress was not found to play a role for proliferation 




concentration was observed in controls and cases with increasing nitrite exposures.  
Further, a significant break-point in the data was observed at nitrite concentrations of 5 
ppm and more (p<0.05). Therefore, the study indicated that light DNA damage was 
observed with increasing nitrite concentration by the activation of pATM in the 
lymphocytes.  
Overall the study had fairly interesting findings on lymphocyte proliferation and 
DNA stress.  And even though the study did not find any significant difference between 
nitric oxide stress and the lymphocytes, it cannot be concluded that increasing nitrite 
concentrations do not have an impact on nitric oxide activity, in fact, ambient levels may 
have been suppressing NO production in the lymphocytes. In the past study, another 
form of nitrite source was used to measure nitric oxide activity such as SNP. In this 
study, exposure of human chondrocytes to less than 1 mMol SNP significantly increased 
cellular NO levels by 38 percent (Cherng et al., 2008).  
Even through there were a small number of participants in this study, the fact 
that increasing nitrite exposure had a negative impact on lymphocyte proliferation and 
DNA stress indicates the need for further studies to understand these processes.  In 
addition, the study participants (40-65 years) were of limited age ranges, due to ease of 
recruitment, funding, and time constraints. It is understandable that osteoarthritis 
progresses with age, but there are people with this disease at younger ages, even in their 
twenties (Amoako & Pujalte, 2014). Future studies should therefore incorporate 
participants at younger ages so that their lymphocyte responses can be explored relative 




lymphocytes were exposed to various nitrite levels in microcell well plates. People are 
exposed to nitrite in their daily lives such as from drinking water, food, and medication, 
those should be carefully monitored with a detailed exposure history in a case and 
control selected population (in vivo case control study) and their lymphocytes 
systematically evaluated as should their cytokine expression.  The one previous in vivo 
study completed found the association with nitrate exposure and arthritis as part of a 
cohort study and not due to a case control design (Zeman et al., 2011). This important 
issue of the role of environmental exposures in the course of chronic diseases and 
conditions of aging should be further pursued to clarify the etiology of conditions and 
the recommendations for prevention and treatment. Additionally, public health 
education is important for people to know about the harmful impact of nitrite especially 
for people drinking private water with unknown nitrate and nitrite level. Drinking nitrate 
and nitrite contaminated water becomes cumulative when combined with consumption 
of food such as vegetable and processed meat with sodium nitrite. Therefore, the 
research recommend public outreach in term of publication, presentation, and sharing 






Abramson, S.B. (2008). Nitric oxide in inflammation and pain associated with 
osteoarthritis. Arthritis Research & Therapy, 10 (2), 1-7. 
 
Abuharfeil, N., Jaran, A., Shabsough, B. & Darmani, H. (2001). Effects of sodium nitrite 
on natural killer cells isolated from human peripheral blood. Archives of Toxicology, 
75, 291-296. 
 
Abuharfeil, N., Sarsour, E. & Hassuneh, M. (2001). The effect of sodium nitrite on some 
parameters of the immune system. Food and Chemical Toxicology, 39, 119-124. 
 
American Public Health Association, APHA (2016). Arthritis: Managing pain through 
healthy moves. The Nation’s Health. Retrieved on April 2, 2016 from 
http://thenationshealth.aphapublications.org/site/healthyyou/HealthyYouArthritis.pdf 
 
Amoako, A.O. & Pujalte, G.G.A. (2014). Osteoarthritis in Young, Active, and Athletic 
Individuals. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 7, 
27-32. 
 
Andreassi, M.G., Picano, E., Ry, S.D., Botto, N., Colombo, M.G., Giannessi, D… 
Biagni, A. (2001). Chronic long-term nitrate therapy: possible cytogenetic effect in 
humans. Mutagenesis, 16 (6), 517-521. 
 
Ansari, F.A., Ali, S.N. & Mahmood, R. (2015). Sodium nitrite-induced oxidative stress 
causes membrane damage, protein oxidation, lipid peroxidation and alters major 
metabolic pathways in human erythrocytes. Toxicology in Vitro, 29, 1878-1886. 
 
Archer, D., Milkowski, A., Coughlin, J.R. & Bryan, N. (2008).Sodium Nitrite: The 
Facts. American Meat Institute. Retrieved May 10, 2016 from 
31Thttps://www.meatinstitute.org/index.php?ht=a/GetDocumentAction/i/44170 
 
31TAsh, C. (2010). Stress, DNA Damage, and ATM. Science, 330 (6003), 425. 
 
31TAvci, D. & Bachmann, G.A. (2011). Osteoarthritis and osteoporosis in postmenopausal 
women: clinical similarities and differences. Menopause, 11 (6), 651-621. 
 
31TBailey S.J., Winyard, P., Vanhatalo, A., Blackwell, J.R., Dimenna, F.J., Wilkerson, 
D.P…Jones, A.M. (2009). Dietary nitrate supplementation reduces the O2 cost of 
low-intensity exercise and enhances tolerance to high-intensity exercise in humans. 






Barbour, K.E, Helmick, C.G., Theis, K.A., Murphy, L.B., Hootman, J.M., Brady, T.J. & 
Cheng, Y.J. (2013). Prevalence of Doctor-Diagnosed Arthritis and Arthritis-
Attributable Activity Limitation, United States, 2010–2012. Morbidity and Mortality 
Weekly Report, 62 (44), 869-873.  
 
Benjamin, N., O’Dris, F., Dougall, H., Duncan, C., Smith, L. & Golden, M. (1994). 
Stomach NO synthesis. Nature, 368, 502. 
 
Bashir, S., Harris, G., Denman, M.A., Blake, D.R. & Winyard, P.G. (1993). Oxidative 
DNA damage and cellular sensitivity to oxidative stress in human autoimmune 
diseases. Annals of Rheumatic Disease, 52 (9), 659-666. 
 
Berenbaum, F. (2013). Osteoarthritis as an inflammatory disease (osteoarthritis is not 
osteoarthrosis!). Osteoarthritis Cartilage, 21 (1), 16-21. 
 
Berke, G. & Clark, W.R. (2007). Killer Lymphocytes. Dordrecht, The Netherlands: 
Springer. 
 
Blaze, J. & Roth, T. (2015). Evidence from clinical and animal model studies of the 
long-term and transgenerational impact of stress on DNA methylation. Seminars in 
Cell & Developmental Biology, 43, 76-84. 
 
Böger, R.H. (2007). The Pharmacodynamics of L-Arginine. The Journal of Nutrition,  
137, 1650S-1655S. 
 
Boink, A. & Speijers, G. (2001). Health effects of nitrates and nitrites: A review. Acta 
Horticulture 563. 29-36. https://doi.org/10.17660/ActaHortic.2001.563.2 
Brass, D., Mckay, P. & Scott, F. (2014). Investigating an incidental finding of 
lymphopenia. BMJ, 348,g1721 
Cammack, R,Joannou, C.L., Cui, X.Y., Martinez, C.T., Maraj, S.R. & Hughes, M.N. 
(1999). Nitrite and nitrosyl compounds in food preservation. Biochimica et 
Biophysica Acta (BBA) - Bioenergetics, 1411, 475-488. 
 
Canter, L.W. (1997). Nitrates in Groundwater. Boca Raton, FL: Lewis Publishers. 
 










Center for Disease Control (2016). Arthritis at a glance: Improving the quality of life for 




31TCherng, Y.G., Chang, H.C., Lin, Y.L., Kou, M.L., Chiu, W.T. & Chen, R.M. (2008). 
Apoptotic Insults to Human Chondrocytes Induced by Sodium Nitroprusside Are 
Involved In Sequential Events, Including Cytoskeletal Remodeling, Phosphorylation 
of Mitogen-Activated Protein Kinase Kinase Kinase-1/c-Jun N-Terminal Kinase, 
and Bax-Mitochondria Mediated Caspase Activation. Journal of Orthopedic 
Research, 26 (7), 1018-1026.  
 
31TCho, H.J., Chang, C.B., Kim, K.W., Park, J.H., Yoo, J.H., Koh, I.J. & Kim, T.K. (2011). 
Gender and Prevalence of Knee Osteoarthritis Types in Elderly Koreans. The 
Journal of Arthroplasty, 26 (7), 994-999. 
 
Choi, M.I., Sinha, R., Gierach, G.L. & Ward, M.H. (2015). Dietary nitrate and nitrite, 
micronutrients, and postmenopausal breast cancer risk in the NIH-AARP Diet and 
Health Study. Cancer Research, Proceedings: AACR 106PthP Annual Meeting. 
Retrieved on April 10, 2016 from 
31Thttp://cancerres.aacrjournals.org/content/75/15_Supplement/1883.short 
 
Chui, H. F., Tsai, S.S., Wu, T. & Tang, C.Y. (2010). Colon cancer and content of 
nitrates and magnesium in drinking water. Magnesium Research, 23 (2), 81-89. 
 
Coggon, D., Reading, I., McLaren, M., Barrett, D. & Cooper, C. (2001). Knee 
osteoarthritis and knee. International Journal of Obesity, 25 (5), 622-627. 
 
Cummins, D., Wilson, M.E., Foulger, K.J., Dawson, D. & Hogarth, A.M. (1998). 
Haematological changes associated with influenza vaccination in people aged over 
65: case report and prospective study. International Society of Laboratory 
Hematology, 20, 285-287. 
 
Diamond, M., Kelly, J.P. & Connor, T.J. (2006). Antidepressants suppress production of 
the Th1 cytokine interferon-g, independent of monoamine transporter blockade. 
European Neuropsychopharmacology, 16, 481-490. 
 
Duncan, C., Dougall, H., Johnston, P., Green, S., Brogan, R., Leifert, C… Benjamin, N. 
(1995). Chemical generation of nitric oxide in the mouth from the enterosalivary 
circulation of dietary nitrate. Nature Medicine, 1 (6), 546-551. 
 
EFSA (European Food Safety Authority) (2008). Nitrate in vegetables: Scientific 





Erisman, J.W., Galloway, J.N., Seitzinger, S., Bleeker, A., Dise, N.B., Petrescu, R… 
Vries, W.D. (2013). Consequences of human modification of the global nitrogen 
cycle. Philosophical Transactions of The Royal Society B, 368, 
31Thttp://dx.doi.org/10.1098/rstb.2013.0116. 
 
31TErsoy, Y, Ozerol, E., Temer, I.,MacWalter, R.S., Meral, U. & Altay, Z.E. (2002). Serum 
nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, 
and osteoarthritis. Annals of Rheumatic Disease, 61, 76-78. 
 
Feelisch, M. (2008). The chemical biology of nitric oxide-an outsider’s reflections about 
its role in osteoarthritis. Osteoarthritis and Cartilage, 10 (2), S3-S13. 
 
Fowler, D., Coyle, M., Skiba, U., Sutton, M.A., Cape, N., Ries, A…Voss, M. (2013). 
The global nitrogen cycle in the twenty-first century. Philosophical Transaction of 
The Royal Society B, 368, 31Thttp://dx.doi.org/10.1098/rstb.2013.016431T 
 
 Galloway, J.N., Schlesinger, W.H., Levy II, H., Micheals, A. & Schnoor, J.L. (1995). 
Nitrogen fixation: Anthropogenic enhancement-environmental response. Global 
Biogeochemical Cycle, 9 (2), 235-252. 
 
 Garfinkel, R.J., Dilisio, M. F. & Agrawal, D.K. (2017). Vitamin D and Its Effects on 
Articular Cartilage and Osteoarthritis, Orthopedic Journal of Sport Medicine, 5 (6), 
1-8. 
 
Gautam, N., Das, S., Mahapatra, S.K., Chakraborty, S.P., Kundu, P.K. & Roy, S. (2010). 
Age associated oxidative damage in lymphocytes. Oxidative Medicine and Cellular 
Longevity, 3 (4), 275-282. 
  
 Gehle, K (2013). ATSDR Case Studies in Environmental Medicine Nitrate/Nitrite 
Toxicity. U.S Department of Health and Human Services, Retrieved on April 12, 
2016 from 31Thttp://www.atsdr.cdc.gov/csem/nitrate_2013/docs/nitrite.pdf31T 
 
Geng, L., Alexander, B., Cole-Dai, J., Steig, E.J., Savarino, J., Sofen, E.D…Schauer, 
A.J. (2014). Nitrogen isotopes in ice core nitrate linked to anthropogenic 
atmospheric acidity change. Proceedings of the National Academy of the United 
State of America, 111 (16), 5808-5812. 
 
Gilchrist, M. & Benjamin, N. (2011). From Atmospheric Nitrogen to Bioactive Nitrogen 
Oxides. In N.S. Bryan & J. Loscalzo (Eds.), Nitrite and Nitrate in Human Health (pp 
9-20). New York, NY: Humana Press. 
 
Goedert, J.J., Wallen, D.L., Strong, D.M., Neuland, C.Y., Greene, M.H., Murray, C… 
Blattner, W.A. (1982). Amyl Nitrite may alter T Lymphocytes in Homosexual Men. 




Grabowski, P.S., Wright, P.K., Hof, R.J., Helfrich, M.H., Oshima, H. & Ralston, S.H. 
(1997). Immunolocalization of inducible nitric oxide synthase in synovium and 
cartilage in rheumatoid arthritis and osteoarthritis. British Journal of Rheumatology, 
36, 651-655.  
  
Gruber, N. & Galloway, J. (2008). An Earth-system perspective of the global nitrogen 
cycle. Nature, 451 (17), 293-296. 
 
Heraud, F., Heraud, A. & Harmand, M.F. (2000). Apoptosis in normal and osteoarthritic 
human articular cartilage. Annals of the Rheumatic Disease, 59 (12), 959-965. 
 
Hord, N.G. (2011). Dietary Nitrates, Nitrites, and Cardiovascular Disease. Current 
Atherosclerosis Reports, 13 (6), 484-492. 
 
Hord, N.G, Tang, Y. & Bryan, N.S (2009). Food sources of nitrates and nitrites: the 
physiologic context for potential health benefits. The American Journal of Clinical 
Nutrition, 90, 1-10. 
 
Hunter, D.J., March, L. & Sambrook, P.N. (2002). Knee osteoarthritis: The influence of 
environmental factors. Environmental Rheumatology, 20, 93-100. 
 
 Innes, K.E., Ducatman, A.M., Luster, M.I. & Shankar, A. (2011). Association of 
Osteoarthritis with Serum Levels of the Environmental Contaminants 
Perfluorooctanoate and Perfluorooctane Sulfonate in a Large Appalachian 
Population. American Journal of Epidemiology, 174 (4), 440-450. 
Jang, D. & Murrell, G.A.C. (1998). Nitric Oxide in Arthritis. Free Radical Biology & 
Medicine, 24 (9), 1511-1519. 
 
Jesus, C., Jesus, I. & Agius, M. (2016). Treatment of Depression in Patients with 
Osteoarthritis: The importance of early diagnosis and the role of Duloxetine. 
Psychiatria Danubina, 28 (1), 149-153 
 
Joint FAO/WHO Expert Committee on Food Additives (2002). Evaluation of certain 
food additives. WHO Technical Report Series. Retrieved on August 10, 2017 from 
http://apps.who.int/iris/bitstream/10665/42601/1/WHO_TRS_913.pdf  
 
Kanof, M.E., Smith, P.D. & Zola, H. (1996). Isolation of whole mononuclear cells from 
peripheral blood and cord blood In Immunologic Studies in Humans. Current 
Protocols in Immunology. Supplement 19. 
 
Kapoor, M., Pelletier, J.M., Lajeunesse, D., Pelletier, J.P. & Fahmi, H. (2011). Role of 
Proinflammatory Cytokines in the Pathophysiology of Osteoarthritis. Nature 




Kim, M.J., Marchand, P., Henegar, C., Antignac, J.P.,Alili, R, Christine, P…Clement, 
K. (2011). Fate and Complex Pathogenic Effects of Dioxins and Polychlorinated 
Biphenyls in Obese Subjects before and after Drastic Weight Loss. Environmental 
Health Perspective, 119 (3), 377-383. 
 
King, L.K., March, L. & Anandacoomarasamy, A. (2013). Obesity and Osteoarthritis. 
Indian Journal of Medical Research, 138 (2), 185-193.  
 
Klengel, T., Pape, J., Binder, E.B. & Mehta, D. (2014). The role of DNA methylation in 
stress-related psychiatric disorders, Neuropharmacology, 80, 115-132. 
 
Kosonen, O., Kankaanranta, H., Vuorinen, P. & Moilanen, E. (1997). Inhibition of 
human lymphocytes proliferation by nitric oxide- releasing oxatriazole derivatives. 
European Journal of Pharmacology, 337 (1), 55-61. 
 
Kraan, P.M. (2012). Age-dependent alteration of TGF-β signalling in osteoarthritis. Cell 
and Tissue Research, 347 (1), 257-265. 
 
Lane, N.E., Williams, E.N., Hung, Y.Y., Hochberg, M.C., Cummins, S.R. & Nevitt, M. 
(2003). Association of Nitrate use with risk of new radiographic features of hip 
osteoarthritis in elderly white women: The study of osteoporotic fractures. Arthritis 
and Rheumatism, 49 (6), 752-758. 
 
Lee, D.H., Steffes, M. & Jacobs, D.R. (2007). Positive Associations of Serum 
Concentration of Polychlorinated Biphenyls or Organochlorine Pesticides with Self-
Reported Arthritis, Especially Rheumatoid Type, in Women. Environmental Health 
Perspectives, 115 (6), 883-888. 
 
Leheita, O., Abed, NY. Younes, S. & Mahmoud, AZ. (2005). Lymphocytes subsets in 
osteoarthritis versus rheumatoid arthritis. The Egyptian Journal of Immunology, 12 
(2), 113-124.  
 
Lin, Z., Willers, C., Xu, J. & Zheng, MH. (2006). The chondrocyte: biology and clinical 
application. Tissue Engineering, 12 (7), 1971-1984. 
 
Loeser, R.F., Goldring, S.R., Scanzello, C.R. & Goldring (2012). Osteoarthritis: A 
disease of the joint as an organ. Arthritis and Rheumatism, 64 (6), 1697-1707. 
 
Lundberg, J.O., Larsen, F.J. & Weitzberg, E. (2011). Supplementation with nitrate and 
nitrite salts in exercise: A word of caution. Journal of Applied Physiology, 111 (2), 
616-617. 
 
Lundberg, J.O., Weitzberg, E. & Benjamin, N. (2004). Nitrate, bacteria, and human 




Lundberg, J.O, Weizberg, E & Gladwin, M.T (2008). The nitrate-nitrite-nitric oxide 
pathway in physiology and therapeutics. Nature Reviews, 7, 156-167. 
 
Machha, A. & Schechter, A.N. (2001). Dietary nitrite and nitrate: a review of potential 
mechanisms of cardiovascular benefits. European Nutritional Journal, 50, 293-303. 
 
Mackenzie, I.S., Rutherford, D. & MacDonald, T.M. (2008). Nitric oxide and 
cardiovascular effects: New insights in the role of nitric oxide for the management of 
osteoarthritis. Arthritis Research & Therapy, 10(2),S3. 
 
Martin, J.A. & Buckwalter, J.A. (2001). Roles of Articular Cartilage Aging and 
Chondrocyte Senescence in the Pathogenesis of Osteoarthritis. The Iowa 
Orthopaedic Journal, 21, 1-7. 
 
McElory, J.A., Dietz, A.T., Gangnon, R.E., Hampton, J.M., Bersch, A.J., Kanarek, M.S. 
& Newcomb, P.A. (2008). Nitrogen-nitrate exposure from drinking water and 
colorectal cancer risk for rural women in Wisconsin. USA. Journal of Water and 
Health, 6(3), 399-409. 
 
McLean, R.R., Jacques, P.F., Selhub, J., Tucker, K.L., Samelson, E.J., Broe, K.E…Kiel, 
D.P. (2004). Homocysteine as a Predictive Factor for Hip Fracture in Older 
Persons. The New England Journal of Medicine, 350, 2042-2049. 
Mensinga, T.T., Speijers, G.J. & Meulenbelt, J. (2003). Health implications of exposure 
to environmental nitrogenous compounds. Toxicology Review, 22 (1), 41-51. 
 
Messier, S.P., Mihalko, S.L., Legault, C., Miller, G.D., Nicklas, B.J., DeVita, 
P…Loeser, R.F. (2013). Effects of Intensive Diet and Exercise on Knee Joint Loads, 
Inflammation, and Clinical Outcomes among Overweight and Obese Adults with 
Knee Osteoarthritis: The IDEA Randomized Clinical Trial. JAMA, 310 (12), 1263-
1283. 
 
Milder, T.Y., Williams, K.M., Ritchie, J.E., Lipworth, W.L. & Day, R.O. (2011). Use of 
NSAIDs for osteoarthritis amongst older-aged primary care patients: engagement 
with information and perceptions of risk. Age and Ageing, 40 (2), 254-259.   
 
Millán, M.M. & Castañeda, S. (2013). Estrogens, osteoarthritis, and inflammation. Joint 
Bone Spine, 80 (4), 368-373. 
 
Millipore Sigma (2013). Muse Multi-Color DNA Damage Kit User’s Guide: Catalog 





Moncada, S., Higgs, E. A., Hodson, H. F., Knowles, R. G., Lopez-Jaramillo, P., McCall, 
T…Schulz, R. (1991). The L-Arginine: Nitric Oxide Pathway. Journal of 
Cardiovascular Pharmacology, 17 (3), S1-S9. 
 
Muramoto, J. (1999). Comparison of Nitrate content in leafy vegetables from organic 
and conventional farms in California. Center for Agroecology and Sustainable Food 
Systems. Retrieved on September 9, 2016 from 
31Thttp://www.agroecology.org/documents/Joji/leafnitrate.pdf 
 
31TNaeim F., Rao P.N, Song S.X. & Grody W.W. (Eds.) (2013). Atlas of 
Hematopathology. Oxford, UK: Academic Press. 
 
Negritto, M.C. (2010). Repairing Double-Strand Breaks. Nature Education, 3 (9), 26. 
 
Newbold, R.R. (2010). Impact of environmental endocrine disrupting chemicals 
on the development of obesity. Hormones, 9 (3), 206-217. 
 
Ogawa, M., Matsuda, T., Ogata, A., Hamasake, T., Kumanogoh, A, Toyofuku, T & 
Tanaka, T. (2013). DNA Damage in Rheumatoid Arthritis: An Age-Dependent 
Increase in the Lipid Peroxidation-Derived DNA Adduct, Heptanone-Etheno-2′-
Deoxycytidine. Autoimmune Disease, 183487, 1-8. 
 
Panda, S.K. & Ravindran, B. (2013). In vitro culture of Human PMBCs. Bio-Protocol, 
(3), 1-3. 
 
Pastén-Zapata, E., Ledesma-Ruiz, R., Harter, T., Ramírez, A.I. & Mahlknecht, J. (2014). 
Assessment of sources and fate of nitrate in shallow groundwater of an 
 agricultural area by using a multi-tracer approach. Science of the Total Environment, 
470, 855-864. 
 
Paules, R.S., Innes, C.L., Sieber, S.O., Shackelford, R.E., Heinloth, A.N., Deming, 
P.B…Kaufmann, W.K. (2001). ATM-dependent responses to DNA-damaging 
agents. Nature Genetics, 27, 78. 
 
Pelletier, J.M. & Pelletier, J.P., (2007). Inflammatory factors involved in Osteoarthritis. 
In J. Buckwater et al. (Eds), Osteoarthritis, Inflammation, and Degradation: A 
Continuum (3-13). Amsterdam, The Netherlands: IOS Press. 
 
Pelletier, J.P., Pelletier, J.M. & Abramson, S.B. (2001). Osteoarthritis, an Inflammatory 
Disease: Potential Implication for the Selection of New Therapeutic Targets. 






Powlson, D.S., Addiscott, T.M., Benjamin, N., Cassman, K.G., Kok, T.M., Grinsven, 
H.V…Kessel, C.V. (2007). When Does Nitrate Become a Risk for Humans? 
Agronomy & Horticulture- Faculty Publications. Paper 102. 
31Thttp://digitalcommons.unl.edu/agronomyfacpub/10231T 
 
Puckett, L.J. (1994). Nonpoint and point sources of nitrogen in major watersheds of the 
United States. Water-Resources Investigation Report. Retrieved on April 1, 2016 
from http://pubs.usgs.gov/wri/1994/4001/report.pdf 
 
Ravindran, A.V., Griffiths, J., Merali, Z. & Anisman, H. (1995). Lymphocyte subsets 
associated with major depression and dysthymia: modification by antidepressant 
treatment. Psychosomatic Medicine, 57 (6), 555-563. 
 
Roman-Blas, J.A., Castañeda, S., Largo, R. & Herrero-Beaumont, G. (2009). 
Osteoarthritis associated with estrogen deficiency. Arthritis Research and Therapy, 
11, 241. 
 
Santamaira, P. (2006). Nitrate in Vegetables: Toxicity, Content, Intake and EC 
Regulation. Journal of the Science of Food and Agriculture, 86, 10-17. 
 
Sato, K., Ozaki, K., Oh, L., Meguro, A., Hatanaka, K., Nagai, T., Muroi, K. & O, K. 
(2007). Nitric oxide plays a critical role in suppression of T-cell proliferation 
by mesenchymal stem cells. Immunobiology, 109 (1), 228-234. 
 
Sawa, T. & Ohshima, H. (2006). Nitrative DNA damage in inflammation and its 
possible role in carcinogenesis. Nitric Oxide, 14, 91-100. 
 
Shao-ting, DU., Tong-song, Z. & Xian-Yong, L. (2007). Accumulation of Nitrate in 
vegetables and its possible implications to human health. Agricultural Science in 
China, 6 (10), 1246-1255. 
 
Sharma, J. N., Al-Omran, A. & Parvathy, S.S. (2007). Role of nitric oxide in 
inflammatory diseases. Inflammopharmacology, 15 (6), 252-259. 
 
Skibsted, L.H. (2011). Nitric oxide and quality and safety of muscle based foods. Nitric 
Oxide, 24, 176-183.  
 
Sokolove, J. & Lepus, C.M. (2013). Role of inflammation in the pathogenesis of 
osteoarthritis: latest findings and interpretations. Therapeutic Advances in 
Musculoskeletal Disease, 5 (2), 77-94. 
 
Spiro, T.G. & Stigliani, W.M. (2002). Chemistry of the Environments (2PndP Edition). 





Sullivan, M.D., Bentley, S., Fan, M.Y. & Gardner, G. (2009). A Single-Blind, Placebo 
Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain, American 
Pain Society, 10 (2), 208-213. 
 
Terkeltaub, R.A. (2007). Aging, Inflammation, and Altered Chrondrocyte Differentation 
in Articular Cartilage Calcification and Osteoarthritis. In J. Buckwater et al. (Eds.). 
Osteoarthritis, Inflammation, and Degradation: A Continuum (31-41). Amsterdam, 
The Netherlands: IOS Press. 
 
United States Department of Agriculture (USDA) (2003). Chapter 2: Profiling food 
consumption in America. Agriculture Fact Book 2001-2002 (pp 13-21). Retrieved on 
May 11, 2016 from 31Thttp://www.usda.gov/documents/usda-factbook-2001-2002.pdf 
 
Unternaehrer, E., Luers, P., Mill, J., Dempster, E., Meyer, A.H., Staehli, … 
Meinlschmidt, D.H. (2012). Translational Psychiatry, 2, 1-7. 
 
Ustyugova, I.V., Zeman, C., Dhanwada, K. & Beltz, L.A. (2002). Nitrate/Nitrite alters 
human lymphocytes proliferation and cytokine production. Environmental 
Contamination and Toxicology, 43, 270-276. 
 
Vuolteenaho, K., Moulanen, T., Knowles, R.G. & Moilanen, E. (2007). The role of 
nitric oxide in osteoarthritis. Scandinavian Journal of Rheumatology, 36 (4), 247-
258.  
 
Wakida, F.T. & Lerner, D.N. (2005). Non-agricultural Sources of Groundwater Nitrate: 
A Review and Case Study. Water Research, 39 (1), 3-16. 
 
Ward, M.H. (2008). Too much of a good thing? Nitrate from nitrogen fertilizers and 
cancer. Reviews on Environmental Health, 24 (4), 357-363. 
 
Ward, M.H., Kilfoy, B.A., Weyer, P.J., Anderson, K.E., Folsom, A.R. & Cerhan, J.R.  
(2010). Nitrate intake and the risk of thyroid cancer and thyroid disease. 
Epidemiology, 21 (3), 389-395.  
 
Weitzberg, E., Hazel, M. & Lundberg, L.O. (2010). Nitrate-Nitrite-Nitric Oxide 
Pathway: Implications for Anesthesiology and Intensive Care. Anesthesiology, 113, 
1460-1475. 
 
Weitzberg, E. & Lundberg, L.O. (2013). Novel Aspects of Dietary Nitrate and Human 
Health. The Annual Review of Nutrition, 33, 129-159. 
 
Weyer, P.J., Cerhan, J.R., Kross, B.C., Hallberg, G.R., Kantamneni, J., Breur, 
G…Lynch, C.F. (2001). Municipal Drinking Water Nitrate Level and Cancer Risk in 




Wimalawansa, S.J. (2010). Nitric oxide and Bone. Annals of the New York Academy of 
Sciences, 1192, 391-403. 
 
World Health Organization (2011). Nitrate and Nitrite in Drinking Water. Retrieved on 
May 5, 2016 from URL 
31Thttp://www.who.int/water_sanitation_health/dwq/chemicals/Nitratenitrite.pdf 
 
31TWorld Health Organization (2017). Evaluation of influenza vaccine effectiveness: a 
guide to the design and interpretation of observational studies. Retrieved on March 
18, 2018 from URL 
http://apps.who.int/iris/bitstream/10665/255203/1/9789241512121-eng.pdf 
 
31TYaqoob, P. & Calder, P. (1998). Cytokine production by Human Peripheral Blood 
Mononuclear Cells: Differential Sensitivity to Glutamine Availability. Cytokine, 10 
(10), 790-794.  
  
Zavodnik, I.B., Lapshina, E.A., Rekawiecka, K., Zavodnik, L.B., Bartosz,G. & 
Bryszewska, M. (1999). Membrane effects of nitrite-induced oxidation of human red 
blood cells. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1421 (2), 306-
316. 
  
Zeman, C., Beltz, L., Linda, M., Maddux, J., Depken, D., Orr, J. & Theran, P. (2011). 
New Questions and Insights into Nitrate/Nitrite and Human Health Effects: A 
Retrospective Cohort Study of Private Well Users’ Immunological and Wellness 
Status. Journal of Environmental Health, 74 (4), 8-18. 
 
Zhang, Y., & Jordan, J.M. (2010). Epidemiology of Osteoarthritis. Clinics in Geriatric 
Medicine, 26 (3), 355-369. 
 
Zhao, J., Guo, Z., Pei, S., Song, L., Wang, C, Jianxio, M… Zhang, H. (2017). pATM 
and γH2AX are effective radiation biomarkers in assessing the radiosensitivity of 













CONSENT TO ACT AS A SUBJECT IN AN EXPERIMENTAL STUDY 
TITLE: On-going in-vitro pilot research in Immunotoxicology and non-cancer 
endpoints. 
INVESTIGATOR:  Catherine Zeman, Ph.D., Professor, KAHHS   
 Office phone number: 273-7090 
  University of Northern Iowa  
  Junu Shrestha, M.S. 
  University of Northern Iowa 
  Phone number: 273-7099 
INVITATION TO PARTICIPATE: You are invited to participate in a research project 
conducted through the University of Northern Iowa, School of Kinesiology, Allied 
Health and Human Services.  The University requires that you give your signed 
agreement to participate in this project.  The following information is provided to help 
you make an informed decision whether or not to participate. 
NATURE AND PURPOSE: You have been asked to participate as a subject in an 
investigation of the abilities of various compounds to alter human immune responses in 
vitro (test-tube based study).  Dr. Zeman will use your blood to test the toxicity of 
various compounds on the human immune system in order to help determine 
environmentally safe levels of these compounds.  These substances include but are not 
limited to the following: arsenic, nitrate, nitrite, Atrazine, and organic plastic derivatives 




blood is withdrawn from the arm.  You will not be exposed to the compounds.  No other 
tests will be conducted on the samples. 
EXPLANATION OF PROCEDURES:  By participating in this study, 15-20ml of blood 
(2-8 teaspoons) will be collected from the vein at your elbow into a 30 ml syringe in a 
session that will take approximately 10 minutes.  Contact information will be maintained 
and you will remain eligible and will be contacted by phone to donate blood on multiple 
occasions for up to 4 years.  You must give consent for each occasion.  Participation is 
entirely voluntary and can be refused at any time for any reason without penalty. 
The blood taken from each donor will be used in its entirety within 4 hours of being 
drawn and will not be stored after that time.  During the procedures, samples will be 
given a numeric identifier so that only Dr. Zeman will know the general demographics 
but not the identity of the donor.  Any white blood cells that are remaining after the 
immune assays are set up will be autoclaved and thus destroyed. 
DISCOMFORT AND RISKS:  The only anticipated adverse effect is the minimal 
discomfort associated with drawing blood or the causation of a bruise or clot 
(hematoma).  There is also a remote chance that you may grow light-headed but that the 
blood-drawing will immediately cease if this were to occur.  You will have told Dr. 
Zeman that you have grown light-headed on previous donations. 
BENEFITS: This research will not be of any direct benefit to you but will help scientists 
determine how these compounds affect the immune response.  You will receive a $10 





REFUSAL TO PARTICIPATE: Your participation is completely voluntary.  You are 
free to withdraw from participation at any time or to choose not to participate at all, and 
that by doing so, you will not be penalized or lose benefits to which you are otherwise 
entitled.  Refusal to donate blood will not involve a penalty or loss of course credits. 
CONFIDENTIALITY: Any information which will identify you will be treated as 
confidential.  While information from this study may be published in an academic 
journal or presented at a scholarly conference, you will not be in any way personally 
identified. 
VOLUNTARY CONSENT: Dr. Zeman has explained all of this to you and has 
answered all of your questions.  Any future questions you have about this research will 
be answered by Dr. Zeman, whom you may call at 273-7090 or write to at the School of 
HPELS, The University of Northern Iowa, Cedar Falls, IA 50614.  You may also contact 
the office of the Human Subjects Coordinator, University of Northern Iowa, and (319) 
273-6148, for answers to questions about the research and about the rights of research 
subjects. 
You are fully aware of the nature and extent of your participation in this project as stated 
above and the possible risks arising from it.  You hereby agree to participate in this 
project.  You acknowledge that you have received a copy of this consent statement.  You 









(Signature of subject)      (Date) 
________________________________________ 
(Printed name of subject) 
_________________________________________________________________ 
(Signature of investigator)   
  (Date) 
INVESTIGATOR’S CERTIFICATION 
I declare that I have personally explained the above information to the donor. 
________________________ _______________________ 






















Environmental Health Sciences Lab                                Participant code: _____________ 
Name:   
Email: 
Phone Number: 
Study Title: On-going in vitro pilot research in immunotoxicology and non-cancer 
endpoints 
Study Purpose: To study environmental toxins and their effect on the immune system 
and non-cancer endpoints. These questions are important in understanding issues that 
may be impacting your current immune system. 
1. Age: 
2. Gender:                                                                                                                                        

















Others. Please explain_________________________________________ 
 
 
5. Have you had a major life change/loss in last six months? (Death of a loved-one, new 

















8. Have you received an immunization in the last 4 weeks?  
Yes 
No 











9. Do you suffer from allergies? 
Yes 
No 
If yes please describe:  
 
10. Do you smoke? 
Yes 
No 
If yes how many per day:  
 
11. Do you know your Blood Type? 
 Yes 
 No 
If yes, then please indicate blood type_____________ 
 




13. Any Diagnosed Immunological diseases? 
 
 


































PROCEDURE FOR PREPARING CHEMICAL MIXTURES 
D1: Make RPMIP*P mixture 
RPMIP* Pmixture include RPMI 1640 with GlutaMAX and 100µl/1ml Pen Strep. 
Calculation 
100µl/1ml Pen Strep mean that we should add 100µl of Pen Strep in 1ml of RPMI 1640 
Therefore, 1ml of RPMI 1640 should contain 100 µl of Pen Strep  
       500ml of RPMI 1640 should contain 100*500µl of Pen Strep 
             50000µl of Pen Strep 
              50ml pf Pen Strep 
Finally, 500ml of RPMI 1640 should contain 50ml of Pen Strep 
Method: 
1. First take 500 ml of RPMI 1640 with GlutaMAX. 
2. Now add 50ml of Pen Strep in 500 ml of RPMI 1640 with GlutaMAX. 
3. Mix well. 
4. Run the mixture through 0.2 PES Nalgene Filter Unit and store at 5-8P0PC temperature 





D2: Make RPMI+ Mixture 
RPMIP+P include RPMI* and 10% of Fetal Bovine Serum (FBS) 
Calculation: 
10% of 40ml RPMI* mixture 
Finally we have/ 10/100*40= 4ml of FBS 
Method: 
1. In a 50ml centrifuge tube, add 4ml of FBS and 36ml of RPMI* 







D3: Reconstitute PHA 
We have 5mg/ml of powdered PHA to be reconstituted. 
Calculation 1: 




From Formula, V2=C1*V1/C2 
V2=5000*1/8 
Therefore, V2= 625ml 
So we need to add 625ml of RPMI* in PHA and reconstitute it. 
Calculation 2:  
Now, we need 10% of FBS in 625ml RPMI* 
So, 10/100*625 
Therefore, 62.5ml of FBS to make total volume of 625ml  
Calculation 3:  
Each cell culture plate need 4.5ml of PHA mixture 




Therefore, this mixture is sufficient for 138 individuals 
Method: 
1. Reconstitute PHA in mixture of 625 ml RPMI* 
2. Filter the mixture through 0.2 micron filter  
3. Then add 10% of FBS  
4. Take a sterile snap cap and fill the final mixture.  





D4: Make 1000 ppm of Nitrite Solution in 10 ml of RPMI+ 
Molecular weight of NaNO2= 68.9945 
Molecular weight of NO2= 46.006 
Converting 10 ml to liter we get 0.01 L 
Converting 1000 ppm to 1000 ppm we get 1000/1000 
Finally, by calculating 
1000/1000*68.9945/46.006*0.01 
1*1.4996*0.01 
0.014996 gm, Therefore 0.014996*1000=14.996 milligram 
Therefore, 14.996 milligram of NaNO2 in 10 ml of RPMIP+P makes 1000 ppm of NO2 
which is the stock solution 
Dilution Factor 
Formula, C1*V1=C2*V2 
C1= concentration of stock solution 
V1=volume of stock solution needed to make new solution 
C2= Final concentration of new solution 
V2= Final volume of new solution 








Now from Formula, C1*V1=C2*V2 
V1= 500*5/1000= 2.5ml 
Take a sterile tube and put 2.5ml of stock solution. Then add 2.5ml of RPMI+ in the 
tube. This will be the final solution that we will use for further dilution. 
Method: 
1. Weigh 14.996 milligram of NaNO2 and dilute in 10 ml of RPMIP+ 
2. Run the mixture through 0.2 micron Syringe Filter and store in sterilized container or 
tube. 
3. Dilute this stock solution into desired concentrations. 












60 ppm from 
500ppm solution in 
1.5ml RPMI+ 
500*V1=60*1.5 
V1=60*1.5/500 = 0.18 ml (converting gives 180µl) 
Therefore, take 180µl from stock solution and then add 1320µl 
RPMIP+P to make final volume of 1.5ml 
40 ppm from 
500ppm solution  in 
1.5ml RPMI+ 
500*V1=40*1.5 
V1= 40*1.5/500 = 0.12 ml (converting gives 120µl) 
Therefore, take 120µl from stock solution and then add 1380µl 
RPMIP+P to make final volume of 1.5ml 
20 ppm from 
500ppm solution  in 
1.5ml RPMI+ 
500*V1=20*1.5 
V1=20*1.5/500=0.06 ml (converting gives 60µl) 
Therefore, take 60µl from stock solution and then add 1440µl  
RPMIP+P to make final volume of 1.5ml 
4 ppm from 500ppm 
solution  in 1.5ml 
RPMI+ 
500*V1=4*1.5 
V1=4*1.5/500=0.012 ml (converting gives 12µl) 
Therefore, take 12µl from stock solution and then add 1488µl  





PREPARATION OF HUMAN MONONUCLEAR CELL POPULATIONS AND 
SUBPOPULATIONS 
1. In order to successfully complete this entire protocol we will need to obtain 4 
green top tubes of blood from OA and non-OA volunteers with a goal of 16 from 
each group or 32 overall.   
2. Sterilize all necessary glassware and equipment and have ready before blood is 
delivered. Sterilize the hood with alcohol (Isopropanol) and UV light. Wipe 
down the top of the hood and cabinet tops to control any dusts. Wipe down the 
top of the hood with IPA. Make sure to run fan at least 15 minutes on high prior 
to beginning, then turn down to low. 
3. Place 15ml of fresh heparinized blood into 50ml conical centrifuge tubes using 
sterile pipet (utilizing the entire 15 ml of each blood sample). 
4. Add 15ml of room temperature PBS using sterile pipet and mix well. 
5. Slowly layer the Ficoll-Hypaque solution underneath the blood/PBS mixture by 
placing the tip of the pipet containing the Ficoll-Hypaque at the bottom of the 
sample tube. Use 3ml of Ficoll-Hypaque per 10ml blood/PBS mixture (10ml for 
30 ml of blood/PBS mixture). It is helpful to hold the centrifuge tube at a 45PoP 
angle. Make sure pipettes are sterile. 
6. Create counter-weight tubes with balance and lab sterile RO water.  Offset the 
blood with the RO water counter-balances. Centrifuge 45 minutes at 1300rpm, 




7. After centrifuge you will see different layers as shown on figure below: 
 
8. Using sterile pipet, remove upper layer that contains the plasma and most of the 
platelets. Using another sterile pipet, transfer the mononuclear cells/lymphocytes 
from centrifuge tube into fresh 50ml sterile centrifuge tube. It is acceptable to 
pull lymphocytes and a tiny bit of the layer above and below without ruining the 
experiment, see red box above (several washings will occur). Centrifuge the tube 
containing the mononuclear cells/lymphocytes for 10 minutes at 1300 rpm.  
9. To wash the cells, remove supernatant (you are after the pellets in the bottom this 
time), re-suspend mononuclear cells/lymphocytes in 5 ml of HBSS and 
centrifuge for 10 minutes at 1300 rpm as before. Repeat this wash step twice to 
remove most of the platelets.  
10. Obtain the pellet from the final wash and re-suspend cells in 1ml of RPMIP+P 






dispersion). So assume that you have a cell recovery concentration at this point 
of 1.5x10P7 Pcells/ml. (concentrated from the subject’s whole blood). 
11. Refer to the MUSE Count & Viability Kit User’s Guide. Use the bottom range 
value on page 4 table: Cell Suspension Dilution Table (recommended volumes). 
Using the Muse Procedure, Count cells using MUSE Unit and determine count 
and viability. 
12.  Depending on the viable cell concentration, dilute the cells to the cell 
experimental concentration of: 4x10P6Pcells/ml with RPMIP+P (RPMI *+10% FBS). 
Add 50ul of cells to each experimental well on the culture plates under each 
experimental condition (CYT, Stress, Counts). Control wells only receive 
RPMIP+P, 150ul per well and the 50ul of cells. The next steps involve challenging 
all experimental wells (except control) with the agent of concern (in this case 
Sodium Nitrite).  This will be followed by adding PHA to the stimulated wells 
(bottom half) of each experimental condition/plate (CYT, Stress, Counts). 
13. In the experimental challenge wells, proceed to challenge all wells/cells (across 
all three experimental plates) with various sodium nitrite concentrations of 0 
(RPMI + cells only), 1, 5, 10, and 15 ppm. Sodium nitrite will be added for a 
total of 50ul per well and must be at 4x the desired final concentration [due to 
dilution in the other cell well constituents].  Thus, our final desired exposure 




14.  Now add 100 ul of 5mg/ml PHA to the designated, “STIMULATED” 
wells/cells of each plate (the bottom 3 experimental wells across all challenge 
conditions, across all of the experimental plates). 
15. In summary re-suspended mononuclear cells in RPMIP+P (RPMI 1640 with 
pen/strep and 10% BFCS, heat inactivated) will be at a final total volume in all 
wells of 200ul/well and will be incubated at 35PoPC, 5% CO2. Therefore, 
importantly, when the plates are ready for incubation all plates will contain 200ul 
by volume or be “topped” off to that volume.  Please note that the relative 
amounts of constituents added to each well differ, depending on the experimental 
condition [challenge] state and the stimulated or non-stimulated state.  However, 
the final volume of the experimental cell/well is 200ul, thus: 
Control, Non-Stimulated: 50ul cells + 150ul RPMIP+P = 200ul 
Control Stimulated, 50ul cells + 100ul PHA at 8ugm/ml +50ul of RPMIP+P = 200ul 
NS, Challenged, 1,5,10, and 15ppm Sodium Nitrite, 50ul cells +50ul Sodium Nitrate 
(at appropriate concentration) + 100ul RPMIP+P= 200µl 
Stimulate, Challenged, 1,5,10, and 15ppm Sodium Nitrite, 50ul cells + 50ul Sodium 
Nitrate (at appropriate concentration) + 100ul PHA at 8 ugm/ml = 200ul 
 16. After 48 hours on incubation the stress tissue culture plates will be used for 
DNA Damage Test, Nitric Oxide Test using MUSE Unit (see Appendix F).  
17. After 96 hours of incubation, counts and viability tissue culture plate will be used 




should be placed under the tissue culture microscope on the highest magnification 
setting and a picture of the cell/well color and cellular constituents obtained for all 
non-stimulate and stimulate conditions along with dosed and undosed one. Save this 
picture by participant ID number and cell ID. 
18. Refer to the Muse methodologies for detailed procedures for completing the 
Counts and Viability tests. 
19. Finally enter the findings from Stress and Counts into the experimental data 
base. 
20. Clean the lab and deal with all biological waste per established, general 






































































DNA MULTI COLOR DNA DAMAGE TEST SAMPLE PREPARATION 
1. This method is for 100,000 cells 
2. Prepare 1X Assay Buffer Solution from 5X Assay Buffer solution that has been 
provided. So if you want to make 15 ml of 1X Assay Buffer Solution, you have 
to take 3ml 5X Assay Buffer solution and add 12 ml deionized water to make 
total volume of 15ml. You can store this solution for one year inside refrigerator. 
3. Spin down cells at 1890 RPM for 5 minutes and discard supernatant 
4. Add 50 µl 1X Assay Buffer Solution to cell sample 
5. Add 50 µl Fixation Buffer to the cell solution 
6. Incubate for 10 minutes on ice 
7. Spin down cells at 1890 RPM for 5 minutes and discard supernatant 
8. Add 100 µl  Ice cold 1X Permeabilization Buffer 
9. Incubate for 10 minutes on ice 
10. Spin down cells at 1890 RPM for 5 minutes and discard supernatant 
11. Re-suspend  90 µl 1X Assay Buffer Solution 
12. Incubate cell testing samples for 30 minutes in dark room temperature 
13. Add 100 µl 1X Assay Buffer Solution 
14. Spin down cells at 1890 RPM for 5 minutes and discard supernatant 
15. Re-suspend cells in each micro centrifuge tube with 200 µl of 1X Assay Buffer 
Solution 





NITRIC OXIDE TEST SAMPLE PREPARATION 
1. Prepare Nitric Oxide Reagent Working Solution: For 10 test, mix 1 µl Nitric 
Oxide Reagent with 999 µl 1X Assay Buffer 
2. Prepare 7-AAD Working Solution: For 10 Test, mix 20 µl 7-AAD Stock 
Solution with 880 µl 1X Assay Buffer 
3. Add 10 µl Cell Suspension in each micro centrifuge tube  
4. Add 100 µl Nitric Oxide Reagent Working Solution to each tube and mix 
thoroughly 
5. Incubate samples for 30 minutes in the 35PoPC incubator with 5% CO2. 
6. After incubation, add 90 µl of 7-AAD Working Solution to each tube and mix 
thoroughly 
7. Incubate at room temperature for 5 minutes, protected from light. 



















ASEPTIC TECHNIQUE FOR THE LABORATORY WORK 
1. Wear Personal Protective Equipment (PPE) such as Lab coat, sterile gloves, head 
cap, and mask before starting laboratory work. 
2. Wipe the hood thoroughly with ethanol (70% v/v) and Kim wipes. 
3. Further sterilize the hood by UV light for about 30 minutes. 
4. Wipe all equipment necessary for laboratory work with ethanol (70% v/v) such 
as pipet aid, biohazard waste can, test tube holder and so on. 
5. Place all equipment inside the hood. 
6. During laboratory work if any new glassware or equipment is needed then first 





















I1: Bivariate Fit of Lymphocyte proliferation, NO activity, and DNA damage at Various 
nitrite concentrations by Age  
 
Experiment on 
Mononuclear Cells  
Nitrite Concentrations 
0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.002 0.013 0.00561 0.085367 0.008897 
F Ratio 0.0735 0.4114 0.1692 2.8 0.2693 
Prob > F 0.7881 0.5261 0.1348 0.1047 0.6076 




RSquare 0.056574 0.004607 0.125372 0.020761 0.013925 
F Ratio 1.3792 0.1203 3.2969 0.5936 0.3813 
Prob > F 0.2522 0.7315 0.0825 0.4475 0.5421 




RSquare 0.160658 0.001095 0.121455 0.027885 0.08214 
F Ratio 2.6797 0.0154 2.2119 0.4876 1.4319 
Prob > F 0.1239 0.9031 0.1564 0.4944 0.2489 
Prob>|t| 0.0803 0.7328 0.3297 0.3037 0.1815 
NO activity 
Total Cells 
RSquare 0.115548 0.00361 0.216822 0.012407 0.018578 
F Ratio 3.7887 0.1051 6.9212 0.3643 0.549 
Prob > F 0.0613 0.7481 0.0144*(I) 0.5508 0.4647 




RSquare 0.000858 0.006248 0.030815 0.001973 0.089908 
F Ratio 0.0172 0.1006 0.5087 0.0395 1.6794 
Prob > F 0.8971 0.7552 0.486 0.8444 0.2123 




RSquare 9.45E-06 0.063532 0.172769 0.000465 0.027697 
F Ratio 0.0002 1.4925 5.0125 0.0102 0.6552 
Prob > F 0.9892 0.2348 0.034*(D) 0.9203 0.4266 
Prob>|t| 0.7583 0.0916 0.011 0.624 0.6982 
DNA Double-
strand Break 
RSquare 0.007326 0.043183 0.006611 0.005504 0.01453 
F Ratio 0.1919 1.0832 0.1597 0.1439 0.3686 
Prob > F 0.665 0.3084 0.693 0.7075 0.5492 






RSquare 0.007326 0.043183 0.006611 0.005504 0.01453 
F Ratio 0.1919 1.0832 0.1597 0.1439 0.3686 
Prob > F 0.665 0.3084 0.693 0.7075 0.5492 
Prob>|t| 0.2805 0.1512 0.3319 0.8999 0.8772 
X-Axis, Independent Variable (Age, 41-65 Years)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
I: Increasing Trend            
D: Decreasing Trend 






I2: One-way analysis of Lymphocyte proliferation, NO activity, and DNA damage at 
Various nitrite concentrations by Gender 
 
Experiment on 
Mononuclear Cells  
Nitrite Concentrations 
0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.033738 0.027583 0.04286 0.022944 0.024514 
F Ratio 1.0475 0.851 1.3435 0.4079 0.7539 
Prob > F 0.3143 0.3636 0.2556 0.4079 0.3921 




RSquare 0.003863 0.092864 0.0126 0.016209 3.16E-05 
F Ratio 0.0892 2.6616 0.2934 0.4613 0.0009 
Prob > F 0.7679 0.1149 0.5933 0.5026 0.9769 




RSquare 0.032296 0.011435 0.27628 0.056813 0.003462 
F Ratio 0.4672 0.1619 6.1078 1.024 0.0556 
Prob > F 0.5054 0.6935 0.025*(M) 0.3258 0.8166 
Prob>|t| 0.5054 0.6935 0.025 0.3258 0.8166 
NO activity 
Total Cells 
RSquare 0.010577 0.08393 0.02784 0.00438 0.084125 
F Ratio 0.31 2.657 0.716 0.1276 2.6637 
Prob > F 0.582 0.1139 0.4055 0.7235 0.1135 




RSquare 0.000717 0.018257 0.04582 0.124447 0.084718 
F Ratio 0.0144 0.2975 0.7683 2.8427 1.5735 
Prob > F 0.9058 0.593 0.3937 0.1073 0.2267 




RSquare 0.025812 0.04739 0.00428 0.050741 0.001014 
F Ratio 0.5299 1.0944 0.1031 1.176 0.0233 
Prob > F 0.4751 0.3068 0.7509 0.2899 0.8799 




RSquare 0.000899 0.000306 0.0385 0.019463 0.002406 
F Ratio 0.0234 0.0073 0.9611 0.5161 0.0603 
Prob > F 0.8796 0.9324 0.3367 0.4789 0.808 
Prob>|t| 0.8796 0.9324 0.3367 0.4789 0.808 
Total DNA 
Damage 
RSquare 0.001914 0.006534 0.16349 0.012871 0.008332 




Prob > F 0.8185 0.6711 0.026*(M) 0.5364 0.6377 
Prob>|t| 0.8185 0.6711 0.026 0.5364 0.6377 
X-Axis, Independent Variable (Gender: Male and Female)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
M: Male 
F: Female 






I3: One-way analysis of Lymphocyte proliferation, NO activity, and DNA damage at 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.00376 0.09933 0.136044 0.0879 0.048071 
F Ratio 0.1133 3.3084 4.724 2.8911 1.515 
Prob > F 0.7388 0.078  0.0378*(CF) 0.0994 0.2279 




RSquare 0.07423 0.01154 0.010803 0.12521 0.053041 
F Ratio 1.8442 0.3034 0.2512 4.0076 1.5123 
Prob > F 0.1876 0.5864 0.621 0.0551 0.2294 




RSquare 0.0417 0.09527 0.032744 0.04328 0.052773 
F Ratio 0.6092 1.4743 0.5416 0.769 0.8914 
Prob > F 0.4481 0.2448 0.4724 0.3927 0.3591 
Prob>|t| 0.4481 0.2448 0.4724 0.3927 0.3591 
NO activity 
Total Cells 
RSquare 0.00616 0.0056 0.047259 0.09003 0.031428 
F Ratio 0.1797 0.1632 1.2401 2.8692 0.941 
Prob > F 0.6748 0.6892 0.276 0.101 0.34 




RSquare 0.03595 0.00255 0.010442 0.09666 0.009884 
F Ratio 0.7457 0.0408 0.1688 2.14 0.1697 
Prob > F 0.3981 0.8424 0.6866 0.159 0.6855 




RSquare 0.00042 0.06389 0.441013 0.01301 0.032565 
F Ratio 0.0084 1.5014 18.9348 0.29 0.7742 
Prob > F 0.928 0.2334 0.0002*(CF) 0.5956 0.388 




RSquare 0.16796 0.00033 0.01822 0.00068 0.05524 
F Ratio 5.2486 0.008 0.4453 0.0177 1.4617 
Prob > F 0.0303*(O) 0.9294 0.5109 0.8953 0.238 
Prob>|t| 0.0303 0.9294 0.5109 0.8953 0.238 




Damage F Ratio 2.2455 0.0328 2.9908 1.548 1.135 
Prob > F 0.1452 0.8575 0.0947 0.2231 0.2961 
Prob>|t| 0.1452 0.8575 0.0947 0.2231 0.2961 
X-Axis, Independent Variable (City of Residence; Cedar Falls, Others)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
CF: Cedar Falls 
O: Others 






I4: One-way analysis of Lymphocyte proliferation, NO activity, and DNA damage at 
Various nitrite concentrations by Drinking Water Source 
 
Experiment on 
Mononuclear Cells  
Nitrite Concentrations 
0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.080961 0.065789 0.012864 0.029057 0.152178 
F Ratio 0.8222 0.6573 0.1216 0.2793 1.6753 
Prob > F 0.4927 0.5852 0.9466 0.8398 0.1949 




RSquare 0.128338 0.08402  0.080961 0.063908 0.030562 
F Ratio 1.0306 0.7338  0.3042 0.5917 0.2627 
Prob > F 0.3992 0.5421  0.4871 0.626 0.8516 




RSquare 0.067091 0.068575 0.080775 0.01362 0.075065 
F Ratio 0.2877 0.2945 0.4101 0.1105 0.3787 
Prob > F 0.8334 0.8287 0.7483 0.8961 0.7698 
Prob>|t| 0.8334 0.8287 0.7483 0.8961 0.7698 
NO activity 
Total Cells 
RSquare 0.048313 0.08478 0.038166 0.08071 0.051299 
F Ratio 0.4569 0.8337 0.3042 0.7902 0.4867 
Prob > F 0.7146 0.4871 0.822 0.51 0.6944 




RSquare 0.03696 0.03599 0.071919 0.097806 0.012174 
F Ratio 0.2303 0.28 0.3616 0.6505 0.0986 
Prob > F 0.8741 0.7596 0.7817 0.5929 0.9067 




RSquare 0.145137 0.01615 0.072816 0.115144 0.098647 
F Ratio 1.6129 0.1724 0.9031 1.3663 1.2039 
Prob > F 0.2254 0.8429 0.4192 0.2768 0.319 
Prob>|t| 0.2254 0.8429 0.4192 0.2768 0.319 
DNA Double-
strand Break 
RSquare 0.048693 0.048632 0.209768 0.054566 0.072475 
F Ratio 0.4095 0.5879 1.9466 0.4617 0.5991 
Prob > F 0.7476 0.5637 0.1516 0.7116 0.6221 
Prob>|t| 0.7476 0.5637 0.1516 0.7116 0.6221 
Total DNA 
Damage 
RSquare 0.063821 0.043323 0.070286 0.019954 0.039366 




Prob > F 0.6266 0.7594 0.587 0.9023 0.7955 
Prob>|t| 0.6266 0.7594 0.587 0.9023 0.7955 
X-Axis, Independent Variable (Drinking Water Source; Private Water, City Water, City    
Water with RO, Bottled Water)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at     





I5:One-way analysis of Lymphocyte proliferation, NO activity, and DNA damage at 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.004385 0.009119 0.00208 0.107465 5.78E-06 
F Ratio 0.1321 0.2761 0.0625 3.6121 0.0002 
Prob > F 0.7188 0.6031 0.8043 0.067 0.9896 




RSquare 0.325242 0.011565 0.6626 0.080357 0.145797 
F Ratio 11.0863 0.3042 0.6626 2.4466 4.6084 
Prob > F 0.0029*(Y) 0.586 0.424 0.129 0.041*(Y) 




RSquare 0.257242 5.02E-05 0.11938 0.489805 0.002689 
F Ratio 4.8487 0.0007 2.169 16.3206 0.0431 
Prob > F 0.0449*(Y) 0.9792 0.1602 0.0009*(Y) 0.8381 
Prob>|t| 0.0449 0.9792 0.1602 0.0009 0.8381 
NO activity 
Total Cells 
RSquare 0.463633 0.016064 0.04784 0.143671 0.001354 
F Ratio 25.0674 0.4735 1.256 4.8655 0.0393 
Prob > F <.0001*(Y) 0.4969 0.2731 0.035*(Y) 0.8442 




RSquare 0.178988 0.00061 0.03704 4.42E-07 0.062386 
F Ratio 4.3602 0.0098 0.6155 0 1.1311 
Prob > F 0.0498*(Y) 0.9225 0.4442 0.9977 0.3024 




RSquare  0.6626 0.133114 0.03512 0.033952  0.4969 
F Ratio  1.256 3.3782 0.8737 0.7732  2.169 
Prob > F 0.825 0.0796 0.3593 0.3887 0.424 




RSquare 0.001915 0.211065 0.0164 0.021859 0.000237 
F Ratio 0.0499 6.4208 0.4002 0.581 0.0059 
Prob > F 0.825 0.018*(Y) 0.533 0.4528 0.9392 
Prob>|t| 0.825 0.018 0.533 0.4528 0.9392 
Total DNA 
Damage 
RSquare 2.99E-05 0.055943 0.00183 0.115144 0.006759 




Prob > F 0.9771 0.2083 0.8223 0.0574 0.6716 
Prob>|t| 0.9771 0.2083 0.8223 0.0574 0.6716 
X-Axis, Independent Variable (Major Life Changing Events; Yes or No)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
Y: Yes 
N: No 









I6: Bivariate Fit of Lymphocyte proliferation, NO activity, and DNA damage at Various 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.029 0.02746 0.0516 0.00028 0.00484 
F Ratio 0.7079 0.6494 1.2524 0.0064 0.1119 
Prob > F 0.4088 0.4286 0.2747 0.9371 0.7411 




RSquare 0.09485 0.02554 0.000581 0.20112 0.144772 
F Ratio 1.7815 0.5243 0.0099 5.5384 3.5548 
Prob > F 0.1996 0.4774 0.922 0.02*(D) 0.073 




RSquare 3.70E-07 0.00311 0.232615 0.03323 0.00021 
F Ratio 0 0.0312 3.3344 0.4812 0.0028 
Prob > F 0.9985 0.8634 0.0951 0.4992 0.9585 
Prob>|t| 0.1891 0.3202 0.01  0.0276 0.3563 
NO activity 
Total Cells 
RSquare 0.16386 0.01468 0.023742 0.14863 0.03755 
F Ratio 4.3114 0.3277 0.4621 4.0151 0.8975 
Prob > F 0.049*(D) 0.5728 0.5049 0.057 0.3533 




RSquare 0.02732 0.10195 0.000567 0.37529 0.03939 
F Ratio 0.4213 1.2488 0.0057 9.011 0.5332 
Prob > F 0.5261 0.2876 0.9414 0.008*(D) 0.4782 




RSquare 0.03362 0.02856 0.009184 0.05003 0.00020 
F Ratio 0.5218 0.4997 0.1761 0.9479 0.0036 
Prob > F 0.4812 0.4892 0.6794 0.3432 0.9527 
Prob>|t| 0.0308 0.0411 0.0183 0.0043 0.0168 
DNA Double-
strand Break 
RSquare 0.02482 0.12964 0.0079 0.0024 0.05391 
F Ratio 0.5599 2.6812 0.1513 0.048 1.1398 
Prob > F 0.4622 0.1189 0.7016 0.8288 0.2984 
Prob>|t| 0.0032 0.0013 0.0055 0.0125 0.0891 
Total DNA 
Damage 
RSquare 0.00375 0.09599 0.001752 0.00093 0.02269 




Prob > F 0.7714 0.1407 0.846 0.8849 0.4823 
Prob>|t| 0.0046 <.0001 0.0003 0.0192 0.2752 
X-Axis, Independent Variable (No. of Supplements; No Answer, 0 to 7)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
I: Increasing Trend 
D: Decreasing Trend 












I7: Bivariate Fit of Lymphocyte proliferation, NO activity, and DNA damage at Various 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.016011 0.033126 0.117222 0.015421 0.182214 
F Ratio 0.4068 0.8565 3.3197 0.3916 5.5704 
Prob > F 0.5294 0.3636 0.0804 0.5371 0.026*(D) 




RSquare 0.014041 0.037839 0.014617 0.014545 0.005489 
F Ratio 0.2706 0.8259 0.2967 0.3395 0.1214 
Prob > F 0.6089 0.3738 0.592 0.5658 0.7308 




RSquare 0.011334 0.06807 0.021118 0.061561 0.099643 
F Ratio 0.1376 0.8765 0.2805 0.984 1.328 
Prob > F 0.7172 0.3676 0.6053 0.337 0.2716 
Prob>|t| 0.1822 0.2712 0.0234 0.2783 0.0978 
NO activity 
Total Cells 
RSquare 0.000143 0.030439 0.024573 0.01549 0.051038 
F Ratio 0.0034 0.7535 0.529 0.3776 1.2908 
Prob > F 0.9537 0.394 0.475 0.5447 0.2671 




RSquare 0.09367 0.024027 0.002422 0.101772 0.003271 
F Ratio 1.6536 0.32 0.0267 1.6995 0.0459 
Prob > F 0.2168 0.5812 0.8731 0.212 0.8334 




RSquare 0.001059 0.067809 0.075063 0.048771 0.004474 
F Ratio 0.017 1.3094 1.6231 0.9229 0.0854 
Prob > F 0.898 0.2675 0.2173 0.3494 0.7733 
Prob>|t| 0.0416 0.0024 0.0483 0.0039 0.0066 
DNA Double-
strand Break 
RSquare 0.118778 0.066763 0.144308 0.025427 0.216371 
F Ratio 2.9653 1.4308 3.3729 0.574 5.7984 
Prob > F 0.0991 0.2456 0.0812 0.4567 0.025*(I) 
Prob>|t| <.0001 0.0010 <.0001 0.0224 0.1452 
Total DNA 
Damage 
RSquare 0.038795 0.227069 0.00069 0.012556 0.029141 




Prob > F 0.3348 0.013*(D) 0.9008 0.5779 0.4146 
Prob>|t| 0.0001 <.0001 0.0002 0.0107 0.2528 
X-Axis, Independent Variable (No. of Medications; No Answer, 0 to 6)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
I: Increasing Trend 
D: Decreasing Trend 





I8:One-way analysis of Lymphocyte proliferation, NO activity, and DNA damage at 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.005004 0.084541 0.01442 0.034835 0.095211 
F Ratio 0.1509 2.7705 0.4389 1.0828 3.1569 
Prob > F 0.7004 0.1064 0.5127 0.3064 0.0857 




RSquare 0.054381 0.041845 0.04774 0.039683 0.023205 
F Ratio 1.3227 1.1355 1.1532 1.157 0.6414 
Prob > F 0.2619 0.2964 0.294 0.2913 0.4302 




RSquare 0.026544 0.01951 0.32518 0.174445 0.027289 
F Ratio 0.3818 0.2786 7.7099 3.5922 0.4489 
Prob > F 0.5466 0.6059 0.0135*(N) 0.075 (Y) 0.5124 
Prob>|t| 0.5466 0.6059 0.0135 0.075 (Y) 0.5124 
NO activity 
Total Cells 
RSquare 0.000817 0.034887 0.05656 0.086951 0.003444 
F Ratio 0.0237 1.0483 1.4986 2.7617 0.1002 
Prob > F 0.8787 0.3144 0.2323 0.1073 0.7538 




RSquare 0.002886 0.037271 0.02079 0.062703 0.088113 
F Ratio 0.0579 0.6194 0.3396 1.338 1.6427 
Prob > F 0.8123 0.4428 0.5682 0.261 0.2172 




RSquare 3.27E-05 1.29E-07 0.09716 0.006132 0.011094 
F Ratio 0.0007 0 2.5827 0.1357 0.258 
Prob > F 0.9799 0.9987 0.1211 0.7161 0.6163 




RSquare 0.000272 0.02825 0.01658 0.003985 0.054804 
F Ratio 0.0071 0.6977 0.4047 0.104 1.4495 
Prob > F 0.9336 0.4118 0.5307 0.7496 0.2399 
Prob>|t| 0.9336 0.4118 0.5307 0.7496 0.2399 
Total DNA 
Damage 
RSquare 0.005711 0.00445 0.04648 0.072864 0.024692 




Prob > F 0.6914 0.7261 0.2526 0.1351 0.4156 
Prob>|t| 0.6914 0.7261 0.2526 0.1351 0.4156 
X-Axis, Independent Variable (Allergies; Yes or No)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
Y: Yes 
N: No 






I9: One-way analysis of Lymphocyte proliferation, NO activity, and DNA damage at 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.01629 0.09133 0.114095 0.03031 0.039305 
F Ratio 0.4968 3.0154 3.8637 0.9378 1.2274 
Prob > F 0.4864 0.0927 0.058 (Y) 0.3406 0.2767 




RSquare 0.12573 0.01025 0.001415 0.00054 0.023914 
F Ratio 3.3077 0.2693 0.0326 0.015 0.6615 
Prob > F 0.082 0.6082 0.8583 0.9035 0.4231 




RSquare 0.0774 0.18425 6.92E-05 0.01489 0.095231 
F Ratio 1.1744 3.1622 0.0011 0.257 1.6841 
Prob > F 0.2968 0.0971 0.9739 0.6187 0.2128 
Prob>|t| 0.2968 0.0971 0.9739 0.6187 0.2128 
NO activity 
Total Cells 
RSquare 0.02773 0.00295 0.011776 0.0101 3.38E-05 
F Ratio 0.827 0.0859 0.2979 0.296 0.001 
Prob > F 0.3706 0.7715 0.59 0.5906 0.9752 




RSquare 0.0826 0.11561 0.174705 0.19679 0.049014 
F Ratio 1.8008 2.0915 3.387 4.9 0.8762 
Prob > F 0.1947 0.1674 0.0843 0.038*(Y) 0.3624 




RSquare 0.00882 0.02991 0.012888 0.00594 0.021331 
F Ratio 0.1779 0.6782 0.3134 0.1314 0.5013 
Prob > F 0.6777 0.419 0.5808 0.7204 0.486 





RSquare 0.07394 0.0354 0.017848 0.00507 0.031977 
F Ratio 2.076 0.8807 0.4361 0.1325 0.8258 
Prob > F 0.1616 0.3574 0.5153 0.7188 0.3722 
Prob>|t| 0.1616 0.3574 0.5153 0.7188 0.3722 
Total DNA 
Damage 
RSquare 0.01197 0.09201 0.088078 0.04445 0.018769 




Prob > F 0.5649 0.1032 0.1113 0.2468 0.4785 
Prob>|t| 0.5649 0.1032 0.1113 0.2468 0.4785 
X-Axis, Independent Variable (Do you have Sweet-Tooth? Yes or No)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA 
Damage at various Nitrite concentrations) 
Y: Yes 
N: No 






I10: Bivariate Fit of Lymphocyte proliferation, NO activity, and DNA damage at 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.082852 0.000621 0.000672 0.004451 0.0002 
F Ratio 2.6198 0.018 0.0195 0.1297 0.0058 
Prob > F 0.1164 0.8941 0.8899 0.7214 0.9398 




RSquare 0.048693 0.020735 0.000857 0.043698 0.104719 
F Ratio 1.1261 0.5293 0.0189 1.2338 3.0412 
Prob > F 0.3001 0.4736 0.892 0.2765 0.093 




RSquare 0.04029 0.053914 0.00741 0.036025 0.205551 
F Ratio 0.5877 0.7978 0.112 0.5979 3.881 
Prob > F 0.456 0.3868 0.7425 0.4506 0.0676 
Prob>|t| 0.1145 0.8335 0.0562 0.0250 0.5316 
NO activity 
Total Cells 
RSquare 0.026476 0.017055 0.024139 0.026599 0.000152 
F Ratio 0.7615 0.4858 0.5937 0.7651 0.0043 
Prob > F 0.3903 0.4915 0.4485 0.3892 0.9484 




RSquare 0.002266 0.043784 0.080193 0.058837 0.109178 
F Ratio 0.0431 0.6868 1.3078 1.1878 1.9609 
Prob > F 0.8377 0.4202 0.2707 0.2894 0.1805 




RSquare 0.025549 0.040041 0.003615 0.156238 0.139755 
F Ratio 0.4982 0.8759 0.0834 3.8885 3.5741 
Prob > F 0.4889 0.36 0.7753 0.0619 0.0719 
Prob>|t| 0.0381 0.0048 0.0432 0.0010 0.3686 
DNA Double-
strand Break 
RSquare 0.003508 0.018295 0.052336 0.01278 0.009866 
F Ratio 0.088 0.4286 1.2702 0.3236 0.2391 
Prob > F 0.7692 0.5192 0.2714 0.5745 0.6293 
Prob>|t| 0.0020 0.0116 0.0446 0.0081 0.0202 
Total DNA 
Damage 
RSquare 0.019251 0.009949 0.000735 0.012919 0.210964 




Prob > F 0.4729 0.6067 0.889 0.5426 0.0139*(I) 
Prob>|t| 0.0359 0.0069 0.0009 0.1777 0.5229 
X-Axis, Independent Variable (Hours spent outside in a good day; Minimum 0 to Maximum 7 
hours)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
I: Increasing Trend 
D: Decreasing Trend 






I11: One-way Analysis of Lymphocyte proliferation, NO activity, and DNA damage at 




0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.070003 0.040925 0.013921 0.010409 0.018774 
F Ratio 1.0915 0.6187 0.2047 0.1525 0.2774 




RSquare 0.000455 0.008863 0.036975 0.201202 0.339227 
F Ratio 0.0105 0.1118 0.8831 3.4004 6.6739 




RSquare 0.021781 0.044934 0.002948 0.452176 0.009129 
F Ratio 0.1447 0.3058 0.0473 14.0319 0.1474 
Prob > F 0.8666 0.7417 0.8306 0.0016*(F) 0.7061 
NO activity 
Total Cells 
RSquare 0.022648 0.010744 0.008921 0.251153 0.049581 
F Ratio 0.3244 0.152 0.225 4.6954 0.7303 




RSquare 0.274651 0.027855 0.299972 0.020114 0.055706 
F Ratio 3.5971 0.4584 3.2139 0.4105 1.0029 




RSquare 0.008695 0.032325 0.084675 0.033999 0.038377 
F Ratio 0.0833 0.3507 1.0638 0.3696 0.439 




RSquare 0.035824 0.047042 0.052916 0.176381 0.286027 
F Ratio 0.4644 0.5677 0.6425 2.6769 4.8074 
Prob > F 0.6338 0.5746 0.5351 0.0884*(F) 0.017*(F) 
Total DNA 
Damage 
RSquare 0.011825 0.060512 0.044796 0.01669 0.007453 
F Ratio 0.1615 0.8695 0.6331 0.2461 0.0976 
Prob > F 0.8516 0.4306 0.5386 0.7835 0.9073 
X-Axis, Independent Variable (Immunological and ChronicDisease; No, Fibromyalgia, 
Psoriasis)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 








I12: One-way Analysis of Lymphocyte proliferation, NO activity, and DNA damage at 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.004045 0.007184 0.001285 0.000208 0.002003 
F Ratio 0.1219 0.2171 0.0386 0.0062 0.0602 
Prob > F 0.7295 0.6446 0.8456 0.9376 0.8078 




RSquare 0.04169 0.000493 0.155493 0.011293 0.006802 
F Ratio 1.0006 0.0128 4.2348 0.3198 0.1849 
Prob > F 0.3276 0.9107 0.0511 0.5762 0.6706 




RSquare 0.002248 0.015698 0.008879 0.035899 0.000208 
F Ratio 0.0315 0.2233 0.1433 0.633 0.0386 
Prob > F 0.8616 0.6438 0.71 0.4372 0.8616 
Prob>|t| 0.8616 0.6438 0.71 0.4372 0.8616 
NO activity 
Total Cells 
RSquare 0.019188 1.24E-05 0.09313 0.021922 0.009055 
F Ratio 0.5673 0.0004 2.5674 0.65 0.265 
Prob > F 0.4574 0.985 0.1217 0.4267 0.6106 




RSquare 0.050587 0.059191 0.052485 0.023435 0.007425 
F Ratio 1.0657 1.0066 0.8863 0.4799 0.1272 
Prob > F 0.3143 0.3306 0.3605 0.4964 0.7258 




RSquare 0.064344 0.470981 0.060845 0.209517 0.011196 
F Ratio 1.3754 19.5864 1.5549 5.8311 0.2604 
Prob > F 0.2547 0.0002*(Y) 0.2244 0.0245*(Y) 0.6147 





RSquare 0.011204 0.021748 0.028394 0.020356 0.006994 
F Ratio 0.2946 0.5336 0.7014 0.5403 0.1761 
Prob > F 0.5919 0.4722 0.4106 0.4689 0.6783 
Prob>|t| 0.5919 0.4722 0.4106 0.4689 0.6783 
Total DNA 
Damage 
RSquare 0.020369 0.000228 0.004674 0.00161 0.005886 




Prob > F 0.4518 0.9368 0.7196 0.8274 0.6924 
Prob>|t| 0.4518 0.9368 0.7196 0.8274 0.6924 
X-Axis, Independent Variable (Immunization; Yes or No)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 
various Nitrite concentrations) 
Y: Yes 
N: No 







I13: One-way Analysis of Lymphocyte proliferation, NO activity, and DNA damage at 





0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
Lymphocyte 
Proliferation 
RSquare 0.01304 0.00013 0.00794 0.07061 0.047881 
F Ratio 0.3962 0.0038 0.2401 2.2794 1.5087 
Prob > F 0.5338 0.9514 0.6277 0.1416 0.2289 




RSquare 0.00035 0.00655 0.036975 0.00443 0.004759 
F Ratio 0.008 0.1714 0.8831 0.1245 0.1291 
Prob > F 0.9293 0.6822 0.3571 0.7268 0.7222 




RSquare 0.01773 0.01231 0.002709 0.00391 0.001674 
F Ratio 0.2527 0.1744 0.0435 0.0667 0.0268 
Prob > F 0.623 0.6825 0.8375 0.7993 0.872 
Prob>|t| 0.623 0.6825 0.8375 0.7993 0.872 
NO activity 
Total Cells 
RSquare 0.02124 0.00769 0.027775 0.00904 0.000303 
F Ratio 0.6293 0.2248 0.7142 0.2644 0.0088 
Prob > F 0.434 0.6389 0.4061 0.611 0.9259 




RSquare 0.02476 0.00391 0.031772 0.02344 0.055706 
F Ratio 0.5077 0.0038 0.525 0.4799 1.0029 
Prob > F 0.4844 0.2289 0.4792 0.4964 0.3307 




RSquare 0.00255 0.03595 0.000157 0.01328 0.003236 
F Ratio 0.0511 0.8205 0.0038 0.2962 0.0747 
Prob > F 0.8235 0.3749 0.9516 0.5918 0.7871 
Prob>|t| 0.8235 0.3749 0.9516 0.5918 0.7871 
DNA Double-
strand Break 
RSquare 0.00116 0.00367 0.013251 0.01318 0.022114 
F Ratio 0.0303 0.0883 0.3223 0.3472 0.5653 
Prob > F 0.8632 0.7689 0.5755 0.5608 0.4591 
Prob>|t| 0.8632 0.7689 0.5755 0.5608 0.4591 
Total DNA 
Damage 
RSquare 0.00087 0.01205 0.00075 0.00078 0.009172 




Prob > F 0.877 0.5637 0.8858 0.8793 0.6212 
Prob>|t| 0.877 0.5637 0.8858 0.8793 0.6212 
X-Axis, Independent Variable (Smoking; Yes or No)  
Y-Axis, Dependent Variable (Lymphocyte Proliferation, NO Activity, DNA Damage at 










Summary of Fit 
Rsquare 0.158283 
Adj Rsquare 0.136561 
Root Mean Square Error 164740.5 
Mean of Response 297701.9 
Observations (or Sum Wgts) 160 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 7.9104e+11 1.978e+11 7.2868 <.0001* 
Error 155 4.2066e+12 2.714e+10   














Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
0 32 395663 29122 338135 453190 
1 32 341394 29122 283866 398922 
5 32 309425 29122 251897 366953 
10 32 246659 29122 189132 304187 
15 32 195369 29122 137841 252897 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
0 32 395663 217667 38478 317185 474140 
1 32 341394 179938 31809 276519 406268 
5 32 309425 170117 30073 248091 370759 
10 32 246659 118844 21009 203811 289507 










Summary of Fit 
Rsquare 0.033182 
Adj Rsquare 0.008232 
Root Mean Square Error 296992 
Mean of Response 337921.3 
Observations (or Sum Wgts) 160 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 4.6922e+11 1.173e+11 1.3299 0.2613 
Error 155 1.3672e+13 8.82e+10   













Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
0 32 417069 52501 313358 520779 
1 32 378516 52501 274805 482226 
5 32 334153 52501 230443 437863 
10 32 282369 52501 178658 386079 
15 32 277500 52501 173790 381210 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






0 32 417069 361590 63921 286702 547436 
1 32 378516 325717 57579 261082 495949 
5 32 334153 319423 56467 218989 449317 
10 32 282369 235443 41621 197483 367255 









Summary of Fit 
Rsquare 0.060137 
Adj Rsquare 0.035882 
Root Mean Square Error 0.670271 
Mean of Response 1.172571 
Observations (or Sum Wgts) 160 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 4.455619 1.11390 2.4794 0.0463* 
Error 155 69.635769 0.44926   
C. Total 159 74.091388    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
0 32 1.05090 0.11849 0.8168 1.2850 















Level Number Mean Std Error Lower 95% Upper 95% 
5 32 1.08449 0.11849 0.8504 1.3186 
10 32 1.11889 0.11849 0.8848 1.3530 
15 32 1.50315 0.11849 1.2691 1.7372 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
0 32 1.05090 0.480380 0.08492 0.8777 1.2241 
1 32 1.10541 0.629718 0.11132 0.8784 1.3325 
5 32 1.08449 0.688305 0.12168 0.8363 1.3327 
10 32 1.11889 0.670338 0.11850 0.8772 1.3606 






I17: One-way Analysis of Lymphocyte Proliferation Quotient and Nitrite Concentration 




Summary of Fit 
Rsquare 0.012833 
Adj Rsquare 0.006585 
Root Mean Square Error 0.680379 
Mean of Response 1.172571 
Observations (or Sum Wgts) 160 
 
t Test 
Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming equal variances 
Difference 0.15735 t Ratio 1.433149 
Std Err Dif 0.10980 DF 158 
Upper CL Dif 0.37421 Prob > |t| 0.1538 
Lower CL Dif  -0.05950 Prob > t 0.0769 





Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 
(<5 ppm to >5 ppm) 
1 0.950789 0.950789 2.0539 0.1538 
Error 158 73.140599 0.462915   
C. Total 159 74.091388    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less Than 5 ppm 64 1.07816 0.08505 0.9102 1.2461 
Equal or More 
Than 5 ppm 
96 1.23551 0.06944 1.0984 1.3727 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
Less Than 5 ppm 64 1.07816 0.556265 0.06953 0.9392 1.2171 
Equal or More 
Than 5 ppm 
96 1.23551 0.751465 0.07670 1.0833 1.3878 
 
  





Equal or More Than 5 PPM-Less Than 5 PPM 
Assuming unequal variances 
Difference 0.15735 t Ratio 1.519977 
Std Err Dif 0.10352 DF 156.211 
Upper CL Dif 0.36184 Prob > |t| 0.1305 
Lower CL Dif  -0.04713 Prob > t 0.0653 








I18: One-way Analysis of Lymphocyte Proliferation Quotient and Nitrite Concentration 
Pooled (Less Than 10 ppm to Equal or More Than 10 ppm) 
 
 
Summary of Fit 
Rsquare 0.027597 
Adj Rsquare 0.021443 
Root Mean Square Error 0.675272 
Mean of Response 1.172571 
Observations (or Sum Wgts) 160 
 
t Test 
Morethan10 ppm -Lessthan10 ppm 
Assuming equal variances 
 
Difference 0.230754 t Ratio 2.117561 
Std Err Dif 0.108971 DF 158 
Upper CL Dif 0.445982 Prob > |t| 0.0358* 
Lower CL Dif 0.015525 Prob > t 0.0179* 









Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 
(<10 ppm to >10 ppm) 
1 2.044696 2.04470 4.4841 0.0358* 
Error 158 72.046692 0.45599   
C. Total 159 74.091388    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less than 10 
ppm 
96 1.08027 0.06892 0.9441 1.2164 
Equal or More 
than10 ppm 
64 1.31102 0.08441 1.1443 1.4777 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Less than10 ppm 96 1.08027 0.599839 0.06122 0.9587 1.2018 
Equal or More 
than10 ppm 







Morethan10 ppm -Lessthan10 ppm 
Assuming unequal variances 
Difference 0.230754 t Ratio 2.013101 
Std Err Dif 0.114626 DF 111.5394 
Upper CL Dif 0.457881 Prob > |t| 0.0465* 
Lower CL Dif 0.003627 Prob > t 0.0233* 










I19: One-way Analysis of Lymphocyte Proliferation Quotient and Nitrite Concentration 





Rsquare 0.059  
Adj Rsquare 0.053045  
Root Mean Square Error 0.664278  
Mean of Response 1.172571  
Observations (or Sum Wgts) 160  
 
t Test 
Less Than 15 ppm -Equal to 15 ppm 
Assuming equal variances 
Difference  -0.41323 t Ratio  -3.14747 
Std Err Dif 0.13129 DF 158 
Upper CL Dif  -0.15392 Prob > |t| 0.0020* 
Lower CL Dif  -0.67254 Prob > t 0.9990 





Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled  
(<15 ppm to =15 ppm) 
1 4.371422 4.37142 9.9066 0.0020* 
Error 158 69.719966 0.44127   
C. Total 159 74.091388    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Equal to 15 ppm 32 1.50315 0.11743 1.2712 1.7351 
Less Than 15 ppm 128 1.08993 0.05871 0.9740 1.2059 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 








Equal to 15 ppm 32 1.50315 0.834
200 
0.14747 1.2024 1.8039 
Less Than 15 ppm 128 1.08993 0.615
722 
0.05442 0.9822 1.1976 
 
  





Less Than 15PPM-Equal to 15PPM 
Assuming unequal variances 
Difference  -0.41323 t Ratio  -2.62887 
Std Err Dif 0.15719 DF 39.83888 
Upper CL Dif  -0.09550 Prob > |t| 0.0121* 
Lower CL Dif  -0.73096 Prob > t 0.9939 










I20 (a): One-way Analysis of Lymphocyte Proliferation Quotient and Osteoarthritis 
(Yes/No) 
 
Parameters Statistics Nitrite Concentrations 
0ppm 1ppm 5ppm 10ppm 15ppm 
Lymphocyte 
Proliferation 
RSquare 0.001445 0.03937 0.13473 0.018805 0.007905 
F Ratio 0.0434 1.2295 4.6713 0.575 0.2391 
Prob > F 0.8364 0.2763 0.0388*(N) 0.4542 0.6284 
Prob>|t| 0.8364 0.2763 0.0388 0.4542 0.6284 
X axis: Osteoarthritis (Yes/No) 
Y axis: Lymphocyte proliferation at various nitrite concentrations 
Y: Yes 
N: No 







I20 (b): One-way Analysis of Lymphocyte Proliferation Quotient and Osteoarthritis 
(Yes/No) at 5 ppm nitrite concentration 
 
 
Summary of Fit 
Rsquare 0.13473 
Adj Rsquare 0.105887 
Root Mean Square Error 0.650844 
Mean of Response 1.084491 



















Assuming equal variances 
Difference  -0.49733 t Ratio  -2.16131 
Std Err Dif 0.23011 DF 30 
Upper CL Dif  -0.02739 Prob > |t| 0.0388* 
Lower CL Dif  -0.96728 Prob > t 0.9806 
Confidence 0.95 Prob < t 0.0194* 
  
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Osteoarthritis 1 1.978731 1.97873 4.6713 0.0388* 
Error 30 12.707925 0.42360   
C. Total 31 14.686656    
 
Means for Oneway Anova 
 
Level Number Mean Std Error Lower 95% Upper 95% 
No 16 1.33316 0.16271 1.0009 1.6655 
Yes 16 0.83582 0.16271 0.5035 1.1681 
Std Error uses a pooled estimate of error variance 





Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
No 80 16 1.33316 0.889725 0.22243 0.85906 




Assuming unequal variances 
 
Difference  -0.49733 t Ratio  -2.16131 
Std Err Dif 0.23011 DF 17.09615 
Upper CL Dif  -0.01206 Prob > |t| 0.0451* 
Lower CL Dif  -0.98261 Prob > t 0.9774 
Confidence 0.95 Prob < t 0.0226* 
  
 









Summary of Fit 
Rsquare 0.034782 
Adj Rsquare 0.005533 
Root Mean Square Error 3.882916 
Mean of Response 1.479745 
Observations (or Sum Wgts) 137 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 71.7169 17.9292 1.1892 0.3186 
Error 132 1990.1687 15.0770   













Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
0 25 1.17780 0.77658  -0.358 2.7140 
1 28 2.68429 0.73380 1.233 4.1358 
5 25 0.50808 0.77658  -1.028 2.0442 
10 30 1.15733 0.70892  -0.245 2.5596 
15 29 1.74821 0.72104 0.322 3.1745 
 
Std Error uses a pooled estimate of error variance 
 
Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
0 25 1.17780 1.73608 0.3472 0.4612 1.8944 
1 28 2.68429 8.00823 1.5134  -0.4210 5.7896 
5 25 0.50808 0.55047 0.1101 0.2809 0.7353 
10 30 1.15733 1.06698 0.1948 0.7589 1.5558 











Summary of Fit 
Rsquare 0.023556 
Adj Rsquare  -0.02408 
Root Mean Square Error 2.89517 
Mean of Response 1.308391 
Observations (or Sum Wgts) 87 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 16.58100 4.14525 0.4945 0.7397 
Error 82 687.32483 8.38201   













Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
0 16 1.45669 0.72379 0.0168 2.8965 
1 16 1.70100 0.72379 0.2611 3.1409 
5 18 0.69439 0.68240  -0.6631 2.0519 
10 19 0.95526 0.66420  -0.3660 2.2766 
15 18 1.81433 0.68240 0.4568 3.1718 
 
Std Error uses a pooled estimate of error variance 
 
Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
0 16 1.45669 2.91719 0.7293  -0.0978 3.0111 
1 16 1.70100 3.62035 0.9051  -0.2281 3.6301 
5 18 0.69439 0.88888 0.2095 0.2524 1.1364 
10 19 0.95526 1.22091 0.2801 0.3668 1.5437 










Summary of Fit 
Rsquare 0.033657 
Adj Rsquare 0.007181 
Root Mean Square Error 2.43232 
Mean of Response 1.288479 
Observations (or Sum Wgts) 151 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 30.08376 7.52094 1.2712 0.2840 
Error 146 863.76218 5.91618   














Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
0 31 1.31915 0.43686 0.456 2.1825 
1 31 1.99191 0.43686 1.129 2.8553 
5 27 0.58130 0.46810  -0.344 1.5064 
10 31 1.10263 0.43686 0.239 1.9660 
15 31 1.35615 0.43686 0.493 2.2195 
 
Std Error uses a pooled estimate of error variance 
 
Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
0 31 1.31915 2.08966 0.37531 0.55266 2.0856 
1 31 1.99191 4.68497 0.84145 0.27345 3.7104 
5 27 0.58130 0.52301 0.10065 0.37441 0.7882 
10 31 1.10263 0.96355 0.17306 0.74920 1.4561 






I24: One-way Analysis of Nitric Oxide by Live Cells in Nitrite Concentration Pooled 
(Less Than 5 ppm to Equal or More Than 5 ppm) 
 
 
Summary of Fit 
Rsquare 0.010228 
Adj Rsquare 0.002896 
Root Mean Square Error 3.88806 
Mean of Response 1.479745 
Observations (or Sum Wgts) 137 
 
t Test 
Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming equal variances 
Difference  -0.8056 t Ratio  -1.18112 
Std Err Dif 0.6820 DF 135 
Upper CL Dif 0.5433 Prob > |t| 0.2396 
Lower CL Dif  -2.1545 Prob > t 0.8802 





Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 
 (<5 ppm to >5 ppm) 
1 21.0890 21.0890 1.3951 0.2396 
Error 135 2040.7965 15.1170   
C. Total 136 2061.8855    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less Than 5 ppm 53 1.97368 0.53407 0.91746 3.0299 
Equal or More 
Than 5 ppm 
84 1.16810 0.42422 0.32911 2.0071 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Less Than 5 ppm 53 1.97368 5.93857 0.81573 0.33681 3.6106 
Equal or More 
Than 5 ppm 
84 1.16810 1.57897 0.17228 0.82544 1.5108 
 
  





Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming unequal variances 
Difference  -0.8056 t Ratio  -0.96625 
Std Err Dif 0.8337 DF 56.67171 
Upper CL Dif 0.8641 Prob > |t| 0.3380 
Lower CL Dif  -2.4753 Prob > t 0.8310 
Confidence 0.95 Prob < t 0.1690 
  
  




I25: One-way Analysis of Nitric Oxide by Live Cells in Nitrite Concentration Pooled 




Summary of Fit 
Rsquare 5.141e-5 
Adj Rsquare  -0.00736 
Root Mean Square Error 3.907997 
Mean of Response 1.479745 
Observations (or Sum Wgts) 137 
 
t Test 
Equal or More than10 ppm –Less than10 ppm 
Assuming equal variances 
 
Difference  -0.0562 t Ratio  -0.08331 
Std Err Dif 0.6743 DF 135 
Upper CL Dif 1.2773 Prob > |t| 0.9337 
Lower CL Dif  -1.3897 Prob > t 0.5331 





Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 1 0.1060 0.1060 0.0069 0.9337 
Error 135 2061.7795 15.2724   
C. Total 136 2061.8855    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less than10 ppm 78 1.50394 0.44249 0.62882 2.3791 
Equal or More 
than10 ppm 
59 1.44776 0.50878 0.44156 2.4540 
 
Std Error uses a pooled estimate of error variance 
 
Means and Std Deviations 






Less than 10 
ppm 
78 1.50394 4.93809 0.55913 0.39057 2.6173 
Equal or More 
than10 ppm 
59 1.44776 1.78187 0.23198 0.98340 1.9121 
 
  





Equal or More than10 ppm-Less than10 ppm 
Assuming unequal variances 
Difference  -0.0562 t Ratio  -0.0928 
Std Err Dif 0.6053 DF 101.7868 
Upper CL Dif 1.1446 Prob > |t| 0.9262 
Lower CL Dif  -1.2569 Prob > t 0.5369 
Confidence 0.95 Prob < t 0.4631 
  
  




I26: One-way Analysis of Nitric Oxide by Live Cells in Nitrite Concentration Pooled 
(Less Than 15 ppm to Equal to 15 ppm) 
 
 
Summary of Fit 
Rsquare 0.001286 
Adj Rsquare  -0.00611 
Root Mean Square Error 3.905584 
Mean of Response 1.479745 
Observations (or Sum Wgts) 137 
 
t Test 
Less Than 15PPM-Equal to 15PPM 
Assuming equal variances 
Difference  -0.3405 t Ratio  -0.41691 
Std Err Dif 0.8168 DF 135 
Upper CL Dif 1.2749 Prob > |t| 0.6774 
Lower CL Dif  -1.9560 Prob > t 0.6613 














Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 
(<15 ppm to =15 ppm) 
1 2.6513 2.6513 0.1738 0.6774 
Error 135 2059.2342 15.2536   
C. Total 136 2061.8855    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Equal to 15 ppm 29 1.74821 0.72525 0.31389 3.1825 
Less Than 15 ppm 108 1.40766 0.37581 0.66441 2.1509 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 








Equal to 15 ppm 29 1.74821 2.283
41 
0.42402 0.87965 2.6168 
Less Than 15 ppm 108 1.40766 4.228
57 
0.40689 0.60104 2.2143 
 
  





Less Than 15 ppm -Equal to 15 ppm 
Assuming unequal variances 
Difference  -0.3405 t Ratio  -0.57949 
Std Err Dif 0.5877 DF 84.54993 
Upper CL Dif 0.8280 Prob > |t| 0.5638 
Lower CL Dif  -1.5091 Prob > t 0.7181 








I27: One-way Analysis of Nitric Oxide by Dead Cells in Nitrite Concentration Pooled 
(Less Than 5 ppm to Equal or More Than 5 ppm) 
 
 
Summary of Fit 
Rsquare 0.00526 
Adj Rsquare  -0.00644 
Root Mean Square Error 2.870137 
Mean of Response 1.308391 
Observations (or Sum Wgts) 87 
 
t Test 
Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming equal variances 
Difference  -0.4278 t Ratio  -0.67041 
Std Err Dif 0.6381 DF 85 
Upper CL Dif 0.8410 Prob > |t| 0.5044 
Lower CL Dif  -1.6966 Prob > t 0.7478 






Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 
(<5 ppm to >5 ppm) 
1 3.70246 3.70246 0.4495 0.5044 
Error 85 700.20337 8.23769   
C. Total 86 703.90583    
 
Means for Oneway Anova 
Level Number Mean Std 
Error 
Lower 95% Upper 95% 
Less Than 5 ppm 32 1.57884 0.50737 0.57005 2.5876 
Equal or More 
Than 5 ppm 
55 1.15104 0.38701 0.38156 1.9205 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Less Than 5 ppm 32 1.57884 3.23654 0.57214 0.41195 2.7457 
Equal or More 
Than 5 ppm 
55 1.15104 2.63689 0.35556 0.43818 1.8639 
 
  





Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming unequal variances 
Difference  -0.4278 t Ratio  -0.63508 
Std Err Dif 0.6736 DF 54.8698 
Upper CL Dif 0.9222 Prob > |t| 0.5280 
Lower CL Dif  -1.7779 Prob > t 0.7360 








I28: One-way Analysis of Nitric Oxide by Dead Cells in Nitrite Concentration Pooled 
(Less Than 10 ppm to Equal or More Than 10 ppm) 
 
 
Summary of Fit 
Rsquare 0.000384 
Adj Rsquare  -0.01138 
Root Mean Square Error 2.877163 
Mean of Response 1.308391 
Observations (or Sum Wgts) 87 
 
t Test 
Equal or More than10 ppm –Less than10 ppm 
Assuming equal variances 
 
Difference 0.1127 t Ratio 0.180707 
Std Err Dif 0.6239 DF 85 
Upper CL Dif 1.3533 Prob > |t| 0.8570 
Lower CL Dif  -1.1278 Prob > t 0.4285 





Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 1 0.27032 0.27032 0.0327 0.8570 
Error 85 703.63551 8.27806   
C. Total 86 703.90583    
 
Means for Oneway Anova 
Level Number Mean Std 
Error 
Lower 95% Upper 95% 
Less than 10 ppm 50 1.26044 0.40689 0.45143 2.0695 
Equal or More 
than10 ppm 
37 1.37319 0.47300 0.43273 2.3136 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Less than10 ppm 50 1.26044 2.66180 0.37644 0.50396 2.0169 
Equal or More 
than10 ppm 
37 1.37319 3.14670 0.51731 0.32403 2.4224 
 
  





Equal or More than10 ppm-Less than10 ppm 
Assuming unequal variances 
Difference 0.1127 t Ratio 0.176231 
Std Err Dif 0.6398 DF 69.83314 
Upper CL Dif 1.3888 Prob > |t| 0.8606 
Lower CL Dif  -1.1633 Prob > t 0.4303 
Confidence 0.95 Prob < t 0.5697 
  
  




I29: One-way Analysis of Nitric Oxide by Dead Cells in Nitrite Concentration Pooled 
(Less Than 15 ppm to Equal to 15 ppm) 
 
 
Summary of Fit 
Rsquare 0.008253 
Adj Rsquare  -0.00341 
Root Mean Square Error 2.865815 
Mean of Response 1.308391 
Observations (or Sum Wgts) 87 
 
t Test 
Less Than 15 ppm -Equal to 15 ppm 
Assuming equal variances 
Difference  -0.6379 t Ratio  -0.84105 
Std Err Dif 0.7585 DF 85 
Upper CL Dif 0.8701 Prob > |t| 0.4027 
Lower CL Dif  -2.1460 Prob > t 0.7987 














Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 
(<15 ppm to =15 ppm) 
1 5.80958 5.80958 0.7074 0.4027 
Error 85 698.09624 8.21290   
C. Total 86 703.90583    
 
Means for Oneway Anova 
Level Number Mean Std 
Error 
Lower 95% Upper 95% 
Equal to 15 ppm 18 1.81433 0.67548 0.47130 3.1574 
Less Than 15 ppm 69 1.17641 0.34500 0.49045 1.8624 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 







Equal to 15 ppm 18 1.81433 4.35761 1.0271  -0.3527 3.9813 
Less Than 15 ppm 69 1.17641 2.34924 0.2828 0.6121 1.7408 
 
  





Less Than 15 ppm -Equal to 15 ppm 
Assuming unequal variances 
 
Difference  -0.6379 t Ratio  -0.59881 
Std Err Dif 1.0653 DF 19.64736 
Upper CL Dif 1.5869 Prob > |t| 0.5561 
Lower CL Dif  -2.8627 Prob > t 0.7219 









I30: One-way Analysis of Nitric Oxide by Total Cells (Live + Dead) in Nitrite 
Concentration Pooled (Less Than 5 ppm to Equal or More Than 5 ppm) 
 
 
Summary of Fit 
Rsquare 0.015855 
Adj Rsquare 0.00925 
Root Mean Square Error 2.429784 
Mean of Response 1.288479 
Observations (or Sum Wgts) 151 
 
t Test 
Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming equal variances 
 
Difference  -0.6227 t Ratio  -1.54935 
Std Err Dif 0.4019 DF 149 
Upper CL Dif 0.1715 Prob > |t| 0.1234 
Lower CL Dif  -1.4170 Prob > t 0.9383 





Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 
(<5 ppm to >5 ppm) 
1 14.17203 14.1720 2.4005 0.1234 
Error 149 879.67391 5.9039   
C. Total 150 893.84594    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less Than 5 ppm 62 1.65553 0.30858 1.0458 2.2653 
Equal or More 
Than 5 ppm 
89 1.03278 0.25756 0.5238 1.5417 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Less Than 5 ppm 62 1.65553 3.61346 0.45891 0.73788 2.5732 
Equal or More 
Than 5 ppm 
89 1.03278 0.97229 0.10306 0.82797 1.2376 
 
  





Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming unequal variances 
 
Difference  -0.6227 t Ratio  -1.32404 
Std Err Dif 0.4703 DF 67.18994 
Upper CL Dif 0.3160 Prob > |t| 0.1900 
Lower CL Dif  -1.5615 Prob > t 0.9050 
Confidence 0.95 Prob < t 0.0950 
  




I31: One-way Analysis of Nitric Oxide by Total Cells (Live + Dead) in Nitrite 
Concentration Pooled (Less Than 10 ppm to Equal or More Than 10 ppm) 
 
 
Summary of Fit 
Rsquare 0.000411 
Adj Rsquare  -0.0063 
Root Mean Square Error 2.448775 
Mean of Response 1.288479 
Observations (or Sum Wgts) 151 
 
t Test 
Equal or More than 10 ppm –Less than 10 ppm 
Assuming equal variances 
 
Difference  -0.10025 t Ratio  -0.24748 
Std Err Dif 0.40509 DF 149 
Upper CL Dif 0.70020 Prob > |t| 0.8049 
Lower CL Dif  -0.90071 Prob > t 0.5976 





Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 1 0.36727 0.36727 0.0612 0.8049 
Error 149 893.47867 5.99650   
C. Total 150 893.84594    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less than 10 
ppm 
89 1.32964 0.25957 0.81673 1.8426 
Equal or More 
than10 ppm 
62 1.22939 0.31099 0.61486 1.8439 
 
Std Error uses a pooled estimate of error variance 
 
Means and Std Deviations 






Less than 10 
ppm 
89 1.32964 3.06242 0.32462 0.68454 1.9747 
Equal or More 
than10 ppm 
62 1.22939 1.05720 0.13426 0.96091 1.4979 
 
  





Equal or More than 10 ppm-Less than10 ppm 
Assuming unequal variances 
 
Difference  -0.10025 t Ratio  -0.28538 
Std Err Dif 0.35129 DF 115.7955 
Upper CL Dif 0.59553 Prob > |t| 0.7759 
Lower CL Dif  -0.79603 Prob > t 0.6121 
Confidence 0.95 Prob < t 0.3879 
  
  




I32: One-way Analysis of Nitric Oxide by Total Cells (Live + Dead) in Nitrite 
Concentration Pooled (Less Than 15 ppm to Equal to 15 ppm) 
 
Summary of Fit 
Rsquare 0.0002 
Adj Rsquare  -0.00651 
Root Mean Square Error 2.449034 
Mean of Response 1.288479 
Observations (or Sum Wgts) 151 
 
t Test 
Less Than 15 ppm-Equal to 15 ppm 
Assuming equal variances 
Difference  -0.0852 t Ratio  -0.17258 
Std Err Dif 0.4934 DF 149 
Upper CL Dif 0.8898 Prob > |t| 0.8632 
Lower CL Dif  -1.0601 Prob > t 0.5684 















Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 
(<15 ppm to =15 ppm) 
1 0.17863 0.17863 0.0298 0.8632 
Error 149 893.66731 5.99777   
C. Total 150 893.84594    
 
Means for Oneway Anova 






Equal to 15 ppm 31 1.35615 0.43986 0.48698 2.2253 
Less Than 15 ppm 120 1.27100 0.22357 0.82923 1.7128 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Equal to 15 ppm 31 1.35615 1.14497 0.20564 0.93617 1.7761 
Less Than 15 ppm 120 1.27100 2.67942 0.24460 0.78667 1.7553 
 
  





Less Than 15 ppm -Equal to 15 ppm 
Assuming unequal variances 
 
Difference  -0.08515 t Ratio  -0.26647 
Std Err Dif 0.31956 DF 116.264 
Upper CL Dif 0.54776 Prob > |t| 0.7904 
Lower CL Dif  -0.71806 Prob > t 0.6048 








I33: One-way Analysis of Nitric Oxide Activity among Osteoarthritis 
Parameters Statistics Nitrite Concentrations 
0 ppm 1 ppm 5 ppm 10 ppm 15 ppm 
NO activity 
with Live Cells 
RSquare 0.058796 0.026538 0.02177 1.8957 0.014335 
F Ratio 1.4368 0.7088 0.5119 1.8957 0.3927 
Prob > F 0.2429 0.4075 0.4815 0.1795 0.5362 




RSquare 0.039804 0.106268 0.006211 0.017949 0.088011 
F Ratio 0.5803 1.6647 0.1 0.3107 1.5441 
Prob > F 0.4588 0.2179 0.7559 0.5845 0.2319 
Prob>|t| 0.4588 0.2179 0.7559 0.5845 0.2319 
NO activity 
Total Cells 
RSquare 0.035454 0.01815 0.013109 0.036438 0.005578 
F Ratio 1.066 0.5361 0.3321 1.0967 0.1627 
Prob > F 0.3104 0.4699 0.5696 0.3037 0.6897 
Prob>|t| 0.3104 0.4699 0.5696 0.3037 0.6897 
X axis: Osteoarthritis (Yes/No) 







I34: One-way Analysis of pATM activity at Various Nitrite Concentration 
 
Summary of Fit 
Rsquare 0.072527 
Adj Rsquare 0.03306 
Root Mean Square Error 1.053149 
Mean of Response 0.819869 
Observations (or Sum Wgts) 99 
 
Analysis of Variance 
 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 8.15279 2.03820 1.8377 0.1281 
Error 94 104.25760 1.10912   















Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
0 22 0.50341 0.22453 0.0576 0.9492 
1 18 0.43894 0.24823  -0.0539 0.9318 
5 18 1.03872 0.24823 0.5459 1.5316 
10 22 1.01609 0.22453 0.5703 1.4619 
15 19 1.11263 0.24161 0.6329 1.5924 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
0 22 0.50341 0.71463 0.15236 0.18656 0.8203 
1 18 0.43894 0.65637 0.15471 0.11254 0.7653 
5 18 1.03872 0.98809 0.23289 0.54736 1.5301 
10 22 1.01609 1.48250 0.31607 0.35879 1.6734 






I35: One-way Analysis of pH2AX activity at Various Nitrite Concentration 
 
Summary of Fit 
Rsquare 0.037396 
Adj Rsquare 0.004203 
Root Mean Square Error 1.355492 
Mean of Response 1.084256 
Observations (or Sum Wgts) 121 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 8.27999 2.07000 1.1266 0.3474 
Error 116 213.13363 1.83736   













Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
0 22 1.29073 0.28899 0.71834 1.8631 
1 24 0.92967 0.27669 0.38165 1.4777 
5 26 1.00242 0.26583 0.47591 1.5289 
10 24 0.73725 0.27669 0.18923 1.2853 
15 25 1.46920 0.27110 0.93226 2.0061 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
0 22 1.29073 1.86202 0.39698 0.46516 2.1163 
1 24 0.92967 1.04170 0.21264 0.48980 1.3695 
5 26 1.00242 1.09093 0.21395 0.56179 1.4431 
10 24 0.73725 0.91986 0.18776 0.34883 1.1257 






I36: One-way Analysis of DNA Double Strand Break at Various Nitrite Concentration 
 
Summary of Fit 
Rsquare 0.039747 
Adj Rsquare 0.010201 
Root Mean Square Error 1.321773 
Mean of Response 1.192022 
Observations (or Sum Wgts) 135 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 9.40107 2.35027 1.3453 0.2567 
Error 130 227.12096 1.74708   













Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
0 28 1.09593 0.24979 0.6017 1.5901 
1 26 1.16038 0.25922 0.6475 1.6732 
5 26 1.21512 0.25922 0.7023 1.7280 
10 28 1.64107 0.24979 1.1469 2.1353 
15 27 0.83422 0.25438 0.3310 1.3375 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 
 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
0 28 1.09593 0.93946 0.17754 0.73164 1.4602 
1 26 1.16038 1.38763 0.27214 0.59991 1.7209 
5 26 1.21512 1.05718 0.20733 0.78811 1.6421 
10 28 1.64107 1.90945 0.36085 0.90066 2.3815 







I37: One-way Analysis of Total DNA Damage at Various Nitrite Concentration 
 
Summary of Fit 
Rsquare 0.020406 
Adj Rsquare  -0.00643 
Root Mean Square Error 2.036341 
Mean of Response 1.327411 
Observations (or Sum Wgts) 151 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration 4 12.61116 3.15279 0.7603 0.5527 
Error 146 605.41618 4.14669   













Means for Oneway ANOVA 
Level Number Mean Std Error Lower 95% Upper 95% 
0 30 1.24830 0.37178 0.5135 1.9831 
1 30 0.97857 0.37178 0.2438 1.7133 
5 30 1.08683 0.37178 0.3521 1.8216 
10 32 1.73725 0.35998 1.0258 2.4487 
15 29 1.56676 0.37814 0.8194 2.3141 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 
Level Number Mean Std Dev Std Err Mean Lower 95% Upper 95% 
0 30 1.24830 1.22793 0.22419 0.78978 1.7068 
1 30 0.97857 0.81706 0.14917 0.67347 1.2837 
5 30 1.08683 0.87014 0.15886 0.76192 1.4117 
10 32 1.73725 2.71519 0.47998 0.75832 2.7162 









I38: One-way Analysis of pATM activity in Nitrite Concentration Pooled (Less Than 5 
ppm to Equal or More Than 5 ppm) 
 
Summary of Fit 
Rsquare 0.071261 
Adj Rsquare 0.061687 
Root Mean Square Error 1.037443 
Mean of Response 0.819869 
Observations (or Sum Wgts) 99 
 
t Test 
Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming equal variances 
Difference 0.57968 t Ratio 2.728137 
Std Err Dif 0.21248 DF 97 
Upper CL Dif 1.00141 Prob > |t| 0.0076* 
Lower CL Dif 0.15796 Prob > t 0.0038* 






Analysis of Variance 
 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled 
(<5 ppm to >5 ppm) 
1 8.01052 8.01052 7.4427 0.0076* 
Error 97 104.39988 1.07629   
C. Total 98 112.41040    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less Than 5 ppm 40 0.47440 0.16403 0.14884 0.8000 
Equal or More 
Than 5 ppm 
59 1.05408 0.13506 0.78602 1.3221 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Less Than 5 ppm 40 0.47440 0.68105 0.10768 0.25659 0.6922 
Equal or More 
Than 5 ppm 
59 1.05408 1.21988 0.15881 0.73618 1.3720 
 
  





Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming unequal variances 
 
Difference 0.579685 t Ratio 3.021074 
Std Err Dif 0.191880 DF 94.03194 
Upper CL Dif 0.960666 Prob > |t| 0.0032* 
Lower CL Dif 0.198704 Prob > t 0.0016* 
Confidence 0.95 Prob < t 0.9984 
  
  




I39: One-way Analysis of pH2AX activity in Nitrite Concentration Pooled (Less Than 5 
ppm to Equal or More Than 5 ppm) 
 
 
Summary of Fit 
Rsquare 0.00011 
Adj Rsquare  -0.00829 
Root Mean Square Error 1.36397 
Mean of Response 1.084256 
Observations (or Sum Wgts) 121 
 
t Test 
Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming equal variances 
 
Difference  -0.02919 t Ratio  -0.11427 
Std Err Dif 0.25544 DF 119 
Upper CL Dif 0.47661 Prob > |t| 0.9092 
Lower CL Dif  -0.53498 Prob > t 0.5454 





Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled  
(<5 ppm to >5 ppm) 
1 0.02429 0.02429 0.0131 0.9092 
Error 119 221.38934 1.86041   
C. Total 120 221.41363    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less Than 5 ppm 46 1.10235 0.20111 0.70414 1.5006 
Equal or More 
Than 5 ppm 
75 1.07316 0.15750 0.76130 1.3850 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Less Than 5 ppm 46 1.10235 1.48521 0.21898 0.66129 1.5434 
Equal or More 
Than 5 ppm 
75 1.07316 1.28466 0.14834 0.77759 1.3687 
 
  





Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming unequal variances 
 
Difference  -0.02919 t Ratio  -0.11035 
Std Err Dif 0.26450 DF 84.90273 
Upper CL Dif 0.49671 Prob > |t| 0.9124 
Lower CL Dif  -0.55509 Prob > t 0.5438 








I40: One-way Analysis of DNA Double Strand Break in Nitrite Concentration Pooled 
(Less Than 5 ppm to Equal or More Than 5 ppm) 
 
Summary of Fit 
Rsquare 0.001611 
Adj Rsquare  -0.0059 
Root Mean Square Error 1.332478 
Mean of Response 1.192022 
Observations (or Sum Wgts) 135 
 
t Test 
Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming equal variances 
Difference 0.10843 t Ratio 0.463202 
Std Err Dif 0.23409 DF 133 
Upper CL Dif 0.57146 Prob > |t| 0.6440 
Lower CL Dif  -0.35459 Prob > t 0.3220 






Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled  
(<5 ppm to >5 ppm) 
1 0.38094 0.38094 0.2146 0.6440 
Error 133 236.14109 1.77550   
C. Total 134 236.52203    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less Than 5 ppm 54 1.12696 0.18133 0.76830 1.4856 
Equal or More 
Than 5 ppm 
81 1.23540 0.14805 0.94255 1.5282 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Less Than 5 ppm 54 1.12696 1.16574 0.15864 0.80878 1.4451 
Equal or More 
Than 5 ppm 
81 1.23540 1.43229 0.15914 0.91869 1.5521 
 
  





Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming unequal variances 
 
Difference 0.10843 t Ratio 0.482553 
Std Err Dif 0.22470 DF 127.683 
Upper CL Dif 0.55306 Prob > |t| 0.6302 
Lower CL Dif  -0.33620 Prob > t 0.3151 










I41: One-way Analysis of Total DNA Damage in Nitrite Concentration Pooled (Less 
Than 5 ppm to Equal or More Than 5 ppm) 
 
Summary of Fit 
Rsquare 0.007376 
Adj Rsquare 0.000714 
Root Mean Square Error 2.029098 
Mean of Response 1.327411 
Observations (or Sum Wgts) 151 
 
t Test 
Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming equal variances 
Difference 0.3551 t Ratio 1.052223 
Std Err Dif 0.3374 DF 149 
Upper CL Dif 1.0218 Prob > |t| 0.2944 
Lower CL Dif  -0.3117 Prob > t 0.1472 





Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Concentration Pooled  
(<5 ppm to >5 ppm) 
1 4.55850 4.55850 1.1072 0.2944 
Error 149 613.46884 4.11724   
C. Total 150 618.02734    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
Less Than 5 ppm 60 1.11343 0.26196 0.5958 1.6311 
Equal or More 
Than 5 ppm 
91 1.46849 0.21271 1.0482 1.8888 
 
Std Error uses a pooled estimate of error variance 
Means and Std Deviations 






Less Than 5 ppm 60 1.11343 1.04296 0.13465 0.84401 1.3829 
Equal or More 
Than 5 ppm 
91 1.46849 2.47047 0.25898 0.95399 1.9830 
 
  





Equal or More Than 5 ppm -Less Than 5 ppm 
Assuming unequal variances 
Difference 0.35506 t Ratio 1.216435 
Std Err Dif 0.29189 DF 130.6678 
Upper CL Dif 0.93250 Prob > |t| 0.2260 
Lower CL Dif  -0.22237 Prob > t 0.1130 
Confidence 0.95 Prob < t 0.8870 
  
  




I42: One-way Analysis of DNA Damage among Osteoarthritis 
Parameters Statistics Nitrite Concentrations 
0ppm 1ppm 5ppm 10ppm 15ppm 
 
pATM 
RSquare 0.003328 0.023545 0.005007 0.061054 0.006008 
F Ratio 0.0668 0.3858 0.0805 1.3005 0.1028 
Prob > F 0.7987 0.5433 0.7802 0.2676 0.7525 




RSquare 0.012947 0.030897 0.073338 0.003254 0.084477 
F Ratio 0.2623 0.7014 1.8994 0.0718 2.1223 
Prob > F 0.6141 0.4113 0.1809 0.7912 0.1587 
Prob>|t| 0.6141 0.4113 0.1809 0.7912 0.1587 
DNA Double-
strand Break 
RSquare 0.000465 0.140188 0.075186 0.002201 0.08635 
F Ratio 0.0121 3.9131 1.9512 0.0573 2.3628 
Prob > F 0.9132 0.0595 0.1752 0.8126 0.1368 
Prob>|t| 0.9132 0.0595 0.1752 0.8126 0.1368 
Total DNA 
Damage 
RSquare 0.074075 0.046181 0.014946 0.004802 0.051692 
F Ratio 2.24 1.3557 0.4248 0.1448 1.4718 
Prob > F 0.1457 0.2541 0.5199 0.7063 0.2356 
Prob>|t| 0.1457 0.2541 0.5199 0.7063 0.2356 
X axis: Osteoarthritis (Yes/No) 








I43: Multivariate Regression on City of Residence and Lymphocyte Proliferation 
 
Stepwise Fit for City 
Stepwise Regression Control 
 
Stopping Rule: Minimum BIC 
Direction: Forward 
Rules:        Combine 
  
8 rows not used due to excluded rows or missing values. 
 
 -LogLikelihood p RSquare AICc BIC 




Lock Entered Parameter Estimate nDF Wald/Score 
ChiSq 
"Sig Prob" 
[x] [x] Intercept[Cedar Falls]  -0.3794896 1 0 1 
[ ] [ ] Lymphocyte Proliferation 
Quotient 0 ppm 
0 1 0.120402 0.7286 
[ ] [ ] Lymphocyte Proliferation 
Quotient 1 ppm 
0 1 3.178482 0.07461 
[ ] [ ] Lymphocyte Proliferation 
Quotient 5 ppm 
0 1 4.353414 0.03693* 
[ ] [ ] Lymphocyte Proliferation 
Quotient 10 ppm 
0 1 2.812766 0.09352 
[ ] [ ] Lymphocyte Proliferation 
Quotient 15 ppm 







I44: Multivariate Regression on Osteoarthritis (Yes/No) and Lymphocyte Proliferation 
 
Stepwise Fit for Osteoarthritis 
Stepwise Regression Control 
 
Stopping Rule: Minimum BIC 
Direction: Forward 
Rules:        Combine 
  
8 rows not used due to excluded rows or missing values. 
 
 -LogLikelihood p RSquare AICc BIC 




Lock Entered Parameter Estimate nDF Wald/Score 
ChiSq 
"Sig Prob" 
[x] [x] Intercept[No]  -9.835e-15 1 0 1 
[ ] [ ] Lymphocyte Proliferation 
Quotient 0 ppm 
0 1 0.046226 0.82977 
[ ] [ ] Lymphocyte Proliferation 
Quotient 1 ppm 
0 1 1.25985 0.26168 
[ ] [ ] Lymphocyte Proliferation 
Quotient 5 ppm 
0 1 4.311354 0.03786* 
[ ] [ ] Lymphocyte Proliferation 
Quotient 10 ppm 
0 1 0.601773 0.4379 
[ ] [ ] Lymphocyte Proliferation 
Quotient 15 ppm 








I45: Multivariate Regression on Number of Medications and Lymphocyte Proliferation 
 
Stepwise Fit for Medication Count 
Stepwise Regression Control 
 
Stopping Rule: Minimum BIC 
Direction: Forward 
  
8 rows not used due to excluded rows or missing values. 
 
SSE DFE RMSE RSquare RSquare Adj Cp p AICc BIC 








[x] [x] Intercept 1.888 1 0 0.000 1 
[ ] [ ] Lymphocyte Proliferation 
Quotient 0 ppm 
0 1 1.675842 0.407 0.5294 
[ ] [ ] Lymphocyte Proliferation 
Quotient 1 ppm 
0 1 3.467237 0.857 0.36356 
[ ] [ ] Lymphocyte Proliferation 
Quotient 5 ppm 
0 1 12.26922 3.320 0.08044 
[ ] [ ] Lymphocyte Proliferation 
Quotient 10 ppm 
0 1 1.614115 0.392 0.53714 
[ ] [ ] Lymphocyte Proliferation 
Quotient 15 ppm 








I46: Multivariate Regression on Age and DNA Damage 
 
Stepwise Fit for Age 
Stepwise Regression Control 
 
Stopping Rule: Minimum BIC 
Direction: Forward 
  
30 rows not used due to excluded rows or missing values. 
SSE DFE RMSE RSquare RSquare Adj Cp p AICc BIC 








[x] [x] Intercept 54.8 1 0 0.000 1 
[ ] [ ] pATM 0 ppm 0 1 27.04864 1.131 0.36559 
[ ] [ ] pATM 1 ppm 0 1 39.75183 2.020 0.25039 
[ ] [ ] pATM 5 ppm 0 1 16.53261 0.603 0.49408 
[ ] [ ] pATM 10 ppm 0 1 3.675664 0.116 0.75595 
[ ] [ ] pATM 15 ppm 0 1 12.91405 0.451 0.54991 
[ ] [ ] DNA Double Strand Break 0 ppm 0 1 6.849604 0.223 0.66867 
[ ] [ ] DNA Double Strand Break 1 ppm 0 1 17.05106 0.626 0.48669 
[ ] [ ] DNA Double Strand Break 5 ppm 0 1 79.45266 12.320 0.0392* 
[ ] [ ] DNA Double Strand Break 10 ppm 0 1 0.717183 0.022 0.89165 
[ ] [ ] DNA Double Strand Break 15 ppm 0 1 51.04381 3.207 0.17127 
[ ] [ ] pH2AX 0 ppm 0 1 39.69554 2.015 0.25083 
[ ] [ ] pH2AX 1 ppm 0 1 0.00242 0.000 0.9937 
[ ] [ ] pH2AX 5 ppm 0 1 2.446449 0.076 0.80048 
[ ] [ ] pH2AX 10 ppm 0 1 6.546395 0.213 0.67591 
[ ] [ ] pH2AX 15 ppm 0 1 0.090438 0.003 0.96148 
[ ] [ ] Total DNA Damage 0 ppm 0 1 34.58279 1.616 0.29331 
[ ] [ ] Total DNA Damage 1 ppm 0 1 16.16394 0.587 0.49941 
[ ] [ ] Total DNA Damage 5 ppm 0 1 44.08672 2.417 0.21784 
[ ] [ ] Total DNA Damage 10 ppm 0 1 9.481657 0.318 0.61197 







I47: Multivariate Regression on Drinking Water Source and DNA Damage 
 
Stepwise Fit for Drinking Water Source 
Stepwise Regression Control 
 
Stopping Rule: Minimum BIC 
Direction: Forward 
Rules:        Combine 
  
 -LogLikelihood p RSquare AICc BIC 








[x] [x] Intercept[City Water] 0.405 1 0 1 
[ ] [ ] pATM 0 ppm 0 1 0.032615 0.85668 
[ ] [ ] pATM 1 ppm 0 1 4.778267 0.02882* 
[ ] [ ] pATM 5 ppm 0 1 0.000392 0.9842 
[ ] [ ] pATM 10 ppm 0 1 1.050069 0.30549 
[ ] [ ] pATM 15 ppm 0 1 0.032601 0.85671 
[ ] [ ] DNA Double Strand Break 0 ppm 0 1 1.279933 0.25791 
[ ] [ ] DNA Double Strand Break 1 ppm 0 1 2.491354 0.11447 
[ ] [ ] DNA Double Strand Break 5 ppm 0 1 1.387456 0.23884 
[ ] [ ] DNA Double Strand Break 10 ppm 0 1 0.000246 0.98749 
[ ] [ ] DNA Double Strand Break 15 ppm 0 1 2.15323 0.14227 
[ ] [ ] pH2AX 0 ppm 0 1 1.705646 0.19155 
[ ] [ ] pH2AX 1 ppm 0 1 0.487483 0.48505 
[ ] [ ] pH2AX 5 ppm 0 1 2.267261 0.13213 
[ ] [ ] pH2AX 10 ppm 0 1 2.330852 0.12683 
[ ] [ ] pH2AX 15 ppm 0 1 1.026954 0.31088 
[ ] [ ] Total DNA Damage 0 ppm 0 1 1.461584 0.22668 
[ ] [ ] Total DNA Damage 1 ppm 0 1 0.192698 0.66068 
[ ] [ ] Total DNA Damage e5 ppm 0 1 0.017997 0.89328 
[ ] [ ] Total DNA Damage 10 ppm 0 1 0.29513 0.58695 










I48: Multivariate Regression on Immunization and DNA Damage 
 
Stepwise Fit for Immunization 
Stepwise Regression Control 
 
Stopping Rule: Minimum BIC 
Direction: Forward 
Rules:        Combine 
  
 -LogLikelihood p RSquare AICc BIC 








[x] [x] Intercept[No] 1.3862 1 0 1 
[ ] [ ] pATM 0 ppm 0 1 0.722033 0.39548 
[ ] [ ] pATM 1 ppm 0 1 0.796378 0.37218 
[ ] [ ] pATM 5 ppm 0 1 1.719622 0.18974 
[ ] [ ] pATM 10 ppm 0 1 0.537646 0.46341 
[ ] [ ] pATM 15 ppm 0 1 1.179936 0.27737 
[ ] [ ] DNA Double Strand Break 0 ppm 0 1 0.227911 0.63308 
[ ] [ ] DNA Double Strand Break 1 ppm 0 1 4.057145 0.04398* 
[ ] [ ] DNA Double Strand Break 5 ppm 0 1 0.095652 0.75711 
[ ] [ ] DNA Double Strand Break 10 ppm 0 1 0.866967 0.3518 
[ ] [ ] DNA Double Strand Break 15 ppm 0 1 2.269595 0.13193 
[ ] [ ] pH2AX 0 ppm 0 1 0.000424 0.98358 
[ ] [ ] pH2AX 1 ppm 0 1 4.214185 0.04009* 
[ ] [ ] pH2AX 5 ppm 0 1 1.833545 0.17571 
[ ] [ ] pH2AX 10 ppm 0 1 1.494962 0.22145 
[ ] [ ] pH2AX 15 ppm 0 1 0.225537 0.63485 
[ ] [ ] T Total DNA Damage 0 ppm 0 1 0.10056 0.75116 
[ ] [ ] Total DNA Damage 1 ppm 0 1 0.909069 0.34036 
[ ] [ ] Total DNA Damage 5 ppm 0 1 0.110717 0.73933 
[ ] [ ] Total DNA Damage 10 ppm 0 1 0.822843 0.36435 








I49: Multivariate Regression on Osteoarthritis and DNA Damage 
 
Stepwise Fit for Osteoarthritis 
Stepwise Regression Control 
 
Stopping Rule: Minimum BIC 
Direction: Forward 
Rules:        Combine 
  
 -LogLikelihood p RSquare AICc BIC 








[x] [x] Intercept[No] 1.3862 1 0 1 
[ ] [ ] pATM 0 ppm 0 1 3.688841 0.05478 
[ ] [ ] pATM 1 ppm 0 1 0.796378 0.37218 
[ ] [ ] pATM 5 ppm 0 1 0.222013 0.63751 
[ ] [ ] pATM 10 ppm 0 1 0.046385 0.82948 
[ ] [ ] pATM 15 ppm 0 1 1.179936 0.27737 
[ ] [ ] DNA Double Strand Break 0 ppm 0 1 3.546542 0.05967 
[ ] [ ] DNA Double Strand Break 1 ppm 0 1 0.129993 0.71844 
[ ] [ ] DNA Double Strand Break 5 ppm 0 1 0.390455 0.53206 
[ ] [ ] DNA Double Strand Break 10 ppm 0 1 3.070727 0.07971 
[ ] [ ] DNA Double Strand Break 15 ppm 0 1 0.157687 0.69129 
[ ] [ ] pH2AX 0 ppm 0 1 4.620307 0.0316* 
[ ] [ ] pH2AX 1 ppm 0 1 0.987492 0.32036 
[ ] [ ] pH2AX 5 ppm 0 1 0.074642 0.78469 
[ ] [ ] pH2AX 10 ppm 0 1 0.68934 0.40639 
[ ] [ ] pH2AX 15 ppm 0 1 1.286918 0.25662 
[ ] [ ] Total DNA Damage 0 ppm 0 1 4.862667 0.02744* 
[ ] [ ] Total DNA Damage 1 ppm 0 1 1.604879 0.20521 
[ ] [ ] TotalDNADamage5 ppm 0 1 0.862482 0.35305 
[ ] [ ] Total DNA Damage 10 ppm 0 1 0.006232 0.93708 
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